<article title='Major_depressive_disorder'><paragraph><template><target>For</target><arg>other types of depression</arg><arg>Mood disorder</arg></template><template><target>pp-semi-indef</target></template><template><target>Use dmy dates</target><arg name="date">February 2015</arg></template><template><target>Infobox disease</target><arg name="Name"><space/>Major depressive disorder
</arg><arg name="Image"><space/>Vincent Willem van Gogh 002.jpg
</arg><arg name="Caption"><space/>[[Vincent van Gogh]]'s 1890 painting<space/><br /><space/>''[[At Eternity's Gate|Sorrowing old man ('At Eternity's Gate')]]''
</arg><arg name="Width"><space/>250
</arg><arg name="Field"><space/>[[Psychiatry]]
</arg><arg name="DiseasesDB"><space/>3589
</arg><arg name="ICD10"><space/>{{ICD10|F|32||f|30}}, {{ICD10|F|33||f|30}}
</arg><arg name="ICD9"><space/>{{ICD9|296.2}}, {{ICD9|296.3}}
</arg><arg name="ICDO">
</arg><arg name="OMIM"><space/>608516
</arg><arg name="MedlinePlus"><space/>003213
</arg><arg name="eMedicineSubj"><space/>med
</arg><arg name="eMedicineTopic"><space/>532
</arg><arg name="MeshID"><space/>D003865
</arg></template></paragraph><preblock><preline><bold>Major depressive disorder</bold><space/>(<bold>MDD</bold>) (also known as<space/><bold>clinical depression</bold>,<space/><bold>major depression</bold>,<space/><bold>unipolar depression</bold>, or<space/><bold>unipolar disorder</bold>; or as<space/><bold>recurrent depression</bold><space/>in the case of repeated episodes) is a<space/><link><target>mental disorder</target></link><space/>characterized by a pervasive and persistent<space/><link><target>depression (mood)</target><part>low mood</part></link><space/>that is accompanied by low<space/><link><target>self-esteem</target></link><space/>and by a<space/><link><target>anhedonia</target><part>loss of interest or pleasure</part></link><space/>in normally enjoyable activities. The term &quot;depression&quot; is used in a number of different ways. It is often used to mean this syndrome but may refer to other mood disorders or simply to a low mood. Major depressive disorder is a disabling condition that adversely affects a person's family, work or school life, sleeping and eating habits, and general health. In the United States, around 3.4% of people with major depression commit<space/><link><target>suicide</target></link>, and up to 60% of people who commit suicide had depression or another mood disorder.<extension extension_name='ref' name="IntegrativeSuicide"></extension></preline></preblock><preblock><preline>The diagnosis of major depressive disorder is based on the patient's self-reported experiences, behavior reported by relatives or friends, and a<space/><link><target>mental status examination</target></link>. There is no laboratory test for major depression, although physicians generally request tests for physical conditions that may cause similar symptoms. The most common time of onset is between the ages of 20 and 30 years, with a later peak between 30 and 40 years.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.health.am/psy/major-depressive-disorder/</arg><arg name="title">Major Depressive Disorder</arg><arg name="publisher">American Medical Network, Inc.</arg><arg name="accessdate">15 January 2011</arg></template></extension></preline></preblock><preblock><preline>Typically, people are treated with<space/><link><target>antidepressant</target></link><space/><link><target>Pharmaceutical drug</target><part>medication</part></link><space/>and, in many cases, also receive counseling, particularly<space/><link><target>cognitive behavioral therapy</target></link><space/>(CBT).<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Driessen Ellen, Hollon Steven D<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="title"><space/>Cognitive Behavioral Therapy for Mood Disorders: Efficacy, Moderators and Mediators<space/></arg><arg name="url"><space/></arg><arg name="journal"><space/>Psychiatric Clinics of North America<space/></arg><arg name="volume"><space/>33<space/></arg><arg name="issue"><space/>3</arg><arg name="pages"><space/>537–55<space/></arg><arg name="doi">10.1016/j.psc.2010.04.005</arg></template></extension><space/>Medication appears to be effective, but the effect may only be significant in the most severely depressed.<extension extension_name='ref' name="Fournier_etal2010"><template><target>cite journal</target><arg name="author"><space/>Fournier JC, DeRubeis RJ, Hollon SD, Dimidjian S, Amsterdam JD, Shelton RC, Fawcett J<space/></arg><arg name="title"><space/>Antidepressant drug effects and depression severity: a patient-level meta-analysis<space/></arg><arg name="journal"><space/>JAMA<space/></arg><arg name="volume"><space/>303<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>47–53<space/></arg><arg name="date"><space/>January 2010<space/></arg><arg name="pmid"><space/>20051569<space/></arg><arg name="pmc"><space/>3712503<space/></arg><arg name="doi"><space/>10.1001/jama.2009.1943<space/></arg><arg name="url"><space/></arg></template></extension><extension extension_name='ref' name="Kirsch_etal2008"><template><target>cite journal</target><arg name="author"><space/>Kirsch I, Deacon BJ, Huedo-Medina TB, Scoboria A, Moore TJ, Johnson BT<space/></arg><arg name="title"><space/>Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration<space/></arg><arg name="journal"><space/>PLoS Med.<space/></arg><arg name="volume"><space/>5<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>e45<space/></arg><arg name="date"><space/>February 2008<space/></arg><arg name="pmid"><space/>18303940<space/></arg><arg name="pmc"><space/>2253608<space/></arg><arg name="doi"><space/>10.1371/journal.pmed.0050045<space/></arg><arg name="url"><space/></arg></template></extension><space/>Hospitalization may be necessary in cases with associated<space/><link><target>self-neglect</target></link><space/>or a significant risk of harm to self or others. A minority are treated with<space/><link><target>electroconvulsive therapy</target></link><space/>(ECT). The course of the disorder varies widely, from one episode lasting weeks to a lifelong disorder with recurrent<space/><link><target>major depressive episode</target><trail>s</trail></link>. Depressed individuals have shorter<space/><link><target>Life expectancy</target><part>life expectancies</part></link><space/>than those without depression, in part because of greater susceptibility to medical illnesses and suicide. It is unclear whether medications affect the risk of suicide. Current and former patients may be<space/><link><target>Social stigma</target><part>stigmatized</part></link>.</preline></preblock><preblock><preline>The understanding of the nature and causes of depression has evolved over the centuries, though this understanding is incomplete and has left many aspects of depression as the subject of discussion and research. Proposed causes include<space/><link><target>Psychology</target><part>psychological</part></link>, psycho-social,<space/><link><target>heredity</target><part>hereditary</part></link>,<space/><link><target>evolution</target><trail>ary</trail></link><space/>and<space/><link><target>biology</target><part>biological</part></link><space/>factors. Long-term<space/><link><target>substance abuse</target></link><space/>may cause or worsen depressive symptoms. Psychological treatments are based on theories of<space/><link><target>Personality theory</target><part>personality</part></link>,<space/><link><target>Communication theory</target><part>interpersonal communication</part></link>, and<space/><link><target>learning theory (education)</target><part>learning</part></link>. Most biological theories focus on the<space/><link><target>monoamine neurotransmitter</target><part>monoamine</part></link><space/>chemicals<space/><link><target>serotonin</target></link>,<space/><link><target>norepinephrine</target></link><space/>and<space/><link><target>dopamine</target></link>, which are naturally present in the<space/><link><target>Human brain</target><part>brain</part></link><space/>and assist communication between<space/><link><target>Neuron</target><part>nerve cells</part></link>. This cluster of symptoms (<link><target>syndrome</target></link>) was named, described and classified as one of the<space/><link><target>mood disorder</target><trail>s</trail></link><space/>in the 1980 edition of the<space/><link><target>American Psychiatric Association</target></link>'s<space/><link><target>Diagnostic and Statistical Manual of Mental Disorders</target><part>diagnostic manual</part></link>.</preline></preblock><paragraph><template><target>TOC limit</target><arg>3</arg></template></paragraph><heading level='2'>Symptoms and signs</heading><paragraph>Major depression significantly affects a person's family and personal relationships, work or school life, sleeping and eating habits, and general health.<extension extension_name='ref' name="NIMHPub"><template><target>cite book</target><arg name="title">Depression</arg><arg name="publisher"><space/>[[National Institute of Mental Health]] (NIMH)</arg><arg name="url"><space/>https://web.archive.org/web/20110727123744/http://www.nimh.nih.gov/health/publications/depression/nimhdepression.pdf</arg><arg name="accessdate"><space/>7 September 2008</arg><arg name="format">PDF</arg></template></extension><space/>Its impact on functioning and well-being has been compared to that of chronic medical conditions such as<space/><link><target>Diabetes mellitus</target><part>diabetes</part></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Hays RD, Wells KB, Sherbourne CD, Rogers W, Spritzer K<space/></arg><arg name="title"><space/>Functioning and well-being outcomes of patients with depression compared with chronic general medical illnesses<space/></arg><arg name="journal"><space/>Archives of General Psychiatry<space/></arg><arg name="volume"><space/>52<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>11–19<space/></arg><arg name="year"><space/>1995<space/></arg><arg name="pmid"><space/>7811158<space/></arg><arg name="doi"><space/>10.1001/archpsyc.1995.03950130011002<space/></arg></template></extension></paragraph><paragraph>A person having a<space/><link><target>major depressive episode</target></link><space/>usually exhibits a very low mood, which pervades all aspects of life, and an<space/><link><target>anhedonia</target><part>inability to experience pleasure</part></link><space/>in activities that were formerly enjoyed. Depressed people may be preoccupied with, or<space/><link><target>Rumination (psychology)</target><part>ruminate</part></link><space/>over, thoughts and feelings of worthlessness, inappropriate guilt or regret, helplessness, hopelessness, and self-hatred.<extension extension_name='ref' name="APA349"><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">349</arg></template></extension><space/>In severe cases, depressed people may have symptoms of<space/><link><target>psychosis</target></link>. These symptoms include<space/><link><target>delusion</target><trail>s</trail></link><space/>or, less commonly,<space/><link><target>hallucination</target><trail>s</trail></link>, usually unpleasant.<extension extension_name='ref'><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">412</arg></template></extension><space/>Other symptoms of depression include poor concentration and memory (especially in those with<space/><link><target>Depression (mood)</target><part>melancholic</part></link><space/>or psychotic features),<extension extension_name='ref' name="Delgado"><template><target>cite journal</target><arg name="author">Delgado PL and Schillerstrom J<space/></arg><arg name="title">Cognitive Difficulties Associated With Depression: What Are the Implications for Treatment?<space/></arg><arg name="journal">Psychiatric Times<space/></arg><arg name="volume">26<space/></arg><arg name="issue">3<space/></arg><arg name="year">2009<space/></arg><arg name="url">http://www.psychiatrictimes.com/display/article/10168/1387631</arg></template></extension><space/>withdrawal from social situations and activities, reduced<space/><link><target>libido</target><part>sex drive</part></link>, and thoughts of death or suicide.<space/><link><target>Insomnia</target></link><space/>is common among the depressed. In the typical pattern, a person wakes very early and cannot get back to sleep.<extension extension_name='ref' name="APA350"><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">350</arg></template></extension><space/><link><target>Hypersomnia</target></link>, or oversleeping, can also happen.<extension extension_name='ref' name="APA350"></extension><space/>Some antidepressants may also cause insomnia due to their stimulating effect.<extension extension_name='ref'><template><target>cite journal</target><arg name="url">http://www.aafp.org/afp/990600ap/3029.html</arg><arg name="title">Insomnia: Assessment and Management in Primary Care</arg><arg name="journal">[[American Family Physician]]</arg><arg name="volume">59</arg><arg name="issue">11</arg><arg name="pages">3029–38</arg><arg name="year">1999</arg><arg name="accessdate">12 November 2014</arg></template></extension></paragraph><paragraph>A depressed person may report multiple physical symptoms such as fatigue, headaches, or digestive problems; physical complaints are the most common presenting problem in developing countries, according to the<space/><link><target>World Health Organization</target></link>'s criteria for depression.<extension extension_name='ref' name="Patel01"><template><target>cite journal</target><arg name="author">Patel V, Abas M, Broadhead J<space/></arg><arg name="year">2001</arg><arg name="title">Depression in developing countries: Lessons from Zimbabwe</arg><arg name="journal">[[BMJ]]</arg><arg name="volume">322<space/></arg><arg name="issue">7284<space/></arg><arg name="pages">482–84</arg><arg name="url">http://www.bmj.com/cgi/content/full/322/7284/482<space/></arg><arg name="doi">10.1136/bmj.322.7284.482</arg></template></extension><space/>Appetite often decreases, with resulting weight loss, although increased appetite and weight gain occasionally occur.<extension extension_name='ref' name="APA349"></extension><space/>Family and friends may notice that the person's behavior is either<space/><link><target>psychomotor agitation</target><part>agitated</part></link><space/>or<space/><link><target>psychomotor retardation</target><part>lethargic</part></link>.<extension extension_name='ref' name="APA350"></extension><space/>Older depressed people may have<space/><link><target>Cognition#Psychology</target><part>cognitive</part></link><space/>symptoms of recent onset, such as forgetfulness,<extension extension_name='ref' name="Delgado"></extension><space/>and a more noticeable slowing of movements.<extension extension_name='ref'><template><target>cite book</target><arg name="title">Consensus Guidelines for Assessment and Management of Depression in the Elderly<space/></arg><arg name="author">Faculty of Psychiatry of Old Age, NSW Branch, RANZCP<space/></arg><arg name="author2">Kitching D Raphael B</arg><arg name="year">2001<space/></arg><arg name="publisher">NSW Health Department<space/></arg><arg name="location">North Sydney, New South Wales<space/></arg><arg name="isbn">0-7347-3341-0<space/></arg><arg name="pages">2</arg><arg name="url">http://www.health.nsw.gov.au/mhdao/publications/Publications/depression-elderly.pdf</arg><arg name="format">PDF</arg></template></extension><space/>Depression often coexists with physical disorders common among the elderly, such as<space/><link><target>stroke</target></link>, other<space/><link><target>cardiovascular diseases</target></link>,<space/><link><target>Parkinson's disease</target></link>, and<space/><link><target>chronic obstructive pulmonary disease</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Yohannes AM and Baldwin RC</arg><arg name="title">Medical Comorbidities in Late-Life Depression</arg><arg name="journal">Psychiatric Times<space/></arg><arg name="volume">25<space/></arg><arg name="issue">14</arg><arg name="year">2008<space/></arg><arg name="url">http://www.psychiatrictimes.com/depression/article/10168/1358135</arg></template></extension></paragraph><paragraph>Depressed children may often display an irritable mood rather than a depressed mood,<extension extension_name='ref' name="APA349"></extension><space/>and show varying symptoms depending on age and situation.<extension extension_name='ref' name="APA354"><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">354</arg></template></extension><space/>Most lose interest in school and show a decline in academic performance. They may be described as clingy, demanding, dependent, or insecure.<extension extension_name='ref' name="APA350"></extension><space/>Diagnosis may be delayed or missed when symptoms are interpreted as normal moodiness.<extension extension_name='ref' name="APA349"></extension><space/>Depression may also coexist with<space/><link><target>attention deficit hyperactivity disorder</target></link><space/>(ADHD), complicating the diagnosis and treatment of both.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Brunsvold GL, Oepen G<space/></arg><arg name="title">Comorbid Depression in ADHD: Children and Adolescents<space/></arg><arg name="journal">Psychiatric Times<space/></arg><arg name="volume">25<space/></arg><arg name="issue">10</arg><arg name="year">2008<space/></arg><arg name="url">http://www.psychiatrictimes.com/adhd/article/10168/1286863</arg></template></extension></paragraph><heading level='3'>Comorbidity</heading><paragraph>Major depression frequently<space/><link><target>Comorbidity</target><part>co-occurs</part></link><space/>with other psychiatric problems. The 199092<space/><italics><link><target>National Comorbidity Survey</target></link></italics><space/>(US) reports that half of those with major depression also have lifetime<space/><link><target>anxiety</target></link><space/>and its associated disorders such as<space/><link><target>generalized anxiety disorder</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Kessler RC, Nelson CB, McGonagle KA, Liu J, Swartz M, Blazer DG<space/></arg><arg name="title"><space/>Comorbidity of DSM-III-R major depressive disorder in the general population: results from the US National Comorbidity Survey<space/></arg><arg name="journal"><space/>British Journal of Psychiatry<space/></arg><arg name="volume"><space/>168<space/></arg><arg name="issue"><space/>suppl 30<space/></arg><arg name="pages"><space/>17–30<space/></arg><arg name="year"><space/>1996<space/></arg><arg name="pmid"><space/>8864145<space/></arg></template></extension><space/>Anxiety symptoms can have a major impact on the course of a depressive illness, with delayed recovery, increased risk of relapse, greater disability and increased suicide attempts.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Hirschfeld RM<space/></arg><arg name="title"><space/>The Comorbidity of Major Depression and Anxiety Disorders: Recognition and Management in Primary Care<space/></arg><arg name="journal"><space/>Primary Care Companion to the Journal of Clinical Psychiatry<space/></arg><arg name="volume"><space/>3<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>244–254<space/></arg><arg name="year"><space/>2001<space/></arg><arg name="pmid"><space/>15014592<space/></arg><arg name="pmc"><space/>181193<space/></arg></template></extension><space/>American neuroendocrinologist<space/><link><target>Robert Sapolsky</target></link><space/>similarly argues that the relationship between stress, anxiety, and depression could be measured and demonstrated biologically.<extension extension_name='ref'><template><target>cite book</target><arg name="author"><space/>Sapolsky Robert M</arg><arg name="year"><space/>2004</arg><arg name="title"><space/>Why zebras don't get ulcers</arg><arg name="pages"><space/>291–98</arg><arg name="publisher"><space/>Henry Holt and Company, LLC</arg><arg name="isbn"><space/>0-8050-7369-8</arg></template></extension><space/>There are increased rates of alcohol and drug abuse and particularly dependence,<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Grant BF<space/></arg><arg name="title"><space/>Comorbidity between DSM-IV drug use disorders and major depression: Results of a national survey of adults<space/></arg><arg name="journal"><space/>Journal of Substance Abuse<space/></arg><arg name="volume"><space/>7<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>481–87<space/></arg><arg name="year"><space/>1995<space/></arg><arg name="pmid"><space/>8838629<space/></arg><arg name="doi"><space/>10.1016/0899-3289(95)90017-9<space/></arg></template></extension><space/>and around a third of individuals diagnosed with<space/><link><target>attention-deficit hyperactivity disorder</target><part>ADHD</part></link><space/>develop comorbid depression.<extension extension_name='ref'><template><target>cite book</target><arg name="title">Delivered from distraction: Getting the most out of life with Attention Deficit Disorder<space/></arg><arg name="author">Hallowell EM, Ratey JJ</arg><arg name="year">2005<space/></arg><arg name="publisher">Ballantine Books<space/></arg><arg name="location">New York</arg><arg name="isbn">0-345-44231-8<space/></arg><arg name="pages">253–55</arg></template></extension><space/><link><target>Post-traumatic stress disorder</target></link><space/>and depression often co-occur.<extension extension_name='ref' name="NIMHPub"></extension></paragraph><paragraph>Depression and<space/><link><target>pain</target></link><space/>often co-occur. One or more pain symptoms are present in 65% of depressed patients, and anywhere from 5 to 85% of patients with pain will be suffering from depression, depending on the setting; there is a lower prevalence in general practice, and higher in specialty clinics. The diagnosis of depression is often delayed or missed, and the outcome worsens. The outcome can also worsen if the depression is noticed but completely misunderstood.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Bair MJ, Robinson RL, Katon W, Kroenke K<space/></arg><arg name="title"><space/>Depression and Pain Comorbidity: A Literature Review<space/></arg><arg name="journal"><space/>Archives of Internal Medicine<space/></arg><arg name="volume"><space/>163<space/></arg><arg name="issue"><space/>20<space/></arg><arg name="pages"><space/>2433–45<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>14609780<space/></arg><arg name="doi"><space/>10.1001/archinte.163.20.2433<space/></arg><arg name="url"><space/>http://archinte.ama-assn.org/cgi/content/full/163/20/2433(fulltext)<space/></arg></template></extension></paragraph><paragraph>Depression is also associated with a 1.5- to 2-fold increased risk of<space/><link><target>cardiovascular disease</target></link>, independent of other known risk factors, and is itself linked directly or indirectly to risk factors such as smoking and obesity. People with major depression are less likely to follow medical recommendations for treating and preventing cardiovascular disorders, which further increases their risk of medical complications.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Swardfager W, Herrmann N, Marzolini S, Saleem M, Farber SB, Kiss A, Oh PI, Lanctôt KL<space/></arg><arg name="title"><space/>Major depressive disorder predicts completion, adherence, and outcomes in cardiac rehabilitation: a prospective cohort study of 195 patients with coronary artery disease.<space/></arg><arg name="journal"><space/>Journal of Clinical Psychiatry<space/></arg><arg name="volume"><space/>72<space/></arg><arg name="issue"><space/>9<space/></arg><arg name="pages"><space/>1181–8<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="pmid"><space/>21208573<space/></arg><arg name="doi"><space/>10.4088/jcp.09m05810blu<space/></arg><arg name="url"><space/>http://www.psychiatrist.com/JCP/article/Pages/2011/v72n09/v72n0904.aspx<space/></arg></template></extension><space/>In addition, cardiologists may not recognize underlying depression that complicates a cardiovascular problem under their care.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Schulman J and Shapiro BA<space/></arg><arg name="year">2008</arg><arg name="journal">Psychiatric Times</arg><arg name="volume">25<space/></arg><arg name="issue">9<space/></arg><arg name="title">Depression and Cardiovascular Disease: What Is the Correlation?</arg><arg name="url">http://www.psychiatrictimes.com/depression/article/10168/1171821</arg></template></extension></paragraph><heading level='2'>Causes</heading><paragraph>The<space/><link><target>biopsychosocial model</target></link><space/>proposes that biological, psychological, and social factors all play a role in causing depression.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Department of Health and Human Services<space/></arg><arg name="year">1999<space/></arg><arg name="url">http://www.surgeongeneral.gov/library/mentalhealth/pdfs/c2.pdf<space/></arg><arg name="title">The fundamentals of mental health and mental illness<space/></arg><arg name="work">Mental Health: A Report of the Surgeon General<space/></arg><arg name="accessdate">11 November 2008</arg><arg name="format">PDF</arg></template></extension><space/>The<space/><link><target>diathesisstress model</target></link><space/>specifies that depression results when a preexisting vulnerability, or diathesis, is activated by stressful life events. The preexisting vulnerability can be either<space/><link><target>gene</target><trail>tic</trail></link>,<extension extension_name='ref' name="Caspi"><template><target>cite journal</target><arg name="author"><space/>Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, McClay J, Mill J, Martin J, Braithwaite A, Poulton R<space/></arg><arg name="title"><space/>Influence of life stress on depression: Moderation by a polymorphism in the 5-HTT gene<space/></arg><arg name="journal"><space/>Science<space/></arg><arg name="volume"><space/>301<space/></arg><arg name="issue"><space/>5631<space/></arg><arg name="pages"><space/>386–89<space/></arg><arg name="date"><space/>July 2003<space/></arg><arg name="pmid"><space/>12869766<space/></arg><arg name="doi"><space/>10.1126/science.1083968<space/></arg><arg name="bibcode"><space/>2003Sci...301..386C<space/></arg></template></extension><extension extension_name='ref' name="pmid18181793"><template><target>cite journal</target><arg name="author"><space/>Haeffel GJ, Getchell M, Koposov RA, Yrigollen CM, Deyoung CG, Klinteberg BA, Oreland L, Ruchkin VV, Grigorenko EL<space/></arg><arg name="title"><space/>Association between polymorphisms in the dopamine transporter gene and depression: evidence for a gene-environment interaction in a sample of juvenile detainees<space/></arg><arg name="journal"><space/>Psychol Sci<space/></arg><arg name="volume"><space/>19<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>62–9<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18181793<space/></arg><arg name="doi"><space/>10.1111/j.1467-9280.2008.02047.x<space/></arg><arg name="url"><space/>http://www.nd.edu/~ghaeffel/Resources/Haeffel%20et%20al.,%202008.pdf<space/></arg><arg name="format">PDF</arg></template></extension><space/>implying an interaction between<space/><link><target>nature and nurture</target></link>, or<space/><link><target>Schema (psychology)</target><part>schematic</part></link>, resulting from views of the world learned in childhood.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Slavich GM</arg><arg name="year">2004<space/></arg><arg name="url">http://www.psychologicalscience.org/observer/getArticle.cfm?id</arg><arg name="title">Deconstructing depression: A diathesis-stress perspective (Opinion)<space/></arg><arg name="work">APS Observer<space/></arg><arg name="accessdate">11 November 2008</arg></template></extension></paragraph><paragraph>Depression may be directly caused by damage to the<space/><link><target>cerebellum</target></link><space/>as is seen in<space/><link><target>cerebellar cognitive affective syndrome</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Schmahmann JD<space/></arg><arg name="title"><space/>Disorders of the cerebellum: ataxia, dysmetria of thought, and the cerebellar cognitive affective syndrome<space/></arg><arg name="journal"><space/>J Neuropsychiatry Clin Neurosci<space/></arg><arg name="volume"><space/>16<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>367–78<space/></arg><arg name="year"><space/>2004<space/></arg><arg name="pmid"><space/>15377747<space/></arg><arg name="doi"><space/>10.1176/appi.neuropsych.16.3.367<space/></arg><arg name="url"><space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Konarski JZ, McIntyre RS, Grupp LA, Kennedy SH<space/></arg><arg name="title"><space/>Is the cerebellum relevant in the circuitry of neuropsychiatric disorders?<space/></arg><arg name="journal"><space/>J Psychiatry Neurosci<space/></arg><arg name="volume"><space/>30<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>178–86<space/></arg><arg name="date"><space/>May 2005<space/></arg><arg name="pmid"><space/>15944742<space/></arg><arg name="url"><space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Schmahmann JD, Weilburg JB, Sherman JC<space/></arg><arg name="title"><space/>The neuropsychiatry of the cerebellum – insights from the clinic<space/></arg><arg name="journal"><space/>Cerebellum<space/></arg><arg name="volume"><space/>6<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>254–67<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17786822<space/></arg><arg name="doi"><space/>10.1080/14734220701490995<space/></arg><arg name="url"><space/></arg></template></extension></paragraph><paragraph>These interactive models have gained<space/><link><target>empirical</target></link><space/>support. For example, researchers in New Zealand took a<space/><link><target>Prospective cohort study</target><part>prospective approach</part></link><space/>to studying depression, by<space/><link><target>Longitudinal study</target><part>documenting over time</part></link><space/>how depression emerged among an initially<space/><link><target>Normality (behavior)</target><part>normal</part></link><space/><link><target>Cohort (statistics)</target><part>cohort</part></link><space/>of people. The researchers concluded that variation among the<space/><link><target>serotonin transporter</target></link><space/>(5-HTT) gene<space/><link><target>Moderation (statistics)</target><part>affects the chances</part></link><space/>that people who have dealt with very stressful life events will go on to experience depression. To be specific, depression may follow such events, but seems more likely to appear in people with one or two short<space/><link><target>allele</target><trail>s</trail></link><space/>of the 5-HTT gene.<extension extension_name='ref' name="Caspi"></extension><space/>In addition, a Swedish study estimated the<space/><link><target>heritability</target></link><space/>of depressionthe degree to which individual differences in occurrence are associated with genetic differencesto be around 40% for women and 30% for men,<extension extension_name='ref' name="pmid16390897"><template><target>cite journal</target><arg name="author"><space/>Kendler KS, Gatz M, Gardner CO, Pedersen NL<space/></arg><arg name="title"><space/>A Swedish national twin study of lifetime major depression<space/></arg><arg name="journal"><space/>American Journal of Psychiatry<space/></arg><arg name="volume"><space/>163<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>109–14<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16390897<space/></arg><arg name="doi"><space/>10.1176/appi.ajp.163.1.109<space/></arg></template></extension><space/>and<space/><link><target>evolutionary psychology</target><part>evolutionary psychologists</part></link><space/>have proposed that the genetic basis for depression lies deep in the history of<space/><link><target>natural selection</target><part>naturally selected</part></link><space/><link><target>adaptation</target><trail>s</trail></link>. A<space/><link><target>Substance induced mood disorder</target><part>substance-induced mood disorder</part></link><space/>resembling major depression has been causally linked to long-term<space/><link><target>Recreational drug use</target><part>drug use</part></link><space/>or<space/><link><target>drug abuse</target></link>, or to<space/><link><target>Drug withdrawal</target><part>withdrawal</part></link><space/>from certain<space/><link><target>sedative</target></link><space/>and<space/><link><target>hypnotic</target><part>hypnotic drugs</part></link>.<extension extension_name='ref' name="pmid9210745"><template><target>cite journal</target><arg name="author"><space/>Schuckit MA, Tipp JE, Bergman M, Reich W, Hesselbrock VM, Smith TL<space/></arg><arg name="title"><space/>Comparison of induced and independent major depressive disorders in 2,945 alcoholics<space/></arg><arg name="journal"><space/>Am J Psychiatry<space/></arg><arg name="volume"><space/>154<space/></arg><arg name="issue"><space/>7<space/></arg><arg name="pages"><space/>948–57<space/></arg><arg name="year"><space/>1997<space/></arg><arg name="pmid"><space/>9210745<space/></arg><arg name="doi">10.1176/ajp.154.7.948</arg></template></extension><extension extension_name='ref' name="ashman"><template><target>cite web</target><arg name="author"><space/>Professor Heather Ashton</arg><arg name="year"><space/>2002</arg><arg name="url"><space/>http://www.benzo.org.uk/manual/bzcha03.htm</arg><arg name="title"><space/>Benzodiazepines: How They Work and How to Withdraw</arg></template></extension></paragraph><heading level='3'>Biological</heading><paragraph><template><target>Main</target><arg>Biology of depression</arg></template></paragraph><heading level='4'>Monoamine hypothesis</heading><paragraph><link><target>Image:SynapseSchematic en.svg</target><part>thumb</part><part>250px</part><part>Diagram of a<space/><link><target>chemical synapse</target></link><space/>between two<space/><link><target>neuron</target><trail>s</trail></link>. Most antidepressants influence the overall balance of three<space/><link><target>neurotransmitters</target></link>:<space/><link><target>serotonin</target></link>,<space/><link><target>norepinephrine</target></link>, and<space/><link><target>dopamine</target></link>. Some antidepressants act on<space/><link><target>neurotransmitter receptor</target><trail>s</trail></link>.</part></link></paragraph><paragraph>Most<space/><link><target>antidepressant</target></link><space/>medications increase the levels of one or more of the monoaminesthe neurotransmitters<space/><link><target>serotonin</target></link>,<space/><link><target>norepinephrine</target></link><space/>and<space/><link><target>dopamine</target></link>in the<space/><link><target>Chemical synapse</target><part>synaptic cleft</part></link><space/>between<space/><link><target>neuron</target><trail>s</trail></link><space/>in the brain. Some medications affect the monoamine receptors directly.</paragraph><paragraph>Serotonin is hypothesized to regulate other neurotransmitter systems; decreased serotonin activity may allow these systems to act in unusual and erratic ways.<extension extension_name='ref' name="IntegrativeSerotonin"><template><target>Harvnb</target><arg>Barlow</arg><arg>2005</arg><arg name="p">226</arg></template></extension><space/>According to this &quot;permissive hypothesis&quot;, depression arises when low serotonin levels promote low levels of norepinephrine, another monoamine neurotransmitter.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Shah N, Eisner T, Farrell M, Raeder C</arg><arg name="date">July–August 1999<space/></arg><arg name="url">http://www.pswi.org/professional/pharmaco/depression.pdf<space/></arg><arg name="title">An overview of SSRIs for the treatment of depression<space/></arg><arg name="work">Journal of the Pharmacy Society of Wisconsin<space/></arg><arg name="accessdate">10 November 2008</arg><arg name="format">PDF</arg></template></extension><space/>Some antidepressants enhance the levels of norepinephrine directly, whereas others raise the levels of dopamine, a third monoamine neurotransmitter. These observations gave rise to the<space/><link><target>monoamine hypothesis</target></link><space/>of depression. In its contemporary formulation, the monoamine hypothesis postulates that a deficiency of certain neurotransmitters is responsible for the corresponding features of depression: &quot;Norepinephrine may be related to alertness and energy as well as anxiety, attention, and interest in life; [lack of] serotonin to anxiety, obsessions, and compulsions; and dopamine to attention, motivation, pleasure, and reward, as well as interest in life.&quot;<extension extension_name='ref' name="pmid18494537"><template><target>cite journal</target><arg name="author"><space/>Nutt DJ<space/></arg><arg name="title"><space/>Relationship of neurotransmitters to the symptoms of major depressive disorder<space/></arg><arg name="journal"><space/>Journal of Clinical Psychiatry<space/></arg><arg name="volume"><space/>69 Suppl E1<space/></arg><arg name="pages"><space/>4–7<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18494537<space/></arg></template></extension><space/>The proponents of this theory recommend the choice of an antidepressant with mechanism of action that impacts the most prominent symptoms. Anxious and irritable patients should be treated with<space/><link><target>SSRI</target><trail>s</trail></link><space/>or<space/><link><target>norepinephrine reuptake inhibitor</target><trail>s</trail></link>, and those experiencing a loss of energy and enjoyment of life with norepinephrine- and dopamine-enhancing drugs.<extension extension_name='ref' name="pmid18494537"></extension></paragraph><paragraph>Besides the clinical observations that drugs that increase the amount of available monoamines are effective antidepressants, advances in<space/><link><target>psychiatric genetics</target></link><space/>indicate that<space/><link><target>phenotypic variation</target></link><space/>in central monoamine function may be marginally associated with vulnerability to depression. Despite these findings, the cause of depression is not simply monoamine deficiency.<extension extension_name='ref' name="nature08"></extension><space/>In the past two decades, research has revealed multiple limitations of the monoamine hypothesis, and its explanatory inadequacy has been highlighted within the psychiatric community.<extension extension_name='ref' name="pmid10775017"><template><target>cite journal</target><arg name="author"><space/>Hirschfeld RM<space/></arg><arg name="title"><space/>History and evolution of the monoamine hypothesis of depression<space/></arg><arg name="journal"><space/>Journal of Clinical Psychiatry<space/></arg><arg name="volume"><space/>61 Suppl 6<space/></arg><arg name="pages"><space/>4–6<space/></arg><arg name="year"><space/>2000<space/></arg><arg name="pmid"><space/>10775017<space/></arg></template></extension><space/>A counterargument is that the mood-enhancing effect of MAO inhibitors and SSRIs takes weeks of treatment to develop, even though the boost in available monoamines occurs within hours. Another counterargument is based on experiments with pharmacological agents that cause depletion of monoamines; while deliberate reduction in the concentration of centrally available monoamines may slightly lower the mood of unmedicated depressed patients, this reduction does not affect the mood of healthy people.<extension extension_name='ref' name="nature08"><template><target>cite journal</target><arg name="author"><space/>Krishnan V, Nestler EJ<space/></arg><arg name="title"><space/>The molecular neurobiology of depression<space/></arg><arg name="journal"><space/>Nature<space/></arg><arg name="volume"><space/>455<space/></arg><arg name="issue"><space/>7215<space/></arg><arg name="pages"><space/>894–902<space/></arg><arg name="date"><space/>October 2008<space/></arg><arg name="pmid"><space/>18923511<space/></arg><arg name="pmc"><space/>2721780<space/></arg><arg name="doi"><space/>10.1038/nature07455<space/></arg><arg name="bibcode"><space/>2008Natur.455..894K<space/></arg></template></extension><space/>The monoamine hypothesis, already limited, has been further oversimplified when presented to the public as a mass marketing tool, usually phrased as a &quot;<link><target>chemical imbalance</target></link>&quot;.<extension extension_name='ref' name="PLoS"><template><target>cite journal</target><arg name="author"><space/>Lacasse JR, Leo J<space/></arg><arg name="title"><space/>Serotonin and depression: A disconnect between the advertisements and the scientific literature<space/></arg><arg name="journal"><space/>[[PLoS Medicine|PLoS Med]]<space/></arg><arg name="volume"><space/>2<space/></arg><arg name="issue"><space/>12<space/></arg><arg name="pages"><space/>e392<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>16268734<space/></arg><arg name="pmc"><space/>1277931<space/></arg><arg name="doi"><space/>10.1371/journal.pmed.0020392<space/></arg><arg name="url"><space/>http://medicine.plosjournals.org/perlserv/?request</arg><arg name="laysummary"><space/>http://www.medscape.com/viewarticle/516262<space/></arg><arg name="laydate"><space/>8 November 2005<space/></arg><arg name="laysource"><space/>[[Medscape]]<space/></arg><arg name="accessdate"><space/>30 October 2008<space/></arg></template></extension></paragraph><paragraph>In 2003 a<space/><link><target>gene-environment interaction</target></link><space/>(GxE) was hypothesized to explain why life stress is a predictor for depressive episodes in some individuals, but not in others, depending on an allelic variation of the serotonin-transporter-linked promoter region (<link><target>5-HTTLPR</target></link>);<extension extension_name='ref' name="Caspi"></extension><space/>a 2009<space/><link><target>meta-analysis</target></link><space/>showed stressful life events were associated with depression, but found no evidence for an association with the 5-HTTLPR genotype.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Risch N, Herrell R, Lehner T, Liang KY, Eaves L, Hoh J, Griem A, Kovacs M, Ott J, Merikangas KR<space/></arg><arg name="title"><space/>Interaction between the serotonin transporter gene (5-HTTLPR), stressful life events, and risk of depression: a meta-analysis<space/></arg><arg name="journal"><space/>JAMA<space/></arg><arg name="volume"><space/>301<space/></arg><arg name="issue"><space/>23<space/></arg><arg name="pages"><space/>2462–71<space/></arg><arg name="date"><space/>June 2009<space/></arg><arg name="pmid"><space/>19531786<space/></arg><arg name="pmc"><space/>2938776<space/></arg><arg name="doi"><space/>10.1001/jama.2009.878<space/></arg></template></extension><space/>Another 2009 meta-analysis agreed with the latter finding.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Munafò MR, Durrant C, Lewis G, Flint J<space/></arg><arg name="title"><space/>Gene X environment interactions at the serotonin transporter locus<space/></arg><arg name="journal"><space/>Biol. Psychiatry<space/></arg><arg name="volume"><space/>65<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>211–9<space/></arg><arg name="date"><space/>February 2009<space/></arg><arg name="pmid"><space/>18691701<space/></arg><arg name="doi"><space/>10.1016/j.biopsych.2008.06.009<space/></arg></template></extension><space/>A 2010 review of studies in this area found a systematic relationship between the method used to assess environmental adversity and the results of the studies; this review also found that both 2009 meta-analyses were significantly biased toward negative studies, which used self-report measures of adversity.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Uher R, McGuffin P<space/></arg><arg name="title"><space/>The moderation by the serotonin transporter gene of environmental adversity in the etiology of depression: 2009 update<space/></arg><arg name="journal"><space/>Mol. Psychiatry<space/></arg><arg name="volume"><space/>15<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>18–22<space/></arg><arg name="date"><space/>January 2010<space/></arg><arg name="pmid"><space/>20029411<space/></arg><arg name="doi"><space/>10.1038/mp.2009.123<space/></arg></template></extension></paragraph><heading level='4'>Other hypotheses</heading><paragraph><link><target>MRI</target></link><space/>scans of patients with depression have revealed a number of differences in brain structure compared to those who are not depressed. Meta-analyses of neuroimaging studies in major depression reported that, compared to controls, depressed patients had increased volume of the<space/><link><target>lateral ventricles</target></link><space/>and<space/><link><target>adrenal gland</target></link><space/>and smaller volumes of the<space/><link><target>basal ganglia</target></link>,<space/><link><target>thalamus</target></link>,<space/><link><target>hippocampus</target></link>, and<space/><link><target>frontal lobe</target></link><space/>(including the<space/><link><target>orbitofrontal cortex</target></link><space/>and<space/><link><target>gyrus rectus</target></link>).<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Kempton MJ, Salvador Z, Munafò MR, Geddes JR, Simmons A, Frangou S, Williams SC<space/></arg><arg name="title"><space/>Structural Neuroimaging Studies in Major Depressive Disorder: Meta-analysis and Comparison With Bipolar Disorder<space/></arg><arg name="journal"><space/>Arch Gen Psychiatry<space/></arg><arg name="volume"><space/>68<space/></arg><arg name="issue"><space/>7<space/></arg><arg name="pages"><space/>675–90<space/></arg><arg name="year"><space/>2011<space/></arg><arg name="pmid"><space/>21727252<space/></arg><arg name="doi"><space/>10.1001/archgenpsychiatry.2011.60<space/></arg><arg name="url"><space/>http://archpsyc.ama-assn.org/cgi/content/full/68/7/675<space/></arg></template><space/>see also MRI database at<space/><link type='external' href='http://sites.google.com/site/depressiondatabase/'>www.depressiondatabase.org</link></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Arnone D, McIntosh AM, Ebmeier KP, Munafò MR, Anderson IM<space/></arg><arg name="title"><space/>Magnetic resonance imaging studies in unipolar depression: Systematic review and meta-regression analyses<space/></arg><arg name="journal"><space/>Eur Neuropsychopharmacol<space/></arg><arg name="volume"><space/>22<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>1–16<space/></arg><arg name="date"><space/>July 2011<space/></arg><arg name="pmid"><space/>21723712<space/></arg><arg name="doi"><space/>10.1016/j.euroneuro.2011.05.003<space/></arg></template></extension><space/>Hyperintensities have been associated with patients with a late age of onset, and have led to the development of the theory of<space/><link><target>Subcortical ischemic depression</target><part>vascular depression</part></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Herrmann LL, Le Masurier M, Ebmeier KP<space/></arg><arg name="title"><space/>White matter hyperintensities in late life depression: a systematic review<space/></arg><arg name="journal"><space/>Journal of Neurology, Neurosurgery, and Psychiatry<space/></arg><arg name="volume"><space/>79<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>619–24<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>17717021<space/></arg><arg name="doi"><space/>10.1136/jnnp.2007.124651<space/></arg></template></extension></paragraph><paragraph>There may be a link between depression and<space/><link><target>neurogenesis</target></link><space/>of the hippocampus,<extension extension_name='ref'><template><target>cite journal</target><arg name="url">http://www.sciam.com/article.cfm?id</arg><arg name="title">Brain pathway may underlie depression<space/></arg><arg name="accessdate">13 September 2008<space/></arg><arg name="author">Mayberg H<space/></arg><arg name="date">6 July 2007<space/></arg><arg name="journal">[[Scientific American]]</arg><arg name="volume">17</arg><arg name="issue">4</arg><arg name="pages">26–31</arg></template></extension><space/>a center for both mood and memory. Loss of hippocampal neurons is found in some depressed individuals and correlates with impaired memory and dysthymic mood. Drugs may increase serotonin levels in the brain, stimulating neurogenesis and thus increasing the total mass of the hippocampus. This increase may help to restore mood and memory.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Sheline YI, Gado MH, Kraemer HC<space/></arg><arg name="title"><space/>Untreated depression and hippocampal volume loss<space/></arg><arg name="journal"><space/>American Journal of Psychiatry<space/></arg><arg name="volume"><space/>160<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>1516–18<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12900317<space/></arg><arg name="doi"><space/>10.1176/appi.ajp.160.8.1516<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Duman RS, Heninger GR, Nestler EJ<space/></arg><arg name="title"><space/>A molecular and cellular theory of depression<space/></arg><arg name="journal"><space/>Archives of General Psychiatry<space/></arg><arg name="volume"><space/>54<space/></arg><arg name="issue"><space/>7<space/></arg><arg name="pages"><space/>597–606<space/></arg><arg name="year"><space/>1997<space/></arg><arg name="pmid"><space/>9236543<space/></arg><arg name="doi"><space/>10.1001/archpsyc.1997.01830190015002<space/></arg></template></extension><space/>Similar relationships have been observed between depression and an area of the<space/><link><target>anterior cingulate cortex</target></link><space/>implicated in the modulation of emotional behavior.<extension extension_name='ref' name="pmid18704022"><template><target>cite journal</target><arg name="author"><space/>Drevets WC, Savitz J, Trimble M<space/></arg><arg name="title"><space/>The subgenual anterior cingulate cortex in mood disorders<space/></arg><arg name="journal"><space/>CNS Spectrums<space/></arg><arg name="volume"><space/>13<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>663–81<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18704022<space/></arg><arg name="pmc"><space/>2729429<space/></arg></template></extension><space/>One of the<space/><link><target>neurotrophin</target><trail>s</trail></link><space/>responsible for neurogenesis is<space/><link><target>brain-derived neurotrophic factor</target></link><space/>(BDNF). The level of BDNF in the blood plasma of depressed subjects is drastically reduced (more than threefold) as compared to the norm. Antidepressant treatment increases the blood level of BDNF. Although decreased plasma BDNF levels have been found in many other disorders, there is some evidence that BDNF is involved in the cause of depression and the mechanism of action of antidepressants.<extension extension_name='ref' name="pmid18571629"><template><target>cite journal</target><arg name="author"><space/>Sen S, Duman R, Sanacora G<space/></arg><arg name="title"><space/>Serum brain-derived neurotrophic factor, depression, and antidepressant medications: Meta-analyses and implications<space/></arg><arg name="journal"><space/>Biological Psychiatry<space/></arg><arg name="volume"><space/>64<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>527–32<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18571629<space/></arg><arg name="pmc"><space/>2597158<space/></arg><arg name="doi"><space/>10.1016/j.biopsych.2008.05.005<space/></arg></template></extension></paragraph><paragraph>There is some evidence that major depression may be caused in part by an overactive<space/><link><target>hypothalamic-pituitary-adrenal axis</target></link><space/>(HPA axis) that results in an effect similar to the neuro-endocrine response to stress. Investigations reveal increased levels of the hormone<space/><link><target>cortisol</target></link><space/>and enlarged pituitary and adrenal glands, suggesting disturbances of the<space/><link><target>endocrine system</target></link><space/>may play a role in some psychiatric disorders, including major depression. Oversecretion of<space/><link><target>corticotropin-releasing hormone</target></link><space/>from the<space/><link><target>hypothalamus</target></link><space/>is thought to drive this, and is implicated in the cognitive and arousal symptoms.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Monteleone P<space/></arg><arg name="url">http://www.co-psychiatry.com/pt/re/copsych/abstract.00001504-200111000-00020.htm;jsessionid</arg><arg name="title">Endocrine disturbances and psychiatric disorders<space/></arg><arg name="publisher">Lippincott Williams & Wilkins, Inc.<space/></arg><arg name="year">2001<space/></arg><arg name="volume">14</arg><arg name="issue">6</arg><arg name="pages">605–10</arg><arg name="journal">Current Opinion in Psychiatry<space/></arg><arg name="issn">0951–7367<space/></arg><arg name="doi">10.1097/00001504-200111000-00020</arg></template></extension></paragraph><paragraph>The hormone<space/><link><target>estrogen</target></link><space/>has been implicated in depressive disorders due to the increase in risk of depressive episodes after puberty, the antenatal period, and reduced rates after<space/><link><target>menopause</target></link>.<extension extension_name='ref' name="pmid12810759"><template><target>cite journal</target><arg name="author"><space/>Cutter WJ, Norbury R, Murphy DG<space/></arg><arg name="title"><space/>Oestrogen, brain function, and neuropsychiatric disorders<space/></arg><arg name="journal"><space/>Journal of Neurology, Neurosurgery and Psychiatry<space/></arg><arg name="volume"><space/>74<space/></arg><arg name="issue"><space/>7<space/></arg><arg name="pages"><space/>837–40<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12810759<space/></arg><arg name="pmc"><space/>1738534<space/></arg><arg name="doi"><space/>10.1136/jnnp.74.7.837<space/></arg></template></extension><space/>On the converse, the premenstrual and postpartum periods of low estrogen levels are also associated with increased risk.<extension extension_name='ref' name="pmid12810759"></extension><space/>Sudden withdrawal of, fluctuations in or periods of sustained low levels of estrogen have been linked to significant mood lowering. Clinical recovery from depression postpartum, perimenopause, and postmenopause was shown to be effective after levels of estrogen were stabilized or restored.<extension extension_name='ref' name="pmid16292022"><template><target>cite journal</target><arg name="author"><space/>Douma SL, Husband C, O'Donnell ME, Barwin BN, Woodend AK<space/></arg><arg name="title"><space/>Estrogen-related Mood Disorders Reproductive Life Cycle Factors<space/></arg><arg name="journal"><space/>Advances in Nursing Science<space/></arg><arg name="volume"><space/>28<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>364–375<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>16292022<space/></arg><arg name="doi"><space/>10.1097/00012272-200510000-00008<space/></arg></template></extension><extension extension_name='ref' name="pmid17909167"><template><target>cite journal</target><arg name="author"><space/>Lasiuk GC, Hegadoren KM<space/></arg><arg name="title"><space/>The Effects of Estradiol on Central Serotonergic Systems and Its Relationship to Mood in Women<space/></arg><arg name="journal"><space/>Biological Research for Nursing (2007),<space/></arg><arg name="volume"><space/>9<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>147–160<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17909167<space/></arg><arg name="doi"><space/>10.1177/1099800407305600<space/></arg></template></extension></paragraph><paragraph>Other research has explored potential roles of molecules necessary for overall<space/><link><target>Cell (biology)</target><part>cellular</part></link><space/>functioning:<space/><link><target>cytokine</target><trail>s</trail></link>. The symptoms of major depressive disorder are nearly identical to those of<space/><link><target>sickness behavior</target></link>, the response of the body when the<space/><link><target>immune system</target></link><space/>is fighting an<space/><link><target>infection</target></link>. This raises the possibility that depression can result from a maladaptive manifestation of sickness behavior as a result of abnormalities in circulating cytokines.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW<space/></arg><arg name="title"><space/>From inflammation to sickness and depression: when the immune system subjugates the brain<space/></arg><arg name="journal"><space/>Nature Reviews Neuroscience<space/></arg><arg name="volume"><space/>9<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>46–56<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18073775<space/></arg><arg name="pmc"><space/>2919277<space/></arg><arg name="doi"><space/>10.1038/nrn2297<space/></arg></template></extension><space/>The involvement of pro-inflammatory cytokines in depression is strongly suggested by a meta-analysis of the clinical literature showing higher blood concentrations of<space/><link><target>Interleukin 6</target><part>IL-6</part></link><space/>and<space/><link><target>TNF-</target></link><space/>in depressed subjects compared to controls.<extension extension_name='ref' name="pmid 20015486"><template><target>cite journal</target><arg name="author"><space/>Dowlati Y, Herrmann N, Swardfager W, Liu H, Sham L, Reim EK, Lanctôt KL<space/></arg><arg name="title"><space/>A meta-analysis of cytokines in major depression<space/></arg><arg name="journal"><space/>Biological Psychiatry<space/></arg><arg name="volume"><space/>67<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>446–457<space/></arg><arg name="year"><space/>2010<space/></arg><arg name="pmid"><space/>20015486<space/></arg><arg name="doi"><space/>10.1016/j.biopsych.2009.09.033<space/></arg></template></extension><space/>These immunological abnormalities may cause excessive prostaglandin E production and likely excessive COX-2 expression. Abnormalities in how<space/><link><target>indoleamine 2,3-dioxygenase</target></link><space/>enzyme activates as well as the metabolism of<space/><link><target>tryptophan</target></link>-<link><target>kynurenine</target></link><space/>may lead to excessive metabolism of tryptophan-kynurenine and lead to increased production of the neurotoxin<space/><link><target>quinolinic acid</target></link>, contributing to major depression. NMDA activation leading to excessive<space/><link><target>glutamatergic</target></link><space/>neurotransmission, may also contribute.<extension extension_name='ref' name="pmid20658274"><template><target>cite journal</target><arg name="author"><space/>Müller N, Myint AM, Schwarz MJ<space/></arg><arg name="title"><space/>Inflammatory biomarkers and depression<space/></arg><arg name="journal"><space/>Neurotox Res<space/></arg><arg name="volume"><space/>19<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>308–18<space/></arg><arg name="date"><space/>February 2011<space/></arg><arg name="pmid"><space/>20658274<space/></arg><arg name="doi"><space/>10.1007/s12640-010-9210-2<space/></arg></template></extension></paragraph><heading level='3'>Psychological</heading><paragraph>Various aspects of<space/><link><target>Personality psychology</target><part>personality</part></link><space/>and its<space/><link><target>personality development</target><part>development</part></link><space/>appear to be integral to the occurrence and persistence of depression,<extension extension_name='ref' name="Raph00"><template><target>cite book</target><arg name="title">Unmet Need in Psychiatry:Problems, Resources, Responses<space/></arg><arg name="editor">Andrews G, Henderson S ''(eds)''</arg><arg name="year">2000<space/></arg><arg name="publisher">Cambridge University Press<space/></arg><arg name="pages">138–39</arg><arg name="chapter"><space/>Unmet Need for Prevention</arg><arg name="author">Raphael B</arg><arg name="isbn">0-521-66229-X</arg></template></extension><space/>with<space/><link><target>Affect theory</target><part>negative emotionality</part></link><space/>as a common precursor.<extension extension_name='ref' name="pmid19187578"><template><target>cite journal</target><arg name="author"><space/>Morris BH, Bylsma LM, Rottenberg J<space/></arg><arg name="title"><space/>Does emotion predict the course of major depressive disorder? A review of prospective studies<space/></arg><arg name="journal"><space/>Br J Clin Psychol<space/></arg><arg name="volume"><space/>48<space/></arg><arg name="issue"><space/>Pt 3<space/></arg><arg name="pages"><space/>255–73<space/></arg><arg name="date"><space/>September 2009<space/></arg><arg name="pmid"><space/>19187578<space/></arg><arg name="doi"><space/>10.1348/014466508X396549<space/></arg><arg name="url"><space/>http://openurl.ingenta.com/content/nlm?genre</arg></template></extension><space/>Although depressive episodes are strongly correlated with adverse events, a person's characteristic style of coping may be correlated with his or her resilience.<extension extension_name='ref' name="Sad541"><template><target>Harvnb</target><arg>Sadock</arg><arg>2002</arg><arg name="p">541</arg></template></extension><space/>In addition, low<space/><link><target>self-esteem</target></link><space/>and self-defeating or distorted thinking are related to depression. Depression is less likely to occur, as well as quicker to remit, among those who are religious.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>McCullough ME, Larson DB<space/></arg><arg name="title"><space/>Religion and depression: a review of the literature<space/></arg><arg name="journal"><space/>Twin Research<space/></arg><arg name="volume"><space/>2<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>126–136<space/></arg><arg name="date"><space/>1 June 1999<space/></arg><arg name="pmid"><space/>10480747<space/></arg><arg name="doi"><space/>10.1375/136905299320565997<space/></arg><arg name="url"><space/>http://www.ingentaconnect.com/content/aap/twr/1999/00000002/00000002/art00008<space/></arg><arg name="ref"><space/>harv<space/></arg><arg name="publisher"><space/>Australian Academic Press<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author">Dein, S<space/></arg><arg name="title">Religion, spirituality and depression: implications for research and treatment<space/></arg><arg name="journal">Primary Care and Community Psychiatry</arg><arg name="volume">11</arg><arg name="issue">2<space/></arg><arg name="pages">67–72<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="url"><space/>http://www.librapharm.com/headeradmin/upload/0178web2.pdf</arg><arg name="format">PDF</arg><arg name="accessdate">21 November 2008<space/></arg><arg name="doi"><space/>10.1185/135525706X121110</arg></template><space/><template><target>Wayback</target><arg name="df">yes</arg><arg name="url">http://www.librapharm.com/headeradmin/upload/0178web2.pdf</arg><arg name="date">20061021164223</arg><arg name="bot">DASHBot</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Moreira-Almeida A, Neto FL, Koenig HG<space/></arg><arg name="title"><space/>Religiousness and mental health: a review<space/></arg><arg name="journal"><space/>Rev. Bras. Psiquiatr.<space/></arg><arg name="volume"><space/>28<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>242–50<space/></arg><arg name="date"><space/>September 2006<space/></arg><arg name="pmid"><space/>16924349<space/></arg><arg name="doi"><space/>10.1590/S1516-44462006005000006<space/></arg><arg name="url"><space/>http://www.scielo.br/scielo.php?script</arg></template></extension><space/>It is not always clear which factors are causes and which are effects of depression; however, depressed persons that are able to reflect upon and challenge their thinking patterns often show improved mood and self-esteem.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Warman DM, [[Aaron Temkin Beck|Beck AT]]</arg><arg name="year">2003<space/></arg><arg name="url">http://www.nami.org/Template.cfm?Section</arg><arg name="title">About treatment and supports: Cognitive behavioral therapy<space/></arg><arg name="work">National Alliance on Mental Illness (NAMI) website</arg><arg name="accessdate">17 October 2008</arg></template></extension></paragraph><paragraph>American psychiatrist<space/><link><target>Aaron T. Beck</target></link>, following on from the earlier work of<space/><link><target>George Kelly (psychologist)</target><part>George Kelly</part></link><space/>and<space/><link><target>Albert Ellis (psychologist)</target><part>Albert Ellis</part></link>, developed what is now known as a cognitive model of depression in the early 1960s. He proposed that three concepts underlie depression: a<space/><link><target>Beck's cognitive triad</target><part>triad</part></link><space/>of negative thoughts composed of cognitive errors about oneself, one's world, and one's future; recurrent patterns of depressive thinking, or<space/><italics>schemas</italics>; and<space/><link><target>cognitive distortions</target><part>distorted information processing</part></link>.<extension extension_name='ref' name="Beckdep"><template><target>Harvnb</target><arg>Beck</arg><arg>1987</arg><arg name="pp">10–15</arg></template></extension><space/>From these principles, he developed the structured technique of<space/><link><target>cognitive behavioral therapy</target></link><space/>(CBT).<extension extension_name='ref'><template><target>Harvnb</target><arg>Beck</arg><arg>1987</arg><arg name="p">3</arg></template></extension><space/>Further support for the concept of distorted information processing in individuals with depression has been provided from several areas of research. These include attention and reward and punishment processing.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Gotlib</arg><arg name="first1">IH</arg><arg name="last2">Joormann</arg><arg name="first2">J</arg><arg name="title">Cognition and depression: current status and future directions.</arg><arg name="journal">Annual review of clinical psychology</arg><arg name="date">2010</arg><arg name="volume">6</arg><arg name="pages">285–312</arg><arg name="pmid">20192795</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Eshel</arg><arg name="first1">N</arg><arg name="last2">Roiser</arg><arg name="first2">JP</arg><arg name="title">Reward and punishment processing in depression.</arg><arg name="journal">Biological psychiatry</arg><arg name="date">15 July 2010</arg><arg name="volume">68</arg><arg name="issue">2</arg><arg name="pages">118–24</arg><arg name="pmid">20303067</arg></template></extension><space/>According to American psychologist<space/><link><target>Martin Seligman</target></link>, depression in humans is similar to<space/><link><target>learned helplessness</target></link><space/>in laboratory animals, who remain in unpleasant situations when they are able to escape, but do not because they initially learned they had no control.<extension extension_name='ref' name="Helplessness"><template><target>cite book</target><arg name="author">Seligman, M</arg><arg name="title">Helplessness: On depression, development and death<space/></arg><arg name="pages">75–106</arg><arg name="chapter">Depression</arg><arg name="publisher">WH Freeman<space/></arg><arg name="location">San Francisco, CA, USA<space/></arg><arg name="year">1975<space/></arg><arg name="isbn">0-7167-0751-9</arg></template></extension></paragraph><paragraph><link><target>Attachment theory</target></link>, which was developed by English psychiatrist<space/><link><target>John Bowlby</target></link><space/>in the 1960s, predicts a relationship between depressive disorder in adulthood and the quality of the earlier bond between the infant and the adult caregiver. In particular, it is thought that &quot;the experiences of early loss, separation and rejection by the parent or caregiver (conveying the message that the child is unlovable) may all lead to insecure internal working models ... Internal cognitive representations of the self as unlovable and of attachment figures as unloving [or] untrustworthy would be consistent with parts of Beck's cognitive triad&quot;.<extension extension_name='ref' name="Ma_attachment"></extension><space/>While a wide variety of studies has upheld the basic tenets of attachment theory, research has been inconclusive as to whether self-reported early attachment and later depression are demonstrably related.<extension extension_name='ref' name="Ma_attachment"><template><target>cite journal</target><arg name="author">Ma, K<space/></arg><arg name="title">Attachment theory in adult psychiatry. Part 1: Conceptualisations, measurement and clinical research findings<space/></arg><arg name="journal">Advances in Psychiatric Treatment</arg><arg name="volume">12<space/></arg><arg name="pages">440–449<space/></arg><arg name="year">2006</arg><arg name="url">http://apt.rcpsych.org/cgi/content/full/12/6/440<space/></arg><arg name="accessdate">21 April 2010<space/></arg><arg name="issue">6<space/></arg><arg name="doi">10.1192/apt.12.6.440</arg></template></extension></paragraph><paragraph>Depressed individuals often blame themselves for negative events,<extension extension_name='ref' name="Integrative"></extension><space/>and, as shown in a 1993 study of hospitalized adolescents with self-reported depression, those who blame themselves for negative occurrences may not take credit for positive outcomes.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Pinto A, Francis G<space/></arg><arg name="title"><space/>Cognitive correlates of depressive symptoms in hospitalized adolescents<space/></arg><arg name="journal"><space/>Adolescence<space/></arg><arg name="volume"><space/>28<space/></arg><arg name="issue"><space/>111<space/></arg><arg name="pages"><space/>661–72<space/></arg><arg name="year"><space/>1993<space/></arg><arg name="pmid"><space/>8237551<space/></arg></template></extension><space/>This tendency is characteristic of a depressive<space/><link><target>Attribution (psychology)</target><part>attributional</part></link>, or pessimistic<space/><link><target>explanatory style</target></link>.<extension extension_name='ref' name="Integrative"><template><target>Harvnb</target><arg>Barlow</arg><arg>2005</arg><arg name="pp">230–32</arg></template></extension><space/>According to<space/><link><target>Albert Bandura</target></link>, a Canadian<space/><link><target>Social psychology (psychology)</target><part>social psychologist</part></link><space/>associated with<space/><link><target>social cognitive theory</target></link>, depressed individuals have negative beliefs about themselves, based on experiences of failure, observing the failure of social models, a lack of social persuasion that they can succeed, and their own somatic and emotional states including tension and stress. These influences may result in a negative<space/><link><target>self-concept</target></link><space/>and a lack of<space/><link><target>self-efficacy</target></link>; that is, they do not believe they can influence events or achieve personal goals.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Kanfer R, Zeiss AM<space/></arg><arg name="title"><space/>Depression, Interpersonal Standard Setting<space/></arg><arg name="journal"><space/>Journal of Abnormal Psychology<space/></arg><arg name="volume"><space/>92<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>319–29<space/></arg><arg name="year"><space/>1983<space/></arg><arg name="pmid"><space/>6619407<space/></arg><arg name="doi"><space/>10.1037/0021-843X.92.3.319<space/></arg></template></extension><extension extension_name='ref'><template><target>cite book</target><arg name="author">Bandura A<space/></arg><arg name="chapter">Self-Efficacy<space/></arg><arg name="title">Encyclopedia of mental health<space/></arg><arg name="editor">Friedman H<space/></arg><arg name="publisher">Academic Press<space/></arg><arg name="location">San Diego</arg><arg name="year">1998</arg><arg name="url">http://www.des.emory.edu/mfp/BanEncy.html<space/></arg><arg name="accessdate">17 August 2008<space/></arg><arg name="isbn">0-12-226676-5</arg></template></extension></paragraph><paragraph>An examination of depression in women indicates that vulnerability factorssuch as early maternal loss, lack of a confiding relationship, responsibility for the care of several young children at home, and unemploymentcan interact with life stressors to increase the risk of depression.<extension extension_name='ref'><template><target>cite book</target><arg name="title">Social Origins of Depression: A Study of Psychiatric Disorder in Women<space/></arg><arg name="author">Brown GW, Harris TO<space/></arg><arg name="origyear">1978<space/></arg><arg name="year">2001<space/></arg><arg name="publisher">Routledge<space/></arg><arg name="isbn">0-415-20268-X</arg><arg name="pages"></arg></template></extension><space/>For older adults, the factors are often health problems, changes in relationships with a spouse or adult children due to the transition to a<space/><link><target>Caregiver</target><part>care-giving</part></link><space/>or care-needing role, the death of a significant other, or a change in the availability or quality of social relationships with older friends because of their own health-related life changes.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Hinrichsen GA, Emery EE<space/></arg><arg name="title">Interpersonal factors and late-life depression<space/></arg><arg name="journal">Clinical Psychology: Science and Practice<space/></arg><arg name="volume">12</arg><arg name="issue">3</arg><arg name="pages">264–75<space/></arg><arg name="year">2006</arg><arg name="subscription">yes<space/></arg><arg name="doi">10.1093/clipsy/bpi027</arg></template></extension></paragraph><paragraph>The understanding of depression has also received contributions from the<space/><link><target>psychoanalysis</target><part>psychoanalytic</part></link><space/>and<space/><link><target>humanistic psychology</target><part>humanistic</part></link><space/>branches of psychology. From the classical psychoanalytic perspective of Austrian psychiatrist<space/><link><target>Sigmund Freud</target></link>, depression, or<space/><italics>melancholia</italics>, may be related to interpersonal loss<extension extension_name='ref' name="Carhart-Harris08"><template><target>cite journal</target><arg name="author"><space/>Carhart-Harris RL, Mayberg HS, Malizia AL, Nutt D<space/></arg><arg name="title"><space/>Mourning and melancholia revisited: Correspondences between principles of Freudian metapsychology and empirical findings in neuropsychiatry<space/></arg><arg name="journal"><space/>Annals of General Psychiatry<space/></arg><arg name="volume"><space/>7<space/></arg><arg name="pages"><space/>9<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18652673<space/></arg><arg name="pmc"><space/>2515304<space/></arg><arg name="doi"><space/>10.1186/1744-859X-7-9<space/></arg></template></extension><extension extension_name='ref' name="autogenerated1"><template><target>cite book</target><arg name="editor">Richards A<space/></arg><arg name="last">Freud</arg><arg name="first"><space/>S</arg><arg name="title">11.On Metapsychology: The Theory of Psycholoanalysis<space/></arg><arg name="chapter">Mourning and Melancholia</arg><arg name="pages">245–69<space/></arg><arg name="publisher">Pelican<space/></arg><arg name="location">Aylesbury, Bucks<space/></arg><arg name="year">1984<space/></arg><arg name="isbn">0-14-021740-1</arg></template></extension><space/>and early life experiences.<extension extension_name='ref' name="Radden2003"></extension><space/><link><target>Existential therapy</target><part>Existential therapists</part></link><space/>have connected depression to the lack of both<space/><link><target>Meaning (existential)</target><part>meaning</part></link><space/>in the present<extension extension_name='ref' name="Frankl"><template><target>cite book</target><arg name="author">Frankl VE<space/></arg><arg name="title">Man's search for ultimate meaning<space/></arg><arg name="publisher">Basic Books<space/></arg><arg name="location">New York, NY, USA<space/></arg><arg name="year">2000<space/></arg><arg name="pages">139–40<space/></arg><arg name="isbn">0-7382-0354-8</arg></template></extension><space/>and a vision of the future.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Geppert C.M.A.</arg><arg name="year">2006<space/></arg><arg name="url">http://www.psychiatrictimes.com/articles/damage-control</arg><arg name="title">Damage control</arg><arg name="work">Psychiatric Times</arg><arg name="accessdate">12 November 2014</arg></template></extension><extension extension_name='ref' name="May"><template><target>Harvnb</target><arg>May</arg><arg>1994</arg><arg name="p">133</arg></template></extension></paragraph><heading level='3'>Social</heading><preblock><preline><link><target>Poverty</target></link><space/>and<space/><link><target>social isolation</target></link><space/>are associated with increased risk of mental health problems in general.<extension extension_name='ref' name="Raph00"></extension><space/><link><target>Child abuse</target></link><space/>(<link><target>physical abuse</target><part>physical</part></link>,<space/><link><target>Psychological abuse</target><part>emotional</part></link>,<space/><link><target>sexual abuse</target><part>sexual</part></link>, or neglect) is also associated with increased risk of developing depressive disorders later in life.<extension extension_name='ref' name="pmid18602762"><template><target>cite journal</target><arg name="author"><space/>Heim C, Newport DJ, Mletzko T, Miller AH, Nemeroff CB<space/></arg><arg name="title"><space/>The link between childhood trauma and depression: insights from HPA axis studies in humans<space/></arg><arg name="journal"><space/>Psychoneuroendocrinology<space/></arg><arg name="volume"><space/>33<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>693–710<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18602762<space/></arg><arg name="doi"><space/>10.1016/j.psyneuen.2008.03.008<space/></arg></template></extension><space/>Such a link has good face validity given that it is during the years of development that a child is learning how to become a social being. Abuse of the child by the caregiver is bound to distort the developing personality and create a much greater risk for depression and many other debilitating mental and emotional states. Disturbances in family functioning, such as parental (particularly maternal) depression, severe marital conflict or divorce, death of a parent, or other disturbances in parenting are additional risk factors.<extension extension_name='ref' name="Raph00"></extension><space/>In adulthood, stressful life events are strongly associated with the onset of major depressive episodes.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Kessler RC<space/></arg><arg name="title"><space/>The effects of stressful life events on depression<space/></arg><arg name="journal"><space/>Annual revue of Psychology<space/></arg><arg name="volume"><space/>48<space/></arg><arg name="pages"><space/>191–214<space/></arg><arg name="year"><space/>1997<space/></arg><arg name="pmid"><space/>9046559<space/></arg><arg name="doi"><space/>10.1146/annurev.psych.48.1.191<space/></arg></template></extension><space/>In this context, life events connected to social rejection appear to be particularly related to depression.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Kendler KS, Hettema JM, Butera F, Gardner CO, Prescott CA<space/></arg><arg name="title"><space/>Life event dimensions of loss, humiliation, entrapment, and danger in the prediction of onsets of major depression and generalized anxiety<space/></arg><arg name="journal"><space/>Archives of General Psychiatry<space/></arg><arg name="volume"><space/>60<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>789–796<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12912762<space/></arg><arg name="doi"><space/>10.1001/archpsyc.60.8.789<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Slavich GM, Thornton T, Torres LD, Monroe SM, Gotlib IH<space/></arg><arg name="title"><space/>Targeted rejection predicts hastened onset of major depression<space/></arg><arg name="journal"><space/>Journal of Social and Clinical Psychology<space/></arg><arg name="volume"><space/>28<space/></arg><arg name="pages"><space/>223–243<space/></arg><arg name="year"><space/>2009<space/></arg><arg name="pmid"><space/>20357895<space/></arg><arg name="pmc"><space/>2847269<space/></arg><arg name="doi"><space/>10.1521/jscp.2009.28.2.223<space/></arg></template></extension><space/>Evidence that a first episode of depression is more likely to be immediately preceded by stressful life events than are recurrent ones is consistent with the hypothesis that people may become increasingly sensitized to life stress over successive recurrences of depression.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Monroe SM, Slavich GM, Torres LD, Gotlib IH<space/></arg><arg name="title"><space/>Major life events and major chronic difficulties are differentially associated with history of major depressive episodes<space/></arg><arg name="journal"><space/>Journal of Abnormal Psychology<space/></arg><arg name="volume"><space/>116<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>116–124<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17324022<space/></arg><arg name="doi"><space/>10.1037/0021-843X.116.1.116<space/></arg></template></extension><extension extension_name='ref'><template><target>Harvnb</target><arg>Sadock</arg><arg>2002</arg><arg name="p">540</arg></template></extension></preline></preblock><paragraph>The relationship between stressful life events and<space/><link><target>social support</target></link><space/>has been a matter of some debate; the lack of social support may increase the likelihood that life stress will lead to depression, or the absence of social support may constitute a form of strain that leads to depression directly.<extension extension_name='ref' name="Vilhjalmsson"><template><target>cite journal</target><arg name="author"><space/>Vilhjalmsson R<space/></arg><arg name="title"><space/>Life stress, social support and clinical depression: A reanalysis of the literature<space/></arg><arg name="journal"><space/>Social Science & Medicine<space/></arg><arg name="volume"><space/>37<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>331–42<space/></arg><arg name="year"><space/>1993<space/></arg><arg name="pmid"><space/>8356482<space/></arg><arg name="doi"><space/>10.1016/0277-9536(93)90264-5<space/></arg></template></extension><space/>There is evidence that neighborhood social disorder, for example, due to crime or illicit drugs, is a risk factor, and that a high neighborhood socioeconomic status, with better<space/><link><target>amenities</target></link>, is a protective factor.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Kim D<space/></arg><arg name="title"><space/>Blues from the neighborhood? Neighborhood characteristics and depression<space/></arg><arg name="journal"><space/>Epidemiologic reviews<space/></arg><arg name="volume"><space/>30<space/></arg><arg name="pages"><space/>101–17<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18753674<space/></arg><arg name="doi"><space/>10.1093/epirev/mxn009<space/></arg></template></extension><space/>Adverse conditions at work, particularly demanding jobs with little scope for decision-making, are associated with depression, although diversity and confounding factors make it difficult to confirm that the relationship is causal.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Bonde JP<space/></arg><arg name="title"><space/>Psychosocial factors at work and risk of depression: A systematic review of the epidemiological evidence<space/></arg><arg name="journal"><space/>Journal of Occupational and Environmental Medicine<space/></arg><arg name="volume"><space/>65<space/></arg><arg name="issue"><space/>7<space/></arg><arg name="pages"><space/>438–45<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18417557<space/></arg><arg name="doi"><space/>10.1136/oem.2007.038430<space/></arg></template></extension></paragraph><paragraph>Depression can be caused by prejudice. This can occur when people hold negative self-stereotypes about themselves. This &quot;deprejudice&quot; can be related to a group membership (e.g., Me-Gay-Bad) or not (Me-Bad). If someone has prejudicial beliefs about a stigmatized group and then becomes a member of that group, they may internalize their prejudice and develop depression. For example, a boy growing up in the United States may learn the negative stereotype that gay men are immoral. When he grows up and realizes he is gay, he may direct this prejudice inward on himself and become depressed. People may also show prejudice internalization through self-stereotyping because of negative childhood experiences such as verbal and physical abuse.<extension extension_name='ref' name="Cox et al. (2012)"><template><target>cite journal</target><arg name="author"><space/>Cox WTL, Abramson LY, Devine PG, Hollon SD<space/></arg><arg name="year"><space/>2012<space/></arg><arg name="title"><space/>Stereotypes, Prejudice, and Depression: The Integrated Perspective<space/></arg><arg name="journal"><space/>[[Perspectives on Psychological Science]]<space/></arg><arg name="volume"><space/>7<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>427–449<space/></arg><arg name="publisher"><space/></arg><arg name="doi"><space/>10.1177/1745691612455204<space/></arg><arg name="url"><space/>http://pps.sagepub.com/content/7/5/427.abstract<space/></arg><arg name="accessdate"><space/></arg></template></extension></paragraph><heading level='3'>Evolutionary</heading><paragraph><template><target>Main</target><arg>Evolutionary approaches to depression</arg></template>From the standpoint of evolutionary theory, major depression is hypothesized, in some instances, to increase an individual's<space/><link><target>Reproduction</target><part>reproductive</part></link><space/><link><target>Fitness (biology)</target><part>fitness</part></link>.<space/><link><target>Evolutionary approaches to depression</target></link><space/>and<space/><link><target>evolutionary psychology</target></link><space/>posit specific mechanisms by which depression may have been genetically incorporated into the human gene pool, accounting for the high<space/><link><target>heritability</target></link><space/>and prevalence of depression by proposing that certain components of depression are adaptations,<extension extension_name='ref' name="Panksepp02"><template><target>cite journal</target><arg name="author"><space/>Panksepp J, Moskal JR, Panksepp JB, Kroes RA<space/></arg><arg name="title"><space/>Comparative approaches in evolutionary psychology: Molecular neuroscience meets the mind<space/></arg><arg name="journal"><space/>Neuroendocrinology Letters<space/></arg><arg name="volume"><space/>23<space/></arg><arg name="issue"><space/>Supplement 4<space/></arg><arg name="pages"><space/>105–15<space/></arg><arg name="year"><space/>2002<space/></arg><arg name="pmid"><space/>12496741<space/></arg><arg name="url"><space/>http://www.nel.edu/pdf_w/23s4/NEL231002R11_Panksepp_.pdf<space/></arg><arg name="format"><space/>PDF<space/></arg></template></extension><space/>such as the behaviors relating to<space/><link><target>attachment theory</target><part>attachment</part></link><space/>and<space/><link><target>Social class</target><part>social rank</part></link>.<extension extension_name='ref' name="Sloman2003"><template><target>cite journal</target><arg name="author"><space/>Sloman L, Gilbert P, Hasey G<space/></arg><arg name="title"><space/>Evolved mechanisms in depression: The role and interaction of attachment and social rank in depression<space/></arg><arg name="journal"><space/>Journal of Affective Disorders<space/></arg><arg name="volume"><space/>74<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>107–21<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12706512<space/></arg><arg name="doi"><space/>10.1016/S0165-0327(02)00116-7<space/></arg></template></extension><space/>Current behaviors can be explained as adaptations to regulate relationships or resources, although the result may be maladaptive in modern environments.<extension extension_name='ref' name="tooby"><template><target>cite book</target><arg name="year">2005</arg><arg name="title">Conceptual foundations of evolutionary psychology. In D. M. Buss (Ed.), ''The Handbook of Evolutionary Psychology''</arg><arg name="pages"><space/>5–67</arg><arg name="publisher">Wiley & Sons</arg><arg name="location"><space/>Hoboken, NJ</arg><arg name="url"><space/>http://www.psych.ucsb.edu/research/cep/papers/bussconceptual05.pdf</arg><arg name="format">PDF</arg><arg name="author">Tooby, J, Cosmides, L</arg></template></extension></paragraph><paragraph>From another viewpoint, a counseling therapist may see depression not as a biochemical illness or disorder but as &quot;a species-wide evolved suite of emotional programs that are mostly activated by a perception, almost always over-negative, of a major decline in personal usefulness, that can sometimes be linked to guilt, shame or perceived rejection&quot;.<extension extension_name='ref' name="Carey05"><template><target>cite journal</target><arg name="title">Evolution, depression and counselling<space/></arg><arg name="journal">Counselling Psychology Quarterly</arg><arg name="year">2005<space/></arg><arg name="author">Carey TJ<space/></arg><arg name="volume">18</arg><arg name="issue">3<space/></arg><arg name="pages">215–22<space/></arg><arg name="url">http://www.ingentaconnect.com/content/routledg/ccpq/2005/00000018/00000003/art00005<space/></arg><arg name="doi">10.1080/09515070500304508</arg></template></extension><space/>This suite may have manifested in aging hunters in humans'<space/><link><target>foraging</target></link><space/>past, who were marginalized by their declining skills, and may continue to appear in<space/><link><target>Social alienation</target><part>alienated members</part></link><space/>of today's society. The feelings of uselessness generated by such marginalization could in theory prompt support from friends and kin. In addition, in a manner analogous to that in which<space/><link><target>pain</target><part>physical pain</part></link><space/>has evolved to hinder actions that may cause further injury, &quot;<link><target>suffering</target><part>psychic misery</part></link>&quot; may have evolved to prevent hasty and maladaptive reactions to distressing situations.<extension extension_name='ref' name="Mashman97"><template><target>cite journal</target><arg name="author">Mashman, RC</arg><arg name="title"><space/>An evolutionary view of psychic misery</arg><arg name="journal"><space/>Journal of Social Behaviour & Personality</arg><arg name="volume"><space/>12</arg><arg name="pages"><space/>979–99<space/></arg><arg name="year">1997</arg><arg name="issn">0886-1641</arg></template></extension></paragraph><heading level='3'>Drug and alcohol use</heading><paragraph><template><target>See also</target><arg>Mood disorder#Substance-induced mood disorders</arg><arg name="label 1">Substance-induced mood disorders</arg></template>Very high levels of substance abuse occur in the psychiatric population, especially alcohol, sedatives and cannabis. Depression and other mental health problems can have a substance induced cause; making a differential or<space/><link><target>dual diagnosis</target></link><space/>regarding whether mental ill-health is substance related or not or co-occurring is an important part of a psychiatric evaluation.<extension extension_name='ref' name="pmid20141784"><template><target>cite journal</target><arg name="author"><space/>Cottencin O<space/></arg><arg name="title"><space/>[Severe depression and addictions]<space/></arg><arg name="language"><space/>French<space/></arg><arg name="journal"><space/>Encephale<space/></arg><arg name="volume"><space/>35 Suppl 7<space/></arg><arg name="issue"><space/></arg><arg name="pages"><space/>S264–8<space/></arg><arg name="date"><space/>December 2009<space/></arg><arg name="pmid"><space/>20141784<space/></arg><arg name="doi"><space/>10.1016/S0013-7006(09)73483-9<space/></arg><arg name="url"><space/></arg></template></extension><space/>According to the DSM-IV, a diagnosis of mood disorder cannot be made if the cause is believed to be due to &quot;the direct physiological effects of a substance&quot;; when a syndrome resembling major depression is believed to be caused immediately by substance abuse or by an adverse drug reaction, it is referred to as, &quot;substance-induced mood disturbance&quot;.<space/><link><target>Alcoholism</target></link><space/>or excessive alcohol consumption significantly increases the risk of developing major depression.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Falk DE, Yi HY, Hilton ME<space/></arg><arg name="title"><space/>Age of onset and temporal sequencing of lifetime DSM-IV alcohol use disorders relative to comorbid mood and anxiety disorders<space/></arg><arg name="journal"><space/>Drug Alcohol Depend<space/></arg><arg name="volume"><space/>94<space/></arg><arg name="issue"><space/>1–3<space/></arg><arg name="pages"><space/>234–45<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18215474<space/></arg><arg name="pmc"><space/>2386955<space/></arg><arg name="doi"><space/>10.1016/j.drugalcdep.2007.11.022<space/></arg></template></extension><extension extension_name='ref' name="pmid21382111"></extension><space/>Like<space/><link><target>Ethanol</target><part>alcohol</part></link>, the<space/><link><target>benzodiazepine</target><trail>s</trail></link><space/>are<space/><link><target>central nervous system</target></link><space/><link><target>depressant</target><trail>s</trail></link>; this class of medication is commonly used to treat<space/><link><target>insomnia</target></link>,<space/><link><target>anxiety</target></link>, and<space/><link><target>muscular spasms</target></link>. Similar to alcohol, benzodiazepines increase the risk of developing major depression. This increased risk of depression may be due in part to the adverse or toxic effects of sedative-hypnotic drugs including alcohol on<space/><link><target>neurochemistry</target></link>,<extension extension_name='ref' name="pmid21382111"><template><target>cite journal</target><arg name="author"><space/>Boden JM, Fergusson DM<space/></arg><arg name="title"><space/>Alcohol and depression<space/></arg><arg name="journal"><space/>Addiction<space/></arg><arg name="volume"><space/>106<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>906–14<space/></arg><arg name="date"><space/>May 2011<space/></arg><arg name="pmid"><space/>21382111<space/></arg><arg name="doi"><space/>10.1111/j.1360-0443.2010.03351.x<space/></arg><arg name="url"><space/></arg></template></extension><space/>such as decreased levels of serotonin and norepinephrine,<extension extension_name='ref' name="ashman"></extension><space/>or activation of immune mediated inflammatory pathways in the brain.<extension extension_name='ref' name="pmid21193024"><template><target>cite journal</target><arg name="author"><space/>Kelley KW, Dantzer R<space/></arg><arg name="title"><space/>Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders<space/></arg><arg name="journal"><space/>Brain Behav. Immun.<space/></arg><arg name="volume"><space/>25 Suppl 1<space/></arg><arg name="issue"><space/></arg><arg name="pages"><space/>S13–20<space/></arg><arg name="date"><space/>June 2011<space/></arg><arg name="pmid"><space/>21193024<space/></arg><arg name="doi"><space/>10.1016/j.bbi.2010.12.013<space/></arg><arg name="url"><space/></arg></template></extension><space/>Chronic use of benzodiazepines also can cause or worsen depression,<extension extension_name='ref'><template><target>cite book</target><arg name="last">Semple</arg><arg name="first">David</arg><arg name="author2">Roger Smyth<space/></arg><arg name="author3">Jonathan Burns<space/></arg><arg name="author4">Rajan Darjee<space/></arg><arg name="author5">Andrew McIntosh<space/></arg><arg name="title">Oxford Handbook of Psychiatry</arg><arg name="origyear">2005</arg><arg name="year">2007</arg><arg name="publisher">Oxford University Press</arg><arg name="location">United Kingdom</arg><arg name="isbn">0-19-852783-7</arg><arg name="page">540</arg><arg name="chapter">13</arg></template></extension><space/>or depression may be part of a<space/><link><target>protracted withdrawal syndrome</target></link>.<extension extension_name='ref'><template><target>cite book</target><arg name="last1">Collier<space/></arg><arg name="first1">Judith<space/></arg><arg name="last2">Longmore<space/></arg><arg name="first2">Murray<space/></arg><arg name="editor1-first">Peter<space/></arg><arg name="editor1-last">Scally<space/></arg><arg name="title">Oxford Handbook of Clinical Specialties<space/></arg><arg name="edition">6<space/></arg><arg name="year">2003<space/></arg><arg name="publisher">Oxford University Press<space/></arg><arg name="isbn">978-0-19-852518-9<space/></arg><arg name="page">366<space/></arg><arg name="chapter">4</arg></template></extension><extension extension_name='ref'><template><target>Cite book</target><arg name="last1"><space/>Janicak<space/></arg><arg name="first1"><space/>Philip G.<space/></arg><arg name="last2"><space/>Marder<space/></arg><arg name="first2"><space/>Stephen R.<space/></arg><arg name="last3"><space/>Pavuluri<space/></arg><arg name="first3"><space/>Mani N.<space/></arg><arg name="title"><space/>Principles and practice of psychopharmacotherap<space/></arg><arg name="url"><space/>https://books.google.com/books?id</arg><arg name="year"><space/>2011<space/></arg><arg name="publisher"><space/>Wolters Kluwer Health/Lippincott Williams Wilkins<space/></arg><arg name="location"><space/>Philadelphia<space/></arg><arg name="isbn"><space/>978-1-60547-565-3<space/></arg><arg name="pages"><space/>507–508<space/></arg></template></extension><space/>About a quarter of people recovering from<space/><link><target>alcoholism</target></link><space/>experience anxiety and depression, which can persist for up to 2 years.<extension extension_name='ref'><template><target>Cite book</target><arg name="last1"><space/>Johnson<space/></arg><arg name="first1"><space/>Bankole A.<space/></arg><arg name="title"><space/>Addiction medicine : science and practic<space/></arg><arg name="url"><space/>https://books.google.com/books?id</arg><arg name="year"><space/>2011<space/></arg><arg name="publisher"><space/>Springer<space/></arg><arg name="location"><space/>New York<space/></arg><arg name="isbn"><space/>978-1-4419-0337-2<space/></arg><arg name="pages"><space/>301–303<space/></arg></template></extension><space/><link><target>Methamphetamine</target></link><space/>abuse is also commonly associated with depression.<extension extension_name='ref' name="pmid20659059"><template><target>cite journal</target><arg name="author"><space/>Marshall BD, Werb D<space/></arg><arg name="title"><space/>Health outcomes associated with methamphetamine use among young people: a systematic review<space/></arg><arg name="journal"><space/>Addiction<space/></arg><arg name="volume"><space/>105<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>991–1002<space/></arg><arg name="date"><space/>June 2010<space/></arg><arg name="pmid"><space/>20659059<space/></arg><arg name="doi"><space/>10.1111/j.1360-0443.2010.02932.x<space/></arg><arg name="url"><space/></arg></template></extension></paragraph><heading level='2'>Diagnosis</heading><heading level='3'>Clinical assessment</heading><paragraph><template><target>further2</target><arg>Rating scales for depression</arg></template></paragraph><paragraph>A diagnostic assessment may be conducted by a suitably trained<space/><link><target>general practitioner</target></link>, or by a<space/><link><target>psychiatrist</target></link><space/>or<space/><link><target>psychologist</target></link>,<extension extension_name='ref' name="NIMHPub"></extension><space/>who<space/><link><target>psychiatric history</target><part>records</part></link><space/>the person's current circumstances, biographical history, current symptoms, and family history. The broad clinical aim is to formulate the relevant biological, psychological, and social factors that may be impacting on the individual's mood. The assessor may also discuss the person's current ways of regulating mood (healthy or otherwise) such as alcohol and drug use. The assessment also includes a<space/><link><target>mental state examination</target></link>, which is an assessment of the person's current mood and thought content, in particular the presence of themes of hopelessness or pessimism,<space/><link><target>self-harm</target></link><space/>or suicide, and an absence of positive thoughts or plans.<extension extension_name='ref' name="NIMHPub"></extension><space/>Specialist mental health services are rare in rural areas, and thus diagnosis and management is left largely to<space/><link><target>primary care</target><part>primary-care</part></link><space/>clinicians.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Kaufmann IM<space/></arg><arg name="title"><space/>Rural psychiatric services. A collaborative model<space/></arg><arg name="journal"><space/>Canadian Family Physician<space/></arg><arg name="volume"><space/>39<space/></arg><arg name="pages"><space/>1957–61<space/></arg><arg name="date"><space/>1 September 1993<space/></arg><arg name="pmid"><space/>8219844<space/></arg><arg name="pmc"><space/>2379905<space/></arg></template></extension><space/>This issue is even more marked in developing countries.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://news.bbc.co.uk/1/hi/health/492941.stm<space/></arg><arg name="title">Call for action over Third World depression<space/></arg><arg name="accessdate">11 October 2008</arg><arg name="date">1 November 1999<space/></arg><arg name="work">BBC News (Health)<space/></arg><arg name="publisher">British Broadcasting Corporation (BBC)</arg></template></extension><space/>The mental health examination may include the use of a<space/><link><target>rating scale</target></link><space/>such as the<space/><link><target>Hamilton Rating Scale for Depression</target></link><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Zimmerman M, Chelminski I, Posternak M<space/></arg><arg name="title"><space/>A Review of Studies of the Hamilton Depression Rating Scale in Healthy Controls: Implications for the Definition of Remission in Treatment Studies Of Depression<space/></arg><arg name="journal"><space/>J Nerv Ment Dis<space/></arg><arg name="volume"><space/>192<space/></arg><arg name="issue"><space/>9<space/></arg><arg name="pages"><space/>595–601<space/></arg><arg name="date"><space/>September 2004<space/></arg><arg name="pmid"><space/>15348975<space/></arg><arg name="doi"><space/>10.1097/01.nmd.0000138226.22761.39<space/></arg></template></extension><space/>or the<space/><link><target>Beck Depression Inventory</target></link><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>McPherson A, Martin CR<space/></arg><arg name="title"><space/>A Narrative Review of the Beck Depression Inventory (BDI) and Implications for its Use in an Alcohol-Dependent Population<space/></arg><arg name="journal"><space/>J Psychiatr Ment Health Nurs<space/></arg><arg name="volume"><space/>17<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>19–30<space/></arg><arg name="date"><space/>February 2010<space/></arg><arg name="pmid"><space/>20100303<space/></arg><arg name="doi"><space/>10.1111/j.1365-2850.2009.01469.x<space/></arg></template></extension><space/>or the<space/><link><target>Suicide Behaviors Questionnaire-Revised</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Osman</arg><arg name="first1">A.</arg><arg name="last2">Bagge</arg><arg name="first2">C. L.</arg><arg name="last3">Gutierrez</arg><arg name="first3">P. M.</arg><arg name="last4">Konick</arg><arg name="first4">L. C.</arg><arg name="last5">Kopper</arg><arg name="first5">B. A.</arg><arg name="last6">Barrios</arg><arg name="first6">F. X.</arg><arg name="title">The Suicidal Behaviors Questionnaire-Revised (SBQ-R):Validation with Clinical and Nonclinical Samples</arg><arg name="journal">Assessment</arg><arg name="date">1 December 2001</arg><arg name="volume">8</arg><arg name="issue">4</arg><arg name="pages">443–454</arg><arg name="doi">10.1177/107319110100800409</arg></template></extension><space/>The score on a rating scale alone is insufficient to diagnose depression to the satisfaction of the DSM or ICD, but it provides an indication of the severity of symptoms for a time period, so a person who scores above a given cut-off point can be more thoroughly evaluated for a depressive disorder diagnosis.<extension extension_name='ref' name="pmid12358212"></extension><space/>Several rating scales are used for this purpose.<extension extension_name='ref' name="pmid12358212"><template><target>cite journal</target><arg name="author"><space/>Sharp LK, Lipsky MS<space/></arg><arg name="title"><space/>Screening for depression across the lifespan: a review of measures for use in primary care settings<space/></arg><arg name="journal"><space/>American Family Physician<space/></arg><arg name="volume"><space/>66<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>1001–8<space/></arg><arg name="year"><space/>2002<space/></arg><arg name="pmid"><space/>12358212<space/></arg></template></extension><space/><link><target>Screening (medicine)</target><part>Screening</part></link><space/>programs have been advocated to improve detection of depression, but there is evidence that they do not improve detection rates, treatment, or outcome.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Gilbody S, House AO, Sheldon TA<space/></arg><arg name="title"><space/>Screening and case finding instruments for depression<space/></arg><arg name="journal"><space/>Cochrane Database of Systematic Reviews<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>CD002792<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>16235301<space/></arg><arg name="doi"><space/>10.1002/14651858.CD002792.pub2<space/></arg><arg name="url"><space/>http://www.cochrane.org/reviews/en/ab002792.html<space/></arg></template></extension></paragraph><paragraph><link><target>Primary-care physician</target><trail>s</trail></link><space/>and other non-psychiatrist physicians have difficulty diagnosing depression, in part because they are trained to recognize and treat physical symptoms, and depression can cause myriad physical (<link><target>psychosomatic</target></link>) symptoms. Non-psychiatrists miss two-thirds of cases and unnecessarily treat other patients.<extension extension_name='ref' name="pmid17968628"><template><target>cite journal</target><arg name="author"><space/>Cepoiu M, McCusker J, Cole MG, Sewitch M, Belzile E, Ciampi A<space/></arg><arg name="title"><space/>Recognition of depression by non-psychiatric physicians—a systematic literature review and meta-analysis<space/></arg><arg name="journal"><space/>J Gen Intern Med<space/></arg><arg name="volume"><space/>23<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>25–36<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>17968628<space/></arg><arg name="pmc"><space/>2173927<space/></arg><arg name="doi"><space/>10.1007/s11606-007-0428-5<space/></arg></template></extension><extension extension_name='ref' name="lancet"><template><target>cite journal</target><arg name="author">Dale J, Sorour E, Milner G<space/></arg><arg name="year">2008<space/></arg><arg name="title">Do psychiatrists perform appropriate physical investigations for their patients? A review of current practices in a general psychiatric inpatient and outpatient setting<space/></arg><arg name="journal">Journal of Mental Health<space/></arg><arg name="volume">17<space/></arg><arg name="issue">3<space/></arg><arg name="pages">293–98</arg><arg name="doi">10.1080/09638230701498325</arg></template></extension></paragraph><paragraph>Before diagnosing a major depressive disorder, in general a doctor performs a medical examination and selected investigations to rule out other causes of symptoms. These include blood tests measuring<space/><link><target>Thyroid-stimulating hormone</target><part>TSH</part></link><space/>and<space/><link><target>thyroxine</target></link><space/>to exclude<space/><link><target>hypothyroidism</target></link>;<space/><link><target>Blood tests#Biochemical analysis</target><part>basic electrolytes</part></link><space/>and serum<space/><link><target>calcium</target></link><space/>to rule out a<space/><link><target>Metabolic disorder</target><part>metabolic disturbance</part></link>; and a<space/><link><target>Complete blood count</target><part>full blood count</part></link><space/>including<space/><link><target>Erythrocyte sedimentation rate</target><part>ESR</part></link><space/>to rule out a<space/><link><target>systemic infection</target></link><space/>or chronic disease.<extension extension_name='ref' name="lancet"></extension><space/>Adverse affective reactions to medications or alcohol misuse are often ruled out, as well.<space/><link><target>Testosterone</target></link><space/>levels may be evaluated to diagnose<space/><link><target>hypogonadism</target></link>, a cause of depression in men.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Orengo CA, Fullerton G, Tan R<space/></arg><arg name="title"><space/>Male depression: A review of gender concerns and testosterone therapy<space/></arg><arg name="journal"><space/>Geriatrics<space/></arg><arg name="volume"><space/>59<space/></arg><arg name="issue"><space/>10<space/></arg><arg name="pages"><space/>24–30<space/></arg><arg name="year"><space/>2004<space/></arg><arg name="pmid"><space/>15508552<space/></arg></template></extension></paragraph><paragraph>Subjective cognitive complaints appear in older depressed people, but they can also be indicative of the onset of a<space/><link><target>dementia</target><part>dementing disorder</part></link>, such as<space/><link><target>Alzheimer's disease</target></link>.<extension extension_name='ref' name="pmid17047326"><template><target>cite journal</target><arg name="author"><space/>Reid LM, Maclullich AM<space/></arg><arg name="title"><space/>Subjective memory complaints and cognitive impairment in older people<space/></arg><arg name="journal"><space/>Dementia and geriatric cognitive disorders<space/></arg><arg name="volume"><space/>22<space/></arg><arg name="issue"><space/>5–6<space/></arg><arg name="pages"><space/>471–85<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>17047326<space/></arg><arg name="doi"><space/>10.1159/000096295<space/></arg></template></extension><extension extension_name='ref' name="pmid9720486"><template><target>cite journal</target><arg name="author"><space/>Katz IR<space/></arg><arg name="title"><space/>Diagnosis and treatment of depression in patients with Alzheimer's disease and other dementias<space/></arg><arg name="journal"><space/>The Journal of clinical psychiatry<space/></arg><arg name="volume"><space/>59 Suppl 9<space/></arg><arg name="pages"><space/>38–44<space/></arg><arg name="year"><space/>1998<space/></arg><arg name="pmid"><space/>9720486<space/></arg></template></extension><space/><link><target>Neuropsychological assessment</target><part>Cognitive testing</part></link><space/>and brain imaging can help distinguish depression from dementia.<extension extension_name='ref' name="pmid18004006"><template><target>cite journal</target><arg name="author"><space/>Wright SL, Persad C<space/></arg><arg name="title"><space/>Distinguishing between depression and dementia in older persons: Neuropsychological and neuropathological correlates<space/></arg><arg name="journal"><space/>Journal of geriatric psychiatry and neurology<space/></arg><arg name="volume"><space/>20<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>189–98<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>18004006<space/></arg><arg name="doi"><space/>10.1177/0891988707308801<space/></arg></template></extension><space/>A<space/><link><target>Computed tomography</target><part>CT scan</part></link><space/>can exclude brain pathology in those with psychotic, rapid-onset or otherwise unusual symptoms.<extension extension_name='ref'><template><target>Harvnb</target><arg>Sadock</arg><arg>2002</arg><arg name="p">108</arg></template></extension><space/>In general, investigations are not repeated for a subsequent episode unless there is a medical indication.</paragraph><paragraph>No biological tests confirm major depression.<extension extension_name='ref'><template><target>Harvnb</target><arg>Sadock</arg><arg>2002</arg><arg name="p">260</arg></template></extension><space/>Biomarkers of depression have been sought to provide an objective method of diagnosis. There are several potential biomarkers, including Brain-Derived Neurotrophic Factor and various functional MRI techniques. One study developed a decision tree model of interpreting a series of fMRI scans taken during various activities. In their subjects, the authors of that study were able to achieve a sensitivity of 80% and a specificity of 87%, corresponding to a negative predictive value of 98% and a positive predictive value of 32% (positive and negative likelihood ratios were 6.15, 0.23, respectively). However, much more research is needed before these tests could be used clinically.<extension extension_name='ref' name="pmid21135315"><template><target>cite journal</target><arg name="author"><space/>Hahn T, Marquand AF, Ehlis AC, Dresler T, Kittel-Schneider S, Jarczok TA, Lesch KP, Jakob PM, Mourao-Miranda J, Brammer MJ, Fallgatter AJ<space/></arg><arg name="title"><space/>Integrating Neurobiological Markers of Depression<space/></arg><arg name="journal"><space/>Arch. Gen. Psychiatry<space/></arg><arg name="volume"><space/>68<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>361–368<space/></arg><arg name="date"><space/>December 2010<space/></arg><arg name="pmid"><space/>21135315<space/></arg><arg name="doi"><space/>10.1001/archgenpsychiatry.2010.178<space/></arg><arg name="url"><space/>http://archpsyc.ama-assn.org/cgi/pmidlookup?view</arg><arg name="accessdate"><space/>1 April 2011<space/></arg></template></extension></paragraph><heading level='3'>DSM-IV-TR and ICD-10 criteria</heading><paragraph>The most widely used criteria for diagnosing depressive conditions are found in the<space/><link><target>American Psychiatric Association</target></link>'s revised fourth edition of the<space/><italics><link><target>Diagnostic and Statistical Manual of Mental Disorders</target></link></italics><space/>(DSM-IV-TR), and the<space/><link><target>World Health Organization</target></link>'s<space/><italics><link><target>ICD</target><part>International Statistical Classification of Diseases and Related Health Problems</part></link></italics><space/>(ICD-10), which uses the name<space/><italics>depressive episode</italics><space/>for a single episode and<space/><italics>recurrent depressive disorder</italics><space/>for repeated episodes.<extension extension_name='ref' name="ICD-10"><template><target>cite web</target><arg name="url">http://apps.who.int/classifications/icd10/browse/2010/en#/F30-F39</arg><arg name="title">Mental and behavioural disorders: Mood [affective] disorders</arg><arg name="publisher">[[World Health Organization]]</arg><arg name="date">2010</arg><arg name="accessdate">8 November 2008</arg></template></extension><space/>The latter system is typically used in European countries, while the former is used in the US and many other non-European nations,<extension extension_name='ref'><template><target>Harvnb</target><arg>Sadock</arg><arg>2002</arg><arg name="p">288</arg></template></extension><space/>and the authors of both have worked towards conforming one with the other.<extension extension_name='ref' name="APA372"><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">xxix</arg></template></extension></paragraph><paragraph>Both DSM-IV-TR and ICD-10 mark out typical (main) depressive symptoms.<extension extension_name='ref' name="DSMvsICD"></extension><space/>ICD-10 defines three typical depressive symptoms (depressed mood, anhedonia, and reduced energy), two of which should be present to determine depressive disorder diagnosis.<extension extension_name='ref' name="DSM-10 diagnosis"><template><target>cite web</target><arg name="title">The ICD-10 Classification of Mental and Behavioural Disorders: Clinical descriptions and diagnostic guidelines</arg><arg name="url">http://www.who.int/classifications/icd/en/bluebook.pdf</arg><arg name="date">2010</arg><arg name="publisher">[[World Health Organization]]</arg><arg name="accessdate">12 November 2014</arg></template></extension><extension extension_name='ref'>The ICD-10 classification of mental and behavioral disorders. Clinical description and diagnostic guideline. Geneva: World Health Organization, 1992</extension><space/>According to DSM-IV-TR, there are two main depressive symptomsdepressed mood and anhedonia. At least one of these must be present to make a diagnosis of major depressive episode.<extension extension_name='ref' name="APA000"><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg></template></extension></paragraph><paragraph>Major depressive disorder is classified as a mood disorder in DSM-IV-TR.<extension extension_name='ref' name="APA345"><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">345</arg></template></extension><space/>The diagnosis hinges on the presence of single or recurrent<space/><link><target>major depressive episode</target><trail>s</trail></link>.<extension extension_name='ref' name="APA349"></extension><space/>Further qualifiers are used to classify both the episode itself and the course of the disorder. The category<space/><link><target>Depressive Disorder Not Otherwise Specified</target></link><space/>is diagnosed if the depressive episode's manifestation does not meet the criteria for a major depressive episode. The<space/><link><target>ICD-10</target></link><space/>system does not use the term<space/><italics>major depressive disorder</italics><space/>but lists very similar criteria for the diagnosis of a depressive episode (mild, moderate or severe); the term<space/><italics>recurrent</italics><space/>may be added if there have been multiple episodes without mania.<extension extension_name='ref' name="ICD-10"></extension></paragraph><heading level='4'>Major depressive episode</heading><paragraph><template><target>Main</target><arg>Major depressive episode</arg></template></paragraph><paragraph>A major depressive episode is characterized by the presence of a severely depressed mood that persists for at least two weeks.<extension extension_name='ref' name="APA349"></extension><space/>Episodes may be isolated or recurrent and are categorized as mild (few symptoms in excess of minimum criteria), moderate, or severe (marked impact on social or occupational functioning). An episode with psychotic featurescommonly referred to as<space/><italics><link><target>psychotic depression</target></link></italics>is automatically rated as severe. If the patient has had an episode of<space/><link><target>mania</target></link><space/>or<space/><link><target>hypomania</target><part>markedly elevated mood</part></link>, a diagnosis of<space/><link><target>bipolar disorder</target></link><space/>is made instead.<extension extension_name='ref' name="autogenerated2"><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">372</arg></template></extension><space/>Depression without mania is sometimes referred to as<space/><italics>unipolar</italics><space/>because the mood remains at one emotional state or &quot;pole&quot;.<extension extension_name='ref'><template><target>Harvnb</target><arg>Parker</arg><arg>1996</arg><arg name="p">173</arg></template></extension></paragraph><paragraph>DSM-IV-TR excludes cases where the symptoms are a result of<space/><link><target>bereavement</target></link>, although it is possible for normal bereavement to evolve into a depressive episode if the mood persists and the characteristic features of a major depressive episode develop.<extension extension_name='ref' name="APA352"><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">352</arg></template></extension><space/>The criteria have been criticized because they do not take into account any other aspects of the personal and social context in which depression can occur.<extension extension_name='ref' name="Wakefield07"><template><target>cite journal</target><arg name="author"><space/>Wakefield JC, Schmitz MF, First MB, Horwitz AV<space/></arg><arg name="title"><space/>Extending the bereavement exclusion for major depression to other losses: Evidence from the National Comorbidity Survey<space/></arg><arg name="journal"><space/>Archives of General Psychiatry<space/></arg><arg name="volume"><space/>64<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>433–40<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17404120<space/></arg><arg name="doi"><space/>10.1001/archpsyc.64.4.433<space/></arg><arg name="url"><space/>http://archpsyc.ama-assn.org/cgi/content/full/64/4/433<space/></arg><arg name="laysummary"><space/>http://www.washingtonpost.com/wp-dyn/content/article/2007/04/02/AR2007040201693.html<space/></arg><arg name="laydate"><space/>3 April 2007<space/></arg><arg name="laysource"><space/>The Washington Post<space/></arg></template></extension><space/>In addition, some studies have found little empirical support for the DSM-IV cut-off criteria, indicating they are a diagnostic convention imposed on a continuum of depressive symptoms of varying severity and duration:<extension extension_name='ref' name="Kendler98"><template><target>cite journal</target><arg name="author"><space/>Kendler KS, Gardner CO<space/></arg><arg name="title"><space/>Boundaries of major depression: An evaluation of DSM-IV criteria<space/></arg><arg name="journal"><space/>American Journal of Psychiatry<space/></arg><arg name="volume"><space/>155<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>172–77<space/></arg><arg name="date"><space/>1 February 1998<space/></arg><arg name="pmid"><space/>9464194<space/></arg><arg name="url"><space/>http://ajp.psychiatryonline.org/cgi/content/full/155/2/172<space/></arg></template></extension><space/>Excluded are a range of related diagnoses, including<space/><link><target>dysthymia</target></link>, which involves a chronic but milder mood disturbance;<extension extension_name='ref' name="harvnb"><template><target>Harvnb</target><arg>Sadock</arg><arg>2002</arg><arg name="p">552</arg></template></extension><space/><link><target>recurrent brief depression</target></link>, consisting of briefer depressive episodes;<extension extension_name='ref'><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">778</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Carta MG, Altamura AC, Hardoy MC, Pinna F, Medda S, Dell'Osso L, Carpiniello B, Angst J<space/></arg><arg name="title"><space/>Is recurrent brief depression an expression of mood spectrum disorders in young people?<space/></arg><arg name="journal"><space/>European Archives of Psychiatry and Clinical Neuroscience<space/></arg><arg name="volume"><space/>253<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>149–53<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12904979<space/></arg><arg name="doi"><space/>10.1007/s00406-003-0418-5<space/></arg></template></extension><space/><link><target>minor depressive disorder</target></link>, whereby only some symptoms of major depression are present;<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Rapaport MH, Judd LL, Schettler PJ, Yonkers KA, Thase ME, Kupfer DJ, Frank E, Plewes JM, Tollefson GD, Rush AJ<space/></arg><arg name="title"><space/>A descriptive analysis of minor depression<space/></arg><arg name="journal"><space/>American Journal of Psychiatry<space/></arg><arg name="volume"><space/>159<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>637–43<space/></arg><arg name="year"><space/>2002<space/></arg><arg name="pmid"><space/>11925303<space/></arg><arg name="doi"><space/>10.1176/appi.ajp.159.4.637<space/></arg></template></extension><space/>and<space/><link><target>Adjustment disorder</target><part>adjustment disorder with depressed mood</part></link>, which denotes low mood resulting from a psychological response to an identifiable event or<space/><link><target>Stress (biological)</target><part>stressor</part></link>.<extension extension_name='ref' name="psychiatric355"><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">355</arg></template></extension></paragraph><heading level='4'>Subtypes</heading><paragraph>The DSM-IV-TR recognizes five further subtypes of MDD, called<space/><italics>specifiers</italics>, in addition to noting the length, severity and presence of psychotic features:</paragraph><list type='bullet'><listitem><bold><link><target>Melancholic depression</target></link></bold><space/>is characterized by a loss of pleasure in most or all activities, a failure of reactivity to pleasurable stimuli, a quality of depressed mood more pronounced than that of<space/><link><target>grief</target></link><space/>or loss, a worsening of symptoms in the morning hours, early-morning waking,<space/><link><target>psychomotor retardation</target></link>, excessive weight loss (not to be confused with<space/><link><target>anorexia nervosa</target></link>), or excessive guilt.<extension extension_name='ref'><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="pp">419–20</arg></template></extension></listitem><listitem><bold><link><target>Atypical depression</target></link></bold><space/>is characterized by mood reactivity (paradoxical anhedonia) and positivity, significant<space/><link><target>weight gain</target></link><space/>or increased appetite (comfort eating), excessive sleep or sleepiness (<link><target>hypersomnia</target></link>), a sensation of heaviness in limbs known as leaden paralysis, and significant social impairment as a consequence of hypersensitivity to perceived<space/><link><target>social rejection</target><part>interpersonal rejection</part></link>.<extension extension_name='ref'><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="pp">421–22</arg></template></extension></listitem><listitem><bold><link><target>Catatonia</target><part>Catatonic</part></link><space/>depression</bold><space/>is a rare and severe form of major depression involving disturbances of motor behavior and other symptoms. Here, the person is mute and almost stuporous, and either remains immobile or exhibits purposeless or even bizarre movements. Catatonic symptoms also occur in<space/><link><target>schizophrenia</target></link><space/>or in manic episodes, or may be caused by<space/><link><target>neuroleptic malignant syndrome</target></link>.<extension extension_name='ref'><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="pp">417–18</arg></template></extension></listitem><listitem><bold><link><target>Postpartum depression</target></link></bold>, or<space/><bold>mental and behavioral disorders associated with the<space/><template><target>linktext</target><arg>puerperium</arg></template>, not elsewhere classified</bold>,<extension extension_name='ref' name="ICD-10"></extension><space/>refers to the intense, sustained and sometimes disabling depression experienced by women after giving birth. Postpartum depression has an incidence rate of 1015% among new mothers. The DSM-IV mandates that, in order to qualify as postpartum depression, onset occur within one month of delivery. It has been said that postpartum depression can last as long as three months.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Nonacs, Ruta M<space/></arg><arg name="url">http://www.emedicine.com/med/topic3408.htm<space/></arg><arg name="publisher">eMedicine<space/></arg><arg name="title">Postpartum depression</arg><arg name="date">4 December 2007</arg><arg name="accessdate">30 October 2008</arg></template></extension></listitem><listitem><bold><link><target>Seasonal affective disorder</target></link></bold><space/>(SAD) is a form of depression in which depressive episodes come on in the autumn or winter, and resolve in spring. The diagnosis is made if at least two episodes have occurred in colder months with none at other times, over a two-year period or longer.<extension extension_name='ref'><template><target>Harvnb</target><arg>American Psychiatric Association</arg><arg>2000a</arg><arg name="p">425</arg></template></extension></listitem></list><heading level='3'>Differential diagnoses</heading><paragraph><template><target>Main</target><arg>Depression (differential diagnoses)</arg></template></paragraph><paragraph>To confer major depressive disorder as the most likely diagnosis, other<space/><link><target>Differential diagnosis</target><part>potential diagnoses</part></link><space/>must be considered, including dysthymia, adjustment disorder with depressed mood, or bipolar disorder.<space/><link><target>Dysthymia</target></link><space/>is a chronic, milder mood disturbance in which a person reports a low mood almost daily over a span of at least two years. The symptoms are not as severe as those for major depression, although people with dysthymia are vulnerable to secondary episodes of major depression (sometimes referred to as<space/><italics>double depression</italics>).<extension extension_name='ref' name="harvnb"></extension><space/><link><target>Adjustment disorder</target><part>Adjustment disorder with depressed mood</part></link><space/>is a mood disturbance appearing as a psychological response to an identifiable event or stressor, in which the resulting emotional or behavioral symptoms are significant but do not meet the criteria for a major depressive episode.<extension extension_name='ref' name="psychiatric355"></extension><space/><link><target>Bipolar disorder</target></link>, also known as<space/><italics>manicdepressive disorder</italics>, is a condition in which depressive phases alternate with periods of mania or<space/><link><target>hypomania</target></link>. Although depression is currently categorized as a separate disorder, there is ongoing debate because individuals diagnosed with major depression often experience some hypomanic symptoms, indicating a mood disorder continuum.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Akiskal HS, Benazzi F<space/></arg><arg name="title"><space/>The DSM-IV and ICD-10 categories of recurrent [major] depressive and bipolar II disorders: Evidence that they lie on a dimensional spectrum<space/></arg><arg name="journal"><space/>Journal of Affective Disorders<space/></arg><arg name="volume"><space/>92<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>45–54<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16488021<space/></arg><arg name="doi"><space/>10.1016/j.jad.2005.12.035<space/></arg></template></extension></paragraph><paragraph>Other disorders need to be ruled out before diagnosing major depressive disorder. They include depressions due to physical illness,<space/><link><target>medications</target></link>, and<space/><link><target>substance abuse</target></link>. Depression due to physical illness is diagnosed as a<space/><link><target>mood disorder</target></link><space/>due to a general medical condition. This condition is determined based on history, laboratory findings, or<space/><link><target>physical examination</target></link>. When the depression is caused by a substance abused including a drug of abuse, a medication, or exposure to a<space/><link><target>toxin</target></link>, it is then diagnosed as a substance-induced mood disorder.<extension extension_name='ref'><template><target>cite web</target><arg name="url">https://web.archive.org/web/20080715124733/http://www.psychnet-uk.com/dsm_iv/major_depression.htm</arg><arg name="title">Major Depressive Episode</arg><arg name="work">psychnet-uk.com</arg><arg name="accessdate"><space/>16 July 2010</arg></template></extension></paragraph><heading level='2'>Prevention</heading><paragraph>Preventative efforts may result in decreases in rates of the condition of between 22 and 38%.<extension extension_name='ref' name="Cuijpers2008"></extension><space/>Eating large amounts of fish may also reduce the risk.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Li</arg><arg name="first1">F</arg><arg name="last2">Liu</arg><arg name="first2">X</arg><arg name="last3">Zhang</arg><arg name="first3">D</arg><arg name="title">Fish consumption and risk of depression: a meta-analysis.</arg><arg name="journal">Journal of epidemiology and community health</arg><arg name="date">10 September 2015</arg><arg name="pmid">26359502</arg></template></extension></paragraph><paragraph>Behavioral interventions, such as<space/><link><target>interpersonal therapy</target></link><space/>and<space/><link><target>cognitive-behavioral therapy</target></link>, are effective at preventing new onset depression.<extension extension_name='ref' name="Cuijpers2008"><template><target>cite journal</target><arg name="author"><space/>Cuijpers P, van Straten A, Smit F, Mihalopoulos C, Beekman A<space/></arg><arg name="title"><space/>Preventing the onset of depressive disorders: a meta-analytic review of psychological interventions<space/></arg><arg name="journal"><space/>Am J Psychiatry<space/></arg><arg name="volume"><space/>165<space/></arg><arg name="issue"><space/>10<space/></arg><arg name="pages"><space/>1272–80<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18765483<space/></arg><arg name="doi"><space/>10.1176/appi.ajp.2008.07091422<space/></arg></template></extension><extension extension_name='ref' name="Munoz2012"><template><target>cite journal</target><arg name="author"><space/>Muñoz RF, Beardslee WR, Leykin Y<space/></arg><arg name="title"><space/>Major depression can be prevented<space/></arg><arg name="journal"><space/>The American Psychologist<space/></arg><arg name="volume"><space/>67<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>285–95<space/></arg><arg name="date"><space/>May–June 2012<space/></arg><arg name="pmid"><space/>22583342<space/></arg><arg name="doi"><space/>10.1037/a0027666<space/></arg></template></extension><extension extension_name='ref' name="Cuijpers2012"><template><target>cite conference</target><arg name="author">Cuijpers, P</arg><arg name="title">Prevention and early treatment of mental ill-health</arg><arg name="url">http://congres.efpa.eu/downloads/Pim-Cuijpers_Prevention-and-early-treatment-of-mental-ill-health-EFPASep%202012.pdf</arg><arg name="place">PSYCHOLOGY FOR HEALTH: Contributions to Policy Making, Brussels</arg><arg name="date">20 September 2012</arg></template></extension><space/>Because such interventions appear to be most effective when delivered to individuals or small groups, it has been suggested that they may be able to reach their large target audience most efficiently through the<space/><link><target>Internet</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Griffiths, K.M.; Farrer, L.; Christensen, H.<space/></arg><arg name="year">2010</arg><arg name="volume"><space/>192</arg><arg name="issue">11</arg><arg name="pages">4–11<space/></arg><arg name="title">The efficacy of internet interventions for depression and anxiety disorders: a review of randomised controlled trials</arg><arg name="journal">Medical Journal of Australia<space/></arg><arg name="url">https://www.mja.com.au/system/files/issues/192_11_070610/gri10844_fm.pdf</arg><arg name="accessdate">12 November 2014</arg></template></extension></paragraph><paragraph>However, an earlier meta-analysis found preventive programs with a competence-enhancing component to be superior to behavior-oriented programs overall, and found behavioral programs to be particularly unhelpful for older people, for whom social support programs were uniquely beneficial. In addition, the programs that best prevented depression comprised more than eight sessions, each lasting between 60 and 90 minutes, were provided by a combination of lay and professional workers, had a high-quality research design, reported<space/><link><target>Churn rate</target><part>attrition rates</part></link>, and had a well-defined intervention.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Jané-Llopis E; Hosman C; Jenkins R; Anderson P.</arg><arg name="year">2003<space/></arg><arg name="url">http://bjp.rcpsych.org/cgi/reprint/183/5/384.pdf<space/></arg><arg name="title">Predictors of efficacy in depression prevention programmes<space/></arg><arg name="work">British Journal of Psychiatry<space/></arg><arg name="accessdate">2 April 2009<space/></arg><arg name="format">PDF</arg></template></extension></paragraph><paragraph>The Netherlands mental health care system provides preventive interventions, such as the &quot;Coping with Depression&quot; course (CWD) for people with sub-threshold depression. The course is claimed to be the most successful of psychoeducational interventions for the treatment and prevention of depression (both for its adaptability to various populations and its results), with a risk reduction of 38% in major depression and an efficacy as a treatment comparing favorably to other psychotherapies.<extension extension_name='ref' name="Munoz2012"></extension><extension extension_name='ref' name="Cuijpers2009"><template><target>cite journal</target><arg name="author"><space/>Cuijpers P, Muñoz RF, Clarke GN, Lewinsohn PM<space/></arg><arg name="title"><space/>Psychoeducational treatment and prevention of depression: the "Coping with Depression" course thirty years later<space/></arg><arg name="journal"><space/>Clinical Psychology Review<space/></arg><arg name="volume"><space/>29<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>449–458<space/></arg><arg name="year"><space/>2009<space/></arg><arg name="pmid"><space/>19450912<space/></arg><arg name="doi"><space/>10.1016/j.cpr.2009.04.005<space/></arg></template></extension></paragraph><heading level='2'>Management</heading><paragraph><template><target>Main</target><arg>Management of depression</arg></template>The three most common treatments for depression are psychotherapy, medication, and electroconvulsive therapy. Psychotherapy is the treatment of choice (over medication) for people under 18. The UK<space/><link><target>National Institute for Health and Care Excellence</target></link><space/>(NICE) 2004 guidelines indicate that antidepressants should not be used for the initial treatment of mild depression, because the risk-benefit ratio is poor. The guidelines recommend that antidepressants treatment in combination with psychosocial interventions should be considered for:</paragraph><list type='ident'><listitem><list type='bullet'><listitem>People with a history of moderate or severe depression</listitem><listitem>Those with mild depression that has been present for a long period</listitem><listitem>As a second line treatment for mild depression that persists after other interventions</listitem><listitem>As a first line treatment for moderate or severe depression.</listitem></list></listitem></list><paragraph>The guidelines further note that antidepressant treatment should be continued for at least six months to reduce the risk of relapse, and that SSRIs are better tolerated than tricyclic antidepressants.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.nice.org.uk/guidance/CG23<space/></arg><arg name="accessdate">20 March 2013<space/></arg><arg name="title">Depression<space/></arg><arg name="publisher">National Institute for Health and Care Excellence<space/></arg><arg name="date">December 2004<space/></arg><arg name="archiveurl">https://web.archive.org/web/20081115042517/http://www.nice.org.uk/Guidance/CG23<space/></arg><arg name="archivedate">15 November 2008<space/></arg><arg name="deadurl">no</arg></template></extension></paragraph><paragraph><link><target>American Psychiatric Association</target></link><space/>treatment guidelines recommend that initial treatment should be individually tailored based on factors including severity of symptoms, co-existing disorders, prior treatment experience, and patient preference. Options may include pharmacotherapy, psychotherapy, electroconvulsive therapy (ECT), transcranial magnetic stimulation (TMS) or light therapy. Antidepressant medication is recommended as an initial treatment choice in people with mild, moderate, or severe major depression, and should be given to all patients with severe depression unless ECT is planned.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://psychiatryonline.org/content.aspx?bookID</arg><arg name="title">PsychiatryOnline &#124; APA Practice Guidelines &#124; Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Third Edition<space/></arg><arg name="format"><space/></arg><arg name="work"><space/></arg><arg name="accessdate"></arg></template></extension></paragraph><paragraph>Treatment options are much more limited in developing countries, where access to mental health staff, medication, and psychotherapy is often difficult. Development of mental health services is minimal in many countries; depression is viewed as a phenomenon of the developed world despite evidence to the contrary, and not as an inherently life-threatening condition.<extension extension_name='ref' name="Patel04"><template><target>cite journal</target><arg name="author"><space/>Patel V, Araya R, Bolton P<space/></arg><arg name="title"><space/>Editorial: Treating depression in the developing world<space/></arg><arg name="journal"><space/>Tropical Medicine & International Health<space/></arg><arg name="volume"><space/>9<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>539–41<space/></arg><arg name="year"><space/>2004<space/></arg><arg name="pmid"><space/>15117296<space/></arg><arg name="doi"><space/>10.1111/j.1365-3156.2004.01243.x<space/></arg><arg name="subscription"><space/>yes<space/></arg></template></extension><space/>A 2014 Cochrane review found insufficient evidence to determine the effectiveness of psychological versus medical therapy in children.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Cox GR, Callahan P, Churchill R, Hunot V, Merry SN, Parker AG, Hetrick SE<space/></arg><arg name="title"><space/>Psychological therapies versus antidepressant medication, alone and in combination for depression in children and adolescents.<space/></arg><arg name="journal"><space/>The Cochrane database of systematic reviews<space/></arg><arg name="volume"><space/>11<space/></arg><arg name="pages"><space/>CD008324<space/></arg><arg name="date"><space/>30 November 2014<space/></arg><arg name="pmid"><space/>25433518<space/></arg><arg name="doi">10.1002/14651858.CD008324.pub3</arg></template></extension></paragraph><heading level='3'>Psychotherapy</heading><paragraph><link><target>Psychotherapy</target></link><space/>can be delivered, to individuals, groups, or families by mental health professionals, including psychotherapists,<space/><link><target>psychiatrists</target></link>,<space/><link><target>psychologists</target></link>, clinical<space/><link><target>social work</target><trail>ers</trail></link>, counselors, and suitably trained psychiatric nurses. With more complex and chronic forms of depression, a combination of medication and psychotherapy may be used.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Thase ME<space/></arg><arg name="title"><space/>When are psychotherapy and pharmacotherapy combinations the treatment of choice for major depressive disorder?<space/></arg><arg name="journal"><space/>Psychiatric Quarterly<space/></arg><arg name="volume"><space/>70<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>333–46<space/></arg><arg name="year"><space/>1999<space/></arg><arg name="pmid"><space/>10587988<space/></arg><arg name="doi"><space/>10.1023/A:1022042316895<space/></arg></template></extension><extension extension_name='ref' name="Cordes"><template><target>cite encyclopedia</target><arg name="last1"><space/>Cordes<space/></arg><arg name="first1"><space/>J.<space/></arg><arg name="title"><space/>Encyclopedia of Sciences and Religions<space/></arg><arg name="pages"><space/>610<space/></arg><arg name="year"><space/>2013<space/></arg><arg name="doi"><space/>10.1007/978-1-4020-8265-8_301<space/></arg><arg name="chapter"><space/>Depression<space/></arg><arg name="isbn"><space/>978-1-4020-8264-1<space/></arg></template></extension><space/>A 2012 review found psychotherapy to be better than no treatment but not other treatments.<extension extension_name='ref' name="Khan2012"><template><target>cite journal</target><arg name="author"><space/>Khan A, Faucett J, Lichtenberg P, Kirsch I, Brown WA<space/></arg><arg name="title"><space/>A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression<space/></arg><arg name="journal"><space/>PLOS ONE<space/></arg><arg name="volume"><space/>7<space/></arg><arg name="issue"><space/>7<space/></arg><arg name="pages"><space/>e41778<space/></arg><arg name="date"><space/>30 July 2012<space/></arg><arg name="pmid"><space/>22860015<space/></arg><arg name="pmc"><space/>3408478<space/></arg><arg name="doi"><space/>10.1371/journal.pone.0041778<space/></arg><arg name="url"><space/>http://www.plosone.org/article/info:doi/10.1371/journal.pone.0041778#abstract0<space/></arg></template></extension><space/>A 2014<space/><link><target>Cochrane Collaboration</target><part>Cochrane review</part></link><space/>found that work-directed interventions combined with clinical interventions helped to reduce sick days taken by people with depression.<extension extension_name='ref' name=":0"><template><target>Cite journal</target><arg name="title"><space/>Interventions to improve return to work in depressed people</arg><arg name="url"><space/>http://www.ncbi.nlm.nih.gov/pubmed/25470301</arg><arg name="journal"><space/>The Cochrane Database of Systematic Reviews</arg><arg name="date"><space/>2014</arg><arg name="issn"><space/>1469-493X</arg><arg name="pmid"><space/>25470301</arg><arg name="pages"><space/>CD006237</arg><arg name="volume"><space/>12</arg><arg name="doi"><space/>10.1002/14651858.CD006237.pub3</arg><arg name="first"><space/>Karen</arg><arg name="last"><space/>Nieuwenhuijsen</arg><arg name="first2"><space/>Babs</arg><arg name="last2"><space/>Faber</arg><arg name="first3"><space/>Jos H.</arg><arg name="last3"><space/>Verbeek</arg><arg name="first4"><space/>Angela</arg><arg name="last4"><space/>Neumeyer-Gromen</arg><arg name="first5"><space/>Hiske L.</arg><arg name="last5"><space/>Hees</arg><arg name="first6"><space/>Arco C.</arg><arg name="last6"><space/>Verhoeven</arg><arg name="first7"><space/>Christina M.</arg><arg name="last7"><space/>van der Feltz-Cornelis</arg><arg name="first8"><space/>Ute</arg><arg name="last8"><space/>Bültmann</arg></template></extension></paragraph><paragraph>Psychotherapy has been shown to be effective in older people.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Wilson KC, Mottram PG, Vassilas CA<space/></arg><arg name="title"><space/>Psychotherapeutic treatments for older depressed people<space/></arg><arg name="journal"><space/>Cochrane Database of Systematic Reviews<space/></arg><arg name="volume"><space/>23<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>CD004853<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18254062<space/></arg><arg name="doi"><space/>10.1002/14651858.CD004853.pub2<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Cuijpers P, van Straten A, Smit F<space/></arg><arg name="title"><space/>Psychological treatment of late-life depression: a meta-analysis of randomized controlled trials<space/></arg><arg name="journal"><space/>International Journal of Geriatric Psychiatry<space/></arg><arg name="volume"><space/>21<space/></arg><arg name="issue"><space/>12<space/></arg><arg name="pages"><space/>1139–49<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16955421<space/></arg><arg name="doi"><space/>10.1002/gps.1620<space/></arg></template></extension><space/>Successful psychotherapy appears to reduce the recurrence of depression even after it has been terminated or replaced by occasional booster sessions.</paragraph><heading level='4'>Cognitive behavioral therapy</heading><paragraph><link><target>Cognitive behavioral therapy</target></link><space/>(CBT) currently has the most research evidence for the treatment of depression in children and adolescents, and CBT and interpersonal psychotherapy (IPT) are preferred therapies for adolescent depression.<extension extension_name='ref' name="abct"><link type='external' href='https://web.archive.org/web/20110726055131/http://www.abct.org/sccap/?m=sPublic&amp;amp;fa=pub_Depression'>Childhood Depression</link>. abct.org. Last updated: 30 July 2010</extension><space/>In people under 18, according to the<space/><link><target>National Institute for Health and Clinical Excellence</target></link>, medication should be offered only in conjunction with a psychological therapy, such as<space/><link><target>Cognitive behavioral therapy</target><part>CBT</part></link>,<space/><link><target>Interpersonal psychotherapy</target><part>interpersonal therapy</part></link>, or family therapy.<extension extension_name='ref' name="NICEkids5"><template><target>cite book</target><arg name="author">[[National Institute for Health and Clinical Excellence|NICE]]<space/></arg><arg name="title">NICE guidelines: Depression in children and adolescents<space/></arg><arg name="publisher">NICE<space/></arg><arg name="location">London<space/></arg><arg name="year">2005<space/></arg><arg name="pages">5<space/></arg><arg name="isbn">1-84629-074-0<space/></arg><arg name="url">http://www.nice.org.uk/Guidance/CG28/QuickRefGuide/pdf/English<space/></arg><arg name="accessdate">16 August 2008</arg></template></extension><space/>Cognitive behavioral therapy has also been shown to reduce the number of sick days taken by people with depression, when used in conjunction with primary care.<extension extension_name='ref' name=":0"></extension></paragraph><paragraph>The most-studied form of psychotherapy for depression is CBT, which teaches clients to challenge self-defeating, but enduring ways of thinking (cognitions) and change counter-productive behaviors. Research beginning in the mid-1990s suggested that CBT could perform as well or as better than antidepressants in patients with moderate to severe depression.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Dobson KS<space/></arg><arg name="title"><space/>A meta-analysis of the efficacy of cognitive therapy for depression<space/></arg><arg name="journal"><space/>J Consult Clin Psychol<space/></arg><arg name="volume"><space/>57<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>414–9<space/></arg><arg name="year"><space/>1989<space/></arg><arg name="pmid"><space/>2738214<space/></arg><arg name="doi"><space/>10.1037/0022-006X.57.3.414<space/></arg></template></extension><extension extension_name='ref' name="RothFonagy78"><template><target>cite book</target><arg name="title">What Works for Whom? Second Edition: A Critical Review of Psychotherapy Research</arg><arg name="last">Roth<space/></arg><arg name="first">Anthony<space/></arg><arg name="author2">Fonagy, Peter<space/></arg><arg name="year">2005</arg><arg name="origyear">1996<space/></arg><arg name="publisher">Guilford Press<space/></arg><arg name="isbn">1-59385-272-X<space/></arg><arg name="page">78</arg></template></extension><space/>CBT may be effective in depressed adolescents,<extension extension_name='ref' name="pmid9444896"><template><target>cite journal</target><arg name="author"><space/>Weersing VR, Walker PN<space/></arg><arg name="title"><space/>Review: Cognitive behavioural therapy for adolescents with depression<space/></arg><arg name="journal"><space/>Evidence-Based Mental Health<space/></arg><arg name="volume"><space/>11<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>76<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18669678<space/></arg><arg name="doi"><space/>10.1136/ebmh.11.3.76<space/></arg><arg name="url"><space/>http://ebmh.bmj.com/cgi/content/full/11/3/76<space/></arg><arg name="accessdate"><space/>27 November 2008<space/></arg></template></extension><space/>although its effects on severe episodes are not definitively known.<extension extension_name='ref' name="pmid9596592"><template><target>cite journal</target><arg name="author"><space/>Harrington R, Whittaker J, Shoebridge P, Campbell F<space/></arg><arg name="title"><space/>Systematic review of efficacy of cognitive behaviour therapies in childhood and adolescent depressive disorder<space/></arg><arg name="journal"><space/>[[BMJ]]<space/></arg><arg name="volume"><space/>325<space/></arg><arg name="issue"><space/>7358<space/></arg><arg name="pages"><space/>229–30<space/></arg><arg name="year"><space/>1998<space/></arg><arg name="pmid"><space/>9596592<space/></arg><arg name="pmc"><space/>28555<space/></arg><arg name="doi"><space/>10.1136/bmj.325.7358.229<space/></arg></template></extension><space/>Several variables predict success for cognitive behavioral therapy in adolescents: higher levels of rational thoughts, less hopelessness, fewer negative thoughts, and fewer cognitive distortions.<extension extension_name='ref'><template><target>cite journal</target><arg name="author">Becker SJ</arg><arg name="title">Cognitive-Behavioral Therapy for Adolescent Depression: Processes of Cognitive Change<space/></arg><arg name="journal">Psychiatric Times</arg><arg name="volume">25<space/></arg><arg name="issue">14<space/></arg><arg name="year">2008<space/></arg><arg name="url"><space/>http://www.psychiatrictimes.com/depression/article/10168/1357884</arg></template></extension><space/>CBT is particularly beneficial in preventing relapse.<extension extension_name='ref' name="pmid15328551"><template><target>cite journal</target><arg name="author"><space/>Almeida AM, Lotufo Neto F<space/></arg><arg name="title"><space/>Cognitive-behavioral therapy in prevention of depression relapses and recurrences: a review<space/></arg><arg name="journal"><space/>Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999)<space/></arg><arg name="volume"><space/>25<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>239–44<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>15328551<space/></arg></template></extension><extension extension_name='ref' name="pmid16787553"><template><target>cite journal</target><arg name="author"><space/>Paykel ES<space/></arg><arg name="title"><space/>Cognitive therapy in relapse prevention in depression<space/></arg><arg name="journal"><space/>The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)<space/></arg><arg name="volume"><space/>10<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>131–6<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>16787553<space/></arg><arg name="doi"><space/>10.1017/S1461145706006912<space/></arg></template></extension></paragraph><heading level='5'>Variants</heading><paragraph>Several variants of cognitive behavior therapy have been used in those with depression, the most notable being<space/><link><target>rational emotive behavior therapy</target></link>,<extension extension_name='ref' name="autogenerated3"><template><target>Harvnb</target><arg>Beck</arg><arg>1987</arg><arg name="p">10</arg></template></extension><space/>and<space/><link><target>mindfulness-based cognitive therapy</target></link>.<extension extension_name='ref' name="pmid18085916"><template><target>cite journal</target><arg name="author"><space/>Coelho HF, Canter PH, Ernst E<space/></arg><arg name="title"><space/>Mindfulness-based cognitive therapy: Evaluating current evidence and informing future research<space/></arg><arg name="journal"><space/>Journal of Consulting and Clinical Psychology<space/></arg><arg name="volume"><space/>75<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>1000–05<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>18085916<space/></arg><arg name="doi"><space/>10.1037/0022-006X.75.6.1000<space/></arg></template></extension><space/>Mindfulness based stress reduction programs may reduce depression symptoms.<extension extension_name='ref' name="Khoury"><template><target>cite journal</target><arg name="author"><space/>Khoury B, Lecomte T, Fortin G, Masse M, Therien P, Bouchard V, Chapleau MA, Paquin K, Hofmann SG<space/></arg><arg name="title"><space/>Mindfulness-based therapy: a comprehensive meta-analysis<space/></arg><arg name="journal"><space/>Clin Psychol Rev.<space/></arg><arg name="volume"><space/>33<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>763–71<space/></arg><arg name="date"><space/>August 2013<space/></arg><arg name="pmid"><space/>23796855<space/></arg><arg name="doi">10.1016/j.cpr.2013.05.005</arg></template></extension><extension extension_name='ref' name="Jain"><template><target>cite journal</target><arg name="vauthors">Jain FA, Walsh RN, Eisendrath SJ, etal<space/></arg><arg name="title"><space/>Critical Analysis of the Efficacy of Meditation Therapies for Acute and Subacute Phase Treatment of Depressive Disorders: A systematic Review<space/></arg><arg name="journal"><space/>Psychosomatics<space/></arg><arg name="pages">297–302<space/></arg><arg name="date"><space/>2014<space/></arg><arg name="doi">10.1016/j.psym.2014.10.007<space/></arg><arg name="volume">56</arg></template></extension><space/>Mindfulness programs also appear to be a promising intervention in youth.<extension extension_name='ref' name="Simkin"><template><target>cite journal</target><arg name="author"><space/>Simkin DR, Black NB<space/></arg><arg name="title"><space/>Meditation and mindfulness in clinical practice.<space/></arg><arg name="journal"><space/>Child and adolescent psychiatric clinics of North America<space/></arg><arg name="volume"><space/>23<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>487–534<space/></arg><arg name="date"><space/>July 2014<space/></arg><arg name="pmid"><space/>24975623<space/></arg><arg name="doi">10.1016/j.chc.2014.03.002</arg></template></extension></paragraph><heading level='4'>Psychoanalysis</heading><paragraph><link><target>Psychoanalysis</target></link><space/>is a school of thought, founded by<space/><link><target>Sigmund Freud</target></link>, which emphasizes the resolution of<space/><link><target>Unconscious mind</target><part>unconscious</part></link><space/>mental conflicts.<extension extension_name='ref' name="isbn0-314-20412-1"><template><target>cite book</target><arg name="author">Dworetzky J<space/></arg><arg name="title">Psychology<space/></arg><arg name="publisher">Brooks/Cole Pub. Co<space/></arg><arg name="location">Pacific Grove, CA, USA<space/></arg><arg name="year">1997<space/></arg><arg name="pages">602<space/></arg><arg name="isbn">0-314-20412-1</arg></template></extension><space/>Psychoanalytic techniques are used by some practitioners to treat clients presenting with major depression.<extension extension_name='ref' name="pmid12206545"><template><target>cite journal</target><arg name="author"><space/>Doidge N, Simon B, Lancee WJ, First M, Brunshaw J, Brauer L, Grant DC, Stevens A, Oldham JM, Mosher P<space/></arg><arg name="title"><space/>Psychoanalytic patients in the US, Canada, and Australia: II. A DSM-III-R validation study<space/></arg><arg name="journal"><space/>Journal of the American Psychoanalytic Association<space/></arg><arg name="volume"><space/>50<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>615–27<space/></arg><arg name="year"><space/>2002<space/></arg><arg name="pmid"><space/>12206545<space/></arg><arg name="doi"><space/>10.1177/00030651020500021101<space/></arg></template></extension><space/>A more widely practiced,<space/><link><target>Eclecticism</target><part>eclectic</part></link><space/>technique, called<space/><link><target>psychodynamic psychotherapy</target></link>, is loosely based on psychoanalysis and has an additional social and interpersonal focus.<extension extension_name='ref' name="IntegrativePP"><template><target>Harvnb</target><arg>Barlow</arg><arg>2005</arg><arg name="p">20</arg></template></extension><space/>In a meta-analysis of three controlled trials of Short Psychodynamic Supportive Psychotherapy, this modification was found to be as effective as medication for mild to moderate depression.<extension extension_name='ref' name="pmid17557313"><template><target>cite journal</target><arg name="author"><space/>de Maat S, Dekker J, Schoevers R, van Aalst G, Gijsbers-van Wijk C, Hendriksen M, Kool S, Peen J, Van R, de Jonghe F<space/></arg><arg name="title"><space/>Short Psychodynamic Supportive Psychotherapy, antidepressants, and their combination in the treatment of major depression: A mega-analysis based on three Randomized Clinical Trials<space/></arg><arg name="journal"><space/>Depression and Anxiety<space/></arg><arg name="volume"><space/>25<space/></arg><arg name="issue"><space/>7<space/></arg><arg name="pages"><space/>565–74<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17557313<space/></arg><arg name="doi"><space/>10.1002/da.20305<space/></arg></template></extension></paragraph><heading level='3'>Antidepressants</heading><paragraph><link><target>File:Zoloft bottles.jpg</target><part>thumb</part><part>Zoloft (<link><target>sertraline</target></link>) is used primarily to treat major depression in adult<space/><link><target>outpatient</target><trail>s</trail></link>. In 2007, it was the most prescribed antidepressant on the U.S. retail market, with 29,652,000 prescriptions.<extension extension_name='ref'>The sertraline prescriptions were calculated as a total of prescriptions for Zoloft and generic Sertraline using data from the charts for generic and<space/><link><target>Brand</target><part>brand name</part></link><space/>drugs, see:<space/><template><target>cite web</target><arg name="url"><space/>http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id</arg><arg name="title"><space/>Top 200 Generic Drugs by Units in 2007</arg><arg name="accessdate"><space/>30 March 2008</arg><arg name="author"><space/>Verispan</arg><arg name="date"><space/>18 February 2008</arg><arg name="format"><space/>PDF</arg><arg name="publisher"><space/>Drug Topics</arg></template><space/>and<space/><template><target>cite web</target><arg name="url"><space/>http://www.drugtopics.com/drugtopics/article/articleDetail.jsp?id</arg><arg name="title"><space/>Top 200 Brand Drugs by Units in 2007</arg><arg name="accessdate"><space/>30 March 2008</arg><arg name="author"><space/>Verispan</arg><arg name="date"><space/>18 February 2008</arg><arg name="format"><space/>PDF</arg><arg name="publisher"><space/>Drug Topics</arg></template></extension></part></link></paragraph><paragraph>Conflicting results have arisen from studies that look at the effectiveness of antidepressants in people with acute, mild to moderate depression. Stronger evidence supports the usefulness of antidepressants in the treatment of depression that is chronic (<link><target>dysthymia</target></link>) or severe.</paragraph><paragraph>While small benefits were found, researchers Irving Kirsch and Thomas Moore state they may be due to issues with the trials rather than a true effect of the medication.<extension extension_name='ref' name="administration2002"><template><target>cite journal</target><arg name="title">The emperor's new drugs: An analysis of antidepressant medication data submitted to the U.S. Food and Drug Administration<space/></arg><arg name="author"><space/>Kirsch I, Moore TJ, Scoboria A, Nicholls SS<space/></arg><arg name="journal"><space/>Prevention & Treatment<space/></arg><arg name="year"><space/>2002<space/></arg><arg name="volume"><space/>5<space/></arg><arg name="doi"><space/>10.1037/1522-3736.5.1.523a<space/></arg></template></extension><space/>In a later publication, Kirsch concluded that the overall effect of new-generation antidepressant medication is below recommended criteria for clinical significance.<extension extension_name='ref' name="Kirsch_etal2008"></extension><space/>Similar results were obtained in a meta analysis by Fornier.<extension extension_name='ref' name="Fournier_etal2010"></extension></paragraph><paragraph>A review commissioned by the<space/><link><target>National Institute for Health and Care Excellence</target></link><space/>concluded that there is strong evidence that SSRIs have greater efficacy than placebo on achieving a 50% reduction in depression scores in moderate and severe major depression, and that there is some evidence for a similar effect in mild depression.<extension extension_name='ref' name="Depression in Adults"><template><target>cite web</target><arg name="title">The treatment and management of depression in adults</arg><arg name="url">http://www.nice.org.uk/guidance/cg90/resources/guidance-depression-in-adults-pdf</arg><arg name="format">PDF<space/></arg><arg name="publisher">[[NICE]]<space/></arg><arg name="date">October 2009</arg><arg name="accessdate">12 November 2014</arg></template></extension><space/>Similarly, a Cochrane systematic review of clinical trials of the generic antidepressant amitriptyline concluded that there is strong evidence that its efficacy is superior to placebo.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Leucht C, Huhn M, Leucht S<space/></arg><arg name="title"><space/>Amitriptyline versus placebo for major depressive disorder<space/></arg><arg name="journal"><space/>Cochrane Database of Systematic Reviews<space/></arg><arg name="volume"><space/>12<space/></arg><arg name="pages"><space/>CD009138<space/></arg><arg name="year"><space/>2012<space/></arg><arg name="pmid"><space/>23235671<space/></arg><arg name="doi"><space/>10.1002/14651858.CD009138.pub2<space/></arg><arg name="editor1-last"><space/>Leucht<space/></arg><arg name="editor1-first"><space/>C<space/></arg></template></extension></paragraph><paragraph>In 2014 the U.S. FDA published a systematic review of all antidepressant maintenance trials submitted to the agency between 1985 and 2012. The authors concluded that maintenance treatment reduced the risk of relapse by 52% compared to placebo, and that this effect was primarily due to recurrent depression in the placebo group rather than a drug withdrawal effect.<extension extension_name='ref' name="Fournier_etal2010"></extension></paragraph><paragraph>To find the most effective antidepressant medication with minimal side-effects, the dosages can be adjusted, and if necessary, combinations of different classes of antidepressants can be tried. Response rates to the first antidepressant administered range from 5075%, and it can take at least six to eight weeks from the start of medication to<space/><link><target>Cure</target><part>remission</part></link>.<extension extension_name='ref' name="apaguidelines"></extension><space/>Antidepressant medication treatment is usually continued for 16 to 20 weeks after remission, to minimize the chance of recurrence,<extension extension_name='ref' name="apaguidelines"><template><target>cite journal</target><arg name="author"><space/>Karasu TB, Gelenberg A, Merriam A, Wang P<space/></arg><arg name="title"><space/>Practice Guideline for the Treatment of Patients With Major Depressive Disorder (Second Edition)<space/></arg><arg name="journal"><space/>Am J Psychiatry<space/></arg><arg name="volume"><space/>157<space/></arg><arg name="issue"><space/>4 Suppl<space/></arg><arg name="pages"><space/>1–45<space/></arg><arg name="date"><space/>April 2000<space/></arg><arg name="pmid"><space/>10767867<space/></arg></template>; Third edition<space/><template><target>doi</target><arg>10.1176/appi.books.9780890423363.48690</arg></template></extension><space/>and even up to one year of continuation is recommended.<extension extension_name='ref' name="pmid17146414"><template><target>cite journal</target><arg name="author"><space/>Thase ME<space/></arg><arg name="title"><space/>Preventing relapse and recurrence of depression: a brief review of therapeutic options<space/></arg><arg name="journal"><space/>CNS spectrums<space/></arg><arg name="volume"><space/>11<space/></arg><arg name="issue"><space/>12 Suppl 15<space/></arg><arg name="pages"><space/>12–21<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>17146414<space/></arg></template></extension><space/>People with chronic depression may need to take medication indefinitely to avoid relapse.<extension extension_name='ref' name="NIMHPub"></extension></paragraph><paragraph><link><target>Selective serotonin reuptake inhibitor</target><trail>s</trail></link><space/>(SSRIs) are the primary medications prescribed, owing to their relatively mild side-effects, and because they are less toxic in overdose than other antidepressants.<extension extension_name='ref' name="2008-BNF-204"><template><target>Harvnb</target><arg>Royal Pharmaceutical Society of Great Britain</arg><arg>2008</arg><arg name="p">204</arg></template></extension><space/>Patients who do not respond to one SSRI can be switched to<space/><link><target>List of antidepressants</target><part>another antidepressant</part></link>, and this results in improvement in almost 50% of cases.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Whooley MA, Simon GE<space/></arg><arg name="title"><space/>Managing Depression in Medical Outpatients<space/></arg><arg name="journal"><space/>New England Journal of Medicine<space/></arg><arg name="volume"><space/>343<space/></arg><arg name="issue"><space/>26<space/></arg><arg name="pages"><space/>1942–50<space/></arg><arg name="year"><space/>2000<space/></arg><arg name="pmid"><space/>11136266<space/></arg><arg name="doi"><space/>10.1056/NEJM200012283432607<space/></arg><arg name="url"><space/>http://content.nejm.org/cgi/content/short/343/26/1942<space/></arg><arg name="accessdate"><space/>11 November 2008<space/></arg></template></extension><space/>Another option is to switch to the atypical antidepressant<space/><link><target>bupropion</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Zisook S, Rush AJ, Haight BR, Clines DC, Rockett CB<space/></arg><arg name="title"><space/>Use of bupropion in combination with serotonin reuptake inhibitors<space/></arg><arg name="journal"><space/>Biological Psychiatry<space/></arg><arg name="volume"><space/>59<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>203–10<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16165100<space/></arg><arg name="doi"><space/>10.1016/j.biopsych.2005.06.027<space/></arg></template></extension><space/><link><target>Venlafaxine</target></link>, an antidepressant with a different mechanism of action, may be modestly more effective than SSRIs.<extension extension_name='ref' name="pmid17588546"><template><target>cite journal</target><arg name="author"><space/>Papakostas GI, Thase ME, Fava M, Nelson JC, Shelton RC<space/></arg><arg name="title"><space/>Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents<space/></arg><arg name="journal"><space/>Biological Psychiatry<space/></arg><arg name="volume"><space/>62<space/></arg><arg name="issue"><space/>11<space/></arg><arg name="pages"><space/>1217–27<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17588546<space/></arg><arg name="doi"><space/>10.1016/j.biopsych.2007.03.027<space/></arg></template></extension><space/>However, venlafaxine is not recommended in the UK as a first-line treatment because of evidence suggesting its risks may outweigh benefits,<extension extension_name='ref'><template><target>cite web</target><arg name="url"><space/>http://www.mhra.gov.uk/home/idcplg?IdcService</arg><arg name="title"><space/>Updated prescribing advice for venlafaxine (Efexor/Efexor XL)<space/></arg><arg name="author"><space/>[[Gordon Duff]]<space/></arg><arg name="publisher">Medicines and Healthcare products Regulatory Agency (MHRA)<space/></arg><arg name="date"><space/>31 May 2006</arg></template></extension><space/>and it is specifically discouraged in children and adolescents.<extension extension_name='ref' name="nice2005"><template><target>cite journal</target><arg name="title">Depression in children and young people: Identification and management in primary, community and secondary care</arg><arg name="year">2005</arg><arg name="publisher">NHS National Institute for Health and Clinical Excellence<space/></arg><arg name="accessdate">12 November 2014</arg><arg name="url">http://www.nice.org.uk/guidance/cg28/resources/guidance-depression-in-children-and-young-people-pdf</arg><arg name="format">PDF</arg></template></extension><extension extension_name='ref' name="pmid16229049"><template><target>cite journal</target><arg name="author"><space/>Mayers AG, Baldwin DS<space/></arg><arg name="title"><space/>Antidepressants and their effect on sleep<space/></arg><arg name="journal"><space/>Human Psychopharmacology<space/></arg><arg name="volume"><space/>20<space/></arg><arg name="issue"><space/>8<space/></arg><arg name="pages"><space/>533–59<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>16229049<space/></arg><arg name="doi"><space/>10.1002/hup.726<space/></arg></template></extension></paragraph><preblock><preline>For adolescent depression, fluoxetine is recommended<extension extension_name='ref' name="nice2005"></extension><space/>Antidepressants appear to have only slight benefit in children.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Tsapakis EM, Soldani F, Tondo L, Baldessarini RJ<space/></arg><arg name="title"><space/>Efficacy of antidepressants in juvenile depression: meta-analysis<space/></arg><arg name="journal"><space/>Br J Psychiatry<space/></arg><arg name="volume"><space/>193<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>10–7<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18700212<space/></arg><arg name="doi"><space/>10.1192/bjp.bp.106.031088<space/></arg></template></extension><space/>There is also insufficient evidence to determine effectiveness in those with depression complicated by<space/><link><target>dementia</target></link>.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Nelson JC, Devanand DP<space/></arg><arg name="title"><space/>A systematic review and meta-analysis of placebo-controlled antidepressant studies in people with depression and dementia<space/></arg><arg name="journal"><space/>Journal of the American Geriatrics Society<space/></arg><arg name="volume"><space/>59<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>577–85<space/></arg><arg name="date"><space/>April 2011<space/></arg><arg name="pmid"><space/>21453380<space/></arg><arg name="doi"><space/>10.1111/j.1532-5415.2011.03355.x<space/></arg></template></extension><space/>Any antidepressant can cause low serum<space/><link><target>Sodium metabolism</target><part>sodium</part></link><space/>levels (also called<space/><link><target>hyponatremia</target></link>);<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Palmer BF, Gates JR, Lader M<space/></arg><arg name="title"><space/>Causes and Management of Hyponatremia<space/></arg><arg name="journal"><space/>Annals of Pharmacotherapy<space/></arg><arg name="volume"><space/>37<space/></arg><arg name="issue"><space/>11<space/></arg><arg name="pages"><space/>1694–702<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>14565794<space/></arg><arg name="doi"><space/>10.1345/aph.1D105<space/></arg></template></extension><space/>nevertheless, it has been reported more often with SSRIs.<extension extension_name='ref' name="2008-BNF-204"></extension><space/>It is not uncommon for SSRIs to cause or worsen insomnia; the sedating antidepressant<space/><link><target>mirtazapine</target></link><space/>can be used in such cases.<extension extension_name='ref' name="pmid17636748"><template><target>cite journal</target><arg name="author"><space/>Guaiana G, Barbui C, Hotopf M<space/></arg><arg name="title"><space/>Amitriptyline for depression<space/></arg><arg name="journal"><space/>Cochrane Database of Systematic Reviews<space/></arg><arg name="volume"><space/>18<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>11–7<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17636748<space/></arg><arg name="doi"><space/>10.1002/14651858.CD004186.pub2<space/></arg></template></extension><extension extension_name='ref' name="pmid10760555"><template><target>cite journal</target><arg name="author"><space/>Anderson IM<space/></arg><arg name="title"><space/>Selective serotonin reuptake inhibitors versus tricyclic antidepressants: A meta-analysis of efficacy and tolerability<space/></arg><arg name="journal"><space/>Journal of Affective Disorders<space/></arg><arg name="volume"><space/>58<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>19–36<space/></arg><arg name="year"><space/>2000<space/></arg><arg name="pmid"><space/>10760555<space/></arg><arg name="doi"><space/>10.1016/S0165-0327(99)00092-0<space/></arg></template></extension></preline></preblock><paragraph>Irreversible<space/><link><target>monoamine oxidase inhibitor</target><trail>s</trail></link>, an older class of antidepressants, have been plagued by potentially life-threatening dietary and drug interactions. They are still used only rarely, although newer and better-tolerated agents of this class have been developed.<extension extension_name='ref' name="pmid17640156"><template><target>cite journal</target><arg name="author"><space/>Krishnan KR<space/></arg><arg name="title"><space/>Revisiting monoamine oxidase inhibitors<space/></arg><arg name="journal"><space/>Journal of Clinical Psychiatry<space/></arg><arg name="volume"><space/>68 Suppl 8<space/></arg><arg name="pages"><space/>35–41<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17640156<space/></arg></template></extension><space/>The safety profile is different with reversible monoamine oxidase inhibitors such as<space/><link><target>moclobemide</target></link><space/>where the risk of serious dietary interactions is negligible and dietary restrictions are less strict.<extension extension_name='ref' name="pmid12595913"><template><target>cite journal</target><arg name="author"><space/>Bonnet U<space/></arg><arg name="title"><space/>Moclobemide: therapeutic use and clinical studies<space/></arg><arg name="journal"><space/>CNS Drug Rev<space/></arg><arg name="volume"><space/>9<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>97–140<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12595913<space/></arg><arg name="doi"><space/>10.1111/j.1527-3458.2003.tb00245.x<space/></arg><arg name="url"><space/></arg></template></extension></paragraph><preblock><preline>For children, adolescents, and probably young adults between 18 and 24 years old, there is a higher risk of both suicidal ideations and suicidal behavior in those treated with SSRIs.<extension extension_name='ref' name="FDA"><template><target>cite web</target><arg name="url"><space/>http://www.fda.gov/OHRMS/DOCKETS/ac/04/briefing/2004-4065b1-10-TAB08-Hammads-Review.pdf</arg><arg name="title"><space/>Review and evaluation of clinical data. Relationship between psychiatric drugs and pediatric suicidality</arg><arg name="accessdate"><space/>29 May 2008</arg><arg name="author"><space/>Hammad TA</arg><arg name="date"><space/>16 August 2004</arg><arg name="format">PDF</arg><arg name="publisher"><space/>FDA</arg><arg name="pages"><space/>42; 115</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Hetrick</arg><arg name="first1">SE</arg><arg name="last2">McKenzie</arg><arg name="first2">JE</arg><arg name="last3">Cox</arg><arg name="first3">GR</arg><arg name="last4">Simmons</arg><arg name="first4">MB</arg><arg name="last5">Merry</arg><arg name="first5">SN</arg><arg name="title">Newer generation antidepressants for depressive disorders in children and adolescents.</arg><arg name="journal">The Cochrane database of systematic reviews</arg><arg name="date">14 November 2012</arg><arg name="volume">11</arg><arg name="pages">CD004851</arg><arg name="pmid">23152227</arg><arg name="doi">10.1002/14651858.CD004851.pub3</arg></template></extension><space/>For adults, it is unclear whether SSRIs affect the risk of suicidality. One review found no connection;<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Gunnell D, Saperia J, Ashby D<space/></arg><arg name="title"><space/>Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review<space/></arg><arg name="journal"><space/>BMJ<space/></arg><arg name="volume"><space/>330<space/></arg><arg name="issue"><space/>7488<space/></arg><arg name="pages"><space/>385<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>15718537<space/></arg><arg name="pmc"><space/>549105<space/></arg><arg name="doi"><space/>10.1136/bmj.330.7488.385<space/></arg></template></extension><space/>another an increased risk;<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Fergusson D, Doucette S, Glass KC, Shapiro S, Healy D, Hebert P, Hutton B<space/></arg><arg name="title"><space/>Association between suicide attempts and selective serotonin reuptake inhibitors: systematic review of randomised controlled trials<space/></arg><arg name="journal"><space/>BMJ<space/></arg><arg name="volume"><space/>330<space/></arg><arg name="issue"><space/>7488<space/></arg><arg name="pages"><space/>396<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>15718539<space/></arg><arg name="pmc"><space/>549110<space/></arg><arg name="doi"><space/>10.1136/bmj.330.7488.396<space/></arg></template></extension><space/>and a third no risk in those 2565 years old and a decrease risk in those more than 65.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Stone M, Laughren T, Jones ML, Levenson M, Holland PC, Hughes A, Hammad TA, Temple R, Rochester G<space/></arg><arg name="title"><space/>Risk of suicidality in clinical trials of antidepressants in adults: analysis of proprietary data submitted to US Food and Drug Administration<space/></arg><arg name="journal"><space/>BMJ (Clinical research ed.)<space/></arg><arg name="volume"><space/>339<space/></arg><arg name="pages"><space/>b2880<space/></arg><arg name="date"><space/>11 August 2009<space/></arg><arg name="pmid"><space/>19671933<space/></arg><arg name="pmc"><space/>2725270<space/></arg><arg name="doi"><space/>10.1136/bmj.b2880<space/></arg></template></extension><space/>A<space/><link><target>black box warning</target></link><space/>was introduced in the United States in 2007 on SSRI and other antidepressant medications due to increased risk of suicide in patients younger than 24 years old.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.fda.gov/bbs/topics/NEWS/2007/NEW01624.html<space/></arg><arg name="title">FDA Proposes New Warnings About Suicidal Thinking, Behavior in Young Adults Who Take Antidepressant Medications</arg><arg name="date">2 May 2007<space/></arg><arg name="publisher">[[U.S. Food and Drug Administration|FDA]]<space/></arg><arg name="accessdate">29 May 2008</arg></template></extension><space/>Similar precautionary notice revisions were implemented by the Japanese Ministry of Health.<extension extension_name='ref'><template><target>cite report</target><arg name="author">Medics and Foods Department<space/></arg><arg name="authorlink">Ministry of Health, Labour and Welfare (Japan)<space/></arg><arg name="url">http://www1.mhlw.go.jp/kinkyu/iyaku_j/iyaku_j/anzenseijyouhou/261.pdf<space/></arg><arg name="title">Pharmaceuticals and Medical Devices Safety Information<space/></arg><arg name="series">261<space/></arg><arg name="format">PDF<space/></arg><arg name="publisher">Ministry of Health, Labour and Welfare (Japan)<space/></arg><arg name="language">Japanese</arg></template></extension></preline></preblock><heading level='3'>Other medications</heading><paragraph>There is some evidence that fish oil supplements containing high levels of<space/><link><target>eicosapentaenoic acid</target></link><space/>(EPA) to<space/><link><target>docosahexaenoic acid</target></link><space/>(DHA) may be effective in major depression,<extension extension_name='ref' name="pmid21939614"><template><target>cite journal</target><arg name="author"><space/>Sublette ME, Ellis SP, Geant AL, Mann JJ<space/></arg><arg name="title"><space/>Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression<space/></arg><arg name="journal"><space/>J Clin Psychiatry<space/></arg><arg name="volume"><space/>72<space/></arg><arg name="issue"><space/>12<space/></arg><arg name="pages"><space/>1577–84<space/></arg><arg name="date"><space/>September 2011<space/></arg><arg name="pmid"><space/>21939614<space/></arg><arg name="pmc"><space/>3534764<space/></arg><arg name="doi"><space/>10.4088/JCP.10m06634<space/></arg><arg name="url"><space/></arg></template></extension><space/>but other meta-analysis of the research conclude that positive effects may be due to publication bias.<extension extension_name='ref' name="pmid21931319"><template><target>cite journal</target><arg name="author"><space/>Bloch MH, Hannestad J<space/></arg><arg name="title"><space/>Omega-3 fatty acids for the treatment of depression: systematic review and meta-analysis<space/></arg><arg name="journal"><space/>Mol Psychiatry<space/></arg><arg name="volume"><space/>17<space/></arg><arg name="issue"><space/>12<space/></arg><arg name="pages"><space/>1272–82<space/></arg><arg name="date"><space/>September 2011<space/></arg><arg name="pmid"><space/>21931319<space/></arg><arg name="pmc"><space/>3625950<space/></arg><arg name="doi"><space/>10.1038/mp.2011.100<space/></arg><arg name="url"><space/></arg></template></extension><space/>There is some preliminary evidence that<space/><link><target>COX-2 inhibitors</target></link><space/>have a beneficial effect on major depression.<extension extension_name='ref' name="pmid20658274"></extension><space/><link><target>Lithium (medication)</target><part>Lithium</part></link><space/>appears effective at lowering the risk of suicide in those with<space/><link><target>bipolar disorder</target></link><space/>and unipolar depression to nearly the same levels as the general population.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Cipriani A, Hawton K, Stockton S, Geddes JR<space/></arg><arg name="title"><space/>Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis<space/></arg><arg name="journal"><space/>BMJ<space/></arg><arg name="volume"><space/>346<space/></arg><arg name="issue"><space/>jun27 4<space/></arg><arg name="pages"><space/>f3646–f3646<space/></arg><arg name="date"><space/>27 June 2013<space/></arg><arg name="pmid"><space/>23814104<space/></arg><arg name="doi"><space/>10.1136/bmj.f3646<space/></arg></template></extension><space/>There is a narrow range of effective and safe dosages of lithium thus close monitoring may be needed.<extension extension_name='ref'>Nolen-Hoeksema, Susan. (2014) &quot;Treatment of Mood Disorders&quot;. In (6th ed.)<space/><italics>Abnormal Psychology</italics><space/>p. 196. New York: McGraw-Hill. ISBN 9780078035388.</extension><space/>Low-dose<space/><link><target>thyroid hormone</target></link><space/>may be added to existing antidepressants to treat persistent depression symptoms in people who have tried multiple courses of medication.<extension extension_name='ref' name="APA MDD Guideline"><template><target>cite web</target><arg name="last1">Gelenberg</arg><arg name="first1">Alan J.</arg><arg name="last2">Freeman</arg><arg name="first2">Marlene P.</arg><arg name="last3">Markowitz</arg><arg name="first3">John C.</arg><arg name="title">Practice Guideline for the Treatment of Patients with Major Depressive Disorder. 3rd edition.</arg><arg name="url">http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf</arg><arg name="publisher">American Psychiatric Association (APA)</arg><arg name="accessdate">3 November 2014</arg></template></extension></paragraph><heading level='3'>Electroconvulsive therapy</heading><paragraph><link><target>Electroconvulsive therapy</target></link><space/>(ECT) is a standard<space/><link><target>psychiatry</target><part>psychiatric</part></link><space/>treatment in which<space/><link><target>seizure</target><trail>s</trail></link><space/>are electrically induced in patients to provide relief from psychiatric illnesses.<extension extension_name='ref' name="Rudorfer">Rudorfer, MV, Henry, ME, Sackeim, HA (2003).<space/><link type='external' href='http://media.wiley.com/assets/138/93/UK_Tasman_Chap92.pdf'>&quot;Electroconvulsive therapy&quot;</link>. In A Tasman, J Kay, JA Lieberman (eds)<space/><italics>Psychiatry, Second Edition</italics>. Chichester: John Wiley &amp; Sons Ltd, 18651901.</extension><template><target>rp</target><arg>1880</arg></template><space/>ECT is used with<space/><link><target>informed consent</target></link><extension extension_name='ref' name="Beloucif">Beloucif S. Informed consent for special procedures: electroconvulsive therapy and psychosurgery.<space/><italics>Curr Opin Anaesthesiol.</italics><space/>2013<space/><template><target>DOI</target><arg>10.1097/ACO.0b013e32835e7380</arg></template><space/>PMID 23385317</extension><space/>as a last line of intervention for major depressive disorder.<extension extension_name='ref' name="FDA2011rev">FDA.<space/><link type='external' href='http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/NeurologicalDevicesPanel/UCM240933.pdf'>FDA Executive Summary</link>. Prepared for the 2728 January 2011 meeting of the Neurological Devices Panel Meeting to Discuss the Classification of Electroconvulsive Therapy Devices (ECT). Quote, p38: &quot;Three major practice guidelines have been published on ECT. These guidelines include: APA Task Force on ECT (2001); Third report of the Royal College of Psychiatrists Special Committee on ECT (2004); National Institute for Health and Clinical Excellence (NICE 2003; NICE 2009). There is significant agreement between the three sets of recommendations.&quot;</extension></paragraph><paragraph>A round of ECT is effective for about 50% of people with treatment-resistant major depressive disorder, whether it is unipolar or<space/><link><target>Bipolar II disorder</target><part>bipolar</part></link>.<extension extension_name='ref' name="Dierckx"><template><target>cite journal</target><arg name="author"><space/>Dierckx B, Heijnen WT, van den Broek WW, Birkenhäger TK<space/></arg><arg name="title"><space/>Efficacy of electroconvulsive therapy in bipolar versus unipolar major depression: A meta-analysis<space/></arg><arg name="journal"><space/>Bipolar Disorders<space/></arg><arg name="volume"><space/>12<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>146–150<space/></arg><arg name="year"><space/>2012<space/></arg><arg name="pmid"><space/>22420590<space/></arg><arg name="doi"><space/>10.1111/j.1399-5618.2012.00997.x<space/></arg><arg name="first4"><space/>TK<space/></arg><arg name="last2"><space/>Heijnen<space/></arg><arg name="first2"><space/>WT<space/></arg><arg name="last4"><space/>Birkenhäger<space/></arg><arg name="last3"><space/>Van Den Broek<space/></arg><arg name="first3"><space/>WW<space/></arg></template></extension><space/>Follow-up treatment is still poorly studied, but about half of people who respond, relapse with twelve months.<extension extension_name='ref' name="Jelovac2013Rev"><template><target>cite journal</target><arg name="vauthors">Jelovac A, etal<space/></arg><arg name="date"><space/>Nov 2013<space/></arg><arg name="title"><space/>Relapse following successful electroconvulsive therapy for major depression: a meta-analysis<space/></arg><arg name="url"><space/></arg><arg name="journal"><space/>Neuropsychopharmacology<space/></arg><arg name="volume"><space/>38<space/></arg><arg name="issue"><space/>12</arg><arg name="pages"><space/>2467–74<space/></arg><arg name="doi"><space/>10.1038/npp.2013.149<space/></arg><arg name="pmid">23774532</arg></template></extension></paragraph><paragraph>Aside from effects in the brain, the general physical risks of ECT are similar to those of brief<space/><link><target>general anesthesia</target></link>.<extension extension_name='ref' name="SG">Surgeon General (1999).<space/><link type='external' href='http://www.surgeongeneral.gov/library/mentalhealth/home.html'>''Mental Health: A Report of the Surgeon General''</link>, chapter 4.</extension><template><target>rp</target><arg>259</arg></template><space/>Immediately following treatment, the most common adverse effects are confusion and memory loss.<extension extension_name='ref' name="FDA2011rev"></extension><extension extension_name='ref' name="APA2001guideline"><template><target>cite book</target><arg name="author">American Psychiatric Association</arg><arg name="title">The practice of electroconvulsive therapy: recommendations for treatment, training, and privileging</arg><arg name="edition">2nd</arg><arg name="location">Washington, DC</arg><arg name="publisher">American Psychiatric Publishing</arg><arg name="year">2001</arg><arg name="url">https://books.google.com/?id</arg><arg name="isbn">978-0-89042-206-9</arg><arg name="author2"><space/>Committee on Electroconvulsive Therapy</arg><arg name="author3"><space/>Richard D. Weiner (chairperson)</arg><arg name="author4">and others</arg><arg name="displayauthors">3</arg></template></extension><space/>ECT is considered one of the least harmful treatment options available for severely depressed pregnant women.<extension extension_name='ref' name="Pompili2014Rev"><template><target>cite journal</target><arg name="vauthors">Pompili M, etal<space/></arg><arg name="date"><space/>Dec 2014<space/></arg><arg name="title"><space/>Electroconvulsive treatment during pregnancy: a systematic review<space/></arg><arg name="url"><space/></arg><arg name="journal"><space/>Expert Rev Neurother<space/></arg><arg name="volume"><space/>14<space/></arg><arg name="issue"><space/>12</arg><arg name="pages"><space/>1377–90<space/></arg><arg name="doi"><space/>10.1586/14737175.2014.972373<space/></arg><arg name="pmid"><space/>25346216<space/></arg></template></extension></paragraph><paragraph>A usual course of ECT involves multiple administrations, typically given two or three times per week until the patient is no longer suffering symptoms ECT is administered under anesthetic with a muscle relaxant.<extension extension_name='ref'>http://psychcentral.com/lib/5-outdated-beliefs-about-ect/00011255</extension><space/>Electroconvulsive therapy can differ in its application in three ways: electrode placement, frequency of treatments, and the electrical waveform of the stimulus. These three forms of application have significant differences in both adverse side effects and symptom remission. After treatment, drug therapy is usually continued, and some patients receive maintenance ECT.<extension extension_name='ref' name="FDA2011rev"></extension></paragraph><preblock><preline></preline></preblock><paragraph>ECT appears to work in the short term via an<space/><link><target>anticonvulsant</target></link><space/>effect mostly in the<space/><link><target>frontal lobes</target></link>, and longer term via<space/><link><target>neurotrophic</target></link><space/>effects primarily in the<space/><link><target>medial temporal lobe</target></link>.<extension extension_name='ref' name="Abbott2014">Abbott CC, et al A review of longitudinal electroconvulsive therapy: neuroimaging investigations.<space/><italics>J Geriatr Psychiatry Neurol.</italics><space/>2014 Mar;27(1):3346. Review.<space/><template><target>DOI</target><arg>10.1177/0891988713516542</arg></template><space/>PMID 24381234</extension></paragraph><heading level='3'>Repetitive transcranial magnetic stimulation</heading><paragraph>Transcranial magnetic stimulation (TMS) or<space/><link><target>deep transcranial magnetic stimulation</target></link><space/>is a noninvasive method used to stimulate small regions of the brain.<extension extension_name='ref'><template><target>Cite web</target><arg name="url"><space/>http://www.nice.org.uk/guidance/ipg477/resources/guidance-transcranial-magnetic-stimulation-for-treating-and-preventing-migraine-pdf</arg><arg name="title"><space/>NiCE. January 2014 Transcranial magnetic stimulation for treating and preventing migraine</arg><arg name="date"><space/></arg><arg name="accessdate"><space/></arg><arg name="website"><space/></arg><arg name="publisher"><space/></arg><arg name="last"><space/></arg><arg name="first"><space/></arg></template></extension><space/>TMS was approved by the FDA for treatment-resistant major depressive disorder in 2008<extension extension_name='ref'><template><target>Cite web</target><arg name="url"><space/>http://www.accessdata.fda.gov/cdrh_docs/pdf8/K083538.pdf</arg><arg name="title"><space/>Melkerson, MN (2008-12-16). "Special Premarket 510(k) Notification for NeuroStar® TMS Therapy System for Major Depressive Disorder" (pdf). Food and Drug Administration. Retrieved 2010-07-16.</arg><arg name="date"><space/></arg><arg name="accessdate"><space/></arg><arg name="website"><space/></arg><arg name="publisher"><space/></arg><arg name="last"><space/></arg><arg name="first"><space/></arg></template></extension><space/>and as of 2014 evidence supports this use.<extension extension_name='ref'><template><target>cite journal</target><arg name="last1">Lefaucheur</arg><arg name="first1">JP</arg><arg name="last2">André-Obadia</arg><arg name="first2">N</arg><arg name="title">Evidence-based guidelines on the therapeutic use of repetitive transcranial magnetic stimulation (rTMS).</arg><arg name="journal">Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology</arg><arg name="date">November 2014</arg><arg name="volume">125</arg><arg name="issue">11</arg><arg name="pages">2150–206</arg><arg name="pmid">25034472</arg><arg name="doi">10.1016/j.clinph.2014.05.021</arg></template></extension><space/>The American Psychiatric Association<extension extension_name='ref'><template><target>Cite web</target><arg name="url"><space/>http://psychiatryonline.org/pb/assets/raw/sitewide/practice_guidelines/guidelines/mdd.pdf</arg><arg name="title"><space/>American Psychiatric Association (2010). (eds: Gelenberg, AJ, Freeman, MP, Markowitz, JC, Rosenbaum, JF, Thase, ME, Trivedi, MH, Van Rhoads, RS). Practice Guidelines for the Treatment of Patients with Major Depressive Disorder, 3rd Edition</arg><arg name="date"><space/></arg><arg name="accessdate"><space/></arg><arg name="website"><space/></arg><arg name="publisher"><space/></arg><arg name="last"><space/></arg><arg name="first"><space/></arg></template></extension><space/>the Canadian Network for Mood and Anxiety Disorders,<extension extension_name='ref'><template><target>Cite web</target><arg name="url"><space/>http://www.canmat.org/resources/CANMAT%20Depression%20Guidelines%202009.pdf</arg><arg name="title"><space/>http://www.canmat.org/resources/CANMAT%20Depression%20Guidelines%202009.pdf</arg><arg name="date"><space/></arg><arg name="accessdate"><space/></arg><arg name="website"><space/></arg><arg name="publisher"><space/></arg><arg name="last"><space/></arg><arg name="first"><space/></arg></template></extension><space/>and the Royal Australia and New Zealand College of Psychiatrists have endorsed rTMS for trMDD.<extension extension_name='ref'><template><target>Cite web</target><arg name="url"><space/>https://dx.doi.org/10.1016%2Fj.biopsych.2005.05.025</arg><arg name="title"><space/>The Royal Australian and New Zealand College of Psychiatrists. (2013) Position Statement 79. Repetitive Transcranial Magnetic Stimulation. Practice and Partnerships Committee</arg><arg name="date"><space/></arg><arg name="accessdate"><space/></arg><arg name="website"><space/></arg><arg name="publisher"><space/></arg><arg name="last"><space/></arg><arg name="first"><space/></arg></template></extension></paragraph><heading level='3'>Other</heading><paragraph><template><target>further</target><arg>Neurobiological effects of physical exercise#Antidepressant effect</arg></template>Bright<space/><link><target>light therapy</target></link><space/>reduces depression symptom severity, with benefit was found for both<space/><link><target>seasonal affective disorder</target></link><space/>and for nonseasonal depression, and an effect similar to those for conventional antidepressants. For non-seasonal depression, adding light therapy to the standard antidepressant treatment was not effective.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Golden RN, Gaynes BN, Ekstrom RD, Hamer RM, Jacobsen FM, Suppes T, Wisner KL, Nemeroff CB<space/></arg><arg name="title"><space/>The efficacy of light therapy in the treatment of mood disorders: a review and meta-analysis of the evidence<space/></arg><arg name="journal"><space/>American Journal of Psychiatry<space/></arg><arg name="volume"><space/>162<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>656–62<space/></arg><arg name="date"><space/>April 2005<space/></arg><arg name="pmid"><space/>15800134<space/></arg><arg name="doi"><space/>10.1176/appi.ajp.162.4.656<space/></arg><arg name="ref"><space/>harv<space/></arg></template></extension><space/>For non-seasonal depression where light was used mostly in combination with antidepressants or<space/><link><target>wake therapy</target></link><space/>a moderate effect was found, with response better than control treatment in high-quality studies, in studies that applied morning light treatment, and with people who respond to total or partial sleep deprivation.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Tuunainen A, Kripke DF, Endo T<space/></arg><arg name="title"><space/>Light therapy for non-seasonal depression<space/></arg><arg name="journal"><space/>Cochrane Database Syst Rev<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>CD004050<space/></arg><arg name="year"><space/>2004<space/></arg><arg name="pmid"><space/>15106233<space/></arg><arg name="doi"><space/>10.1002/14651858.CD004050.pub2<space/></arg><arg name="ref"><space/>harv<space/></arg><arg name="editor1-last"><space/>Tuunainen<space/></arg><arg name="editor1-first"><space/>Arja<space/></arg></template></extension><space/>Both analyses noted poor quality, short duration, and small size of most of the reviewed studies.</paragraph><paragraph>There is a small amount of evidence that skipping a night's sleep may help.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Giedke H, Schwärzler F<space/></arg><arg name="title"><space/>Therapeutic use of sleep deprivation in depression<space/></arg><arg name="journal"><space/>Sleep Medicine Reviews<space/></arg><arg name="volume"><space/>6<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>361–77<space/></arg><arg name="year"><space/>2002<space/></arg><arg name="pmid"><space/>12531127<space/></arg><arg name="doi"><space/>10.1053/smrv.2002.0235<space/></arg><arg name="ref"><space/>harv<space/></arg></template></extension><space/><link><target>Physical exercise</target></link><space/>is recommended for management of mild depression,<extension extension_name='ref' name="nice2007"><template><target>cite web</target><arg name="url"><space/>http://www.nice.org.uk/nicemedia/pdf/CG023fullguideline.pdf</arg><arg name="format">PDF</arg><arg name="title"><space/>Management of depression in primary and secondary care</arg><arg name="accessdate">4 November 2008<space/></arg><arg name="work">National Clinical Practice Guideline Number 23<space/></arg><arg name="publisher">[[National Institute for Health and Clinical Excellence]]<space/></arg><arg name="year">2007</arg></template></extension><space/>and has a moderate effect on symptoms.<extension extension_name='ref' name="Coo2013"></extension><space/>It is equivalent to the use of medications or psychological therapies in most people.<extension extension_name='ref' name="Coo2013"><template><target>cite journal</target><arg name="author"><space/>Cooney GM, Dwan K, Greig CA, Lawlor DA, Rimer J, Waugh FR, McMurdo M, Mead GE<space/></arg><arg name="title"><space/>Exercise for depression<space/></arg><arg name="journal"><space/>Cochrane Database of Systematic Reviews<space/></arg><arg name="volume"><space/>9<space/></arg><arg name="pages"><space/>CD004366<space/></arg><arg name="date"><space/>12 September 2013<space/></arg><arg name="pmid"><space/>24026850<space/></arg><arg name="doi"><space/>10.1002/14651858.CD004366.pub6<space/></arg><arg name="editor1-last"><space/>Mead<space/></arg><arg name="editor1-first"><space/>Gillian E<space/></arg></template></extension><space/>In the older people it does appear to decrease depression.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Bridle C, Spanjers K, Patel S, Atherton NM, Lamb SE<space/></arg><arg name="title"><space/>Effect of exercise on depression severity in older people: systematic review and meta-analysis of randomised controlled trials<space/></arg><arg name="journal"><space/>Br J Psychiatry<space/></arg><arg name="volume"><space/>201<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>180–5<space/></arg><arg name="date"><space/>September 2012<space/></arg><arg name="pmid"><space/>22945926<space/></arg><arg name="doi"><space/>10.1192/bjp.bp.111.095174<space/></arg><arg name="url"><space/></arg></template></extension><space/>In unblinded, non-randomized observational studies<space/><link><target>Smoking cessation</target></link><space/>has benefits in depression as large as or larger than those of medications.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Taylor G, McNeill A, Girling A, Farley A, Lindson-Hawley N, Aveyard P<space/></arg><arg name="title"><space/>Change in mental health after smoking cessation: systematic review and meta-analysis<space/></arg><arg name="journal"><space/>BMJ<space/></arg><arg name="volume"><space/>348<space/></arg><arg name="issue"><space/>feb13 1<space/></arg><arg name="pages"><space/>g1151–g1151<space/></arg><arg name="date"><space/>13 February 2014<space/></arg><arg name="pmid"><space/>24524926<space/></arg><arg name="pmc"><space/>3923980<space/></arg><arg name="doi"><space/>10.1136/bmj.g1151<space/></arg></template></extension><space/>Cognitive behavioral therapy and occupational programs (including modification of work activities and assistance) have been shown to be effective in reducing sick days taken by workers with depression.<extension extension_name='ref' name="pmid25470301"><template><target>cite journal</target><arg name="vauthors">Nieuwenhuijsen K, Faber B, Verbeek JH, Neumeyer-Gromen A, Hees HL, Verhoeven AC, van der Feltz-Cornelis CM, Bültmann U<space/></arg><arg name="title">Interventions to improve return to work in depressed people<space/></arg><arg name="journal">The Cochrane Database of Systematic Reviews<space/></arg><arg name="volume">12<space/></arg><arg name="issue"><space/></arg><arg name="pages">CD006237<space/></arg><arg name="year">2014<space/></arg><arg name="pmid">25470301<space/></arg><arg name="doi">10.1002/14651858.CD006237.pub3<space/></arg><arg name="url"></arg></template></extension></paragraph><heading level='2'>Prognosis</heading><paragraph>Major depressive episodes often resolve over time whether or not they are treated. Outpatients on a waiting list show a 1015% reduction in symptoms within a few months, with approximately 20% no longer meeting the full criteria for a depressive disorder.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Posternak MA, Miller I<space/></arg><arg name="title"><space/>Untreated short-term course of major depression: A meta-analysis of outcomes from studies using wait-list control groups<space/></arg><arg name="journal"><space/>Journal of Affective Disorders<space/></arg><arg name="volume"><space/>66<space/></arg><arg name="issue"><space/>2–3<space/></arg><arg name="pages"><space/>139–46<space/></arg><arg name="year"><space/>2001<space/></arg><arg name="pmid"><space/>11578666<space/></arg><arg name="doi"><space/>10.1016/S0165-0327(00)00304-9<space/></arg></template></extension><space/>The<space/><link><target>median</target></link><space/>duration of an episode has been estimated to be 23 weeks, with the highest rate of recovery in the first three months.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Posternak MA, Solomon DA, Leon AC, Mueller TI, Shea MT, Endicott J, Keller MB<space/></arg><arg name="title"><space/>The naturalistic course of unipolar major depression in the absence of somatic therapy<space/></arg><arg name="journal"><space/>Journal of Nervous and Mental Disease<space/></arg><arg name="volume"><space/>194<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>324–29<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>16699380<space/></arg><arg name="doi"><space/>10.1097/01.nmd.0000217820.33841.53<space/></arg></template></extension></paragraph><paragraph>Studies have shown that 80% of those suffering from their first major depressive episode will suffer from at least 1 more during their life,<extension extension_name='ref' name="pmid17144786"><template><target>cite journal</target><arg name="author"><space/>Fava GA, Park SK, Sonino N<space/></arg><arg name="title"><space/>Treatment of recurrent depression.<space/></arg><arg name="journal"><space/>Expert Review of Neurotherapeutics<space/></arg><arg name="volume"><space/>6<space/></arg><arg name="issue"><space/>11<space/></arg><arg name="pages"><space/>1735–1740<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>17144786<space/></arg><arg name="doi"><space/>10.1586/14737175.6.11.1735<space/></arg></template></extension><space/>with a lifetime average of 4 episodes.<extension extension_name='ref' name="pmid17555914"><template><target>cite journal</target><arg name="author"><space/>Limosin F, Mekaoui L, Hautecouverture S<space/></arg><arg name="title"><space/>Stratégies thérapeutiques prophylactiques dans la dépression unipolaire [Prophylactic treatment for recurrent major depression]<space/></arg><arg name="journal"><space/>La Presse Médicale<space/></arg><arg name="volume"><space/>36<space/></arg><arg name="issue"><space/>11-C2<space/></arg><arg name="pages"><space/>1627–1633<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17555914<space/></arg><arg name="doi"><space/>10.1016/j.lpm.2007.03.032<space/></arg></template></extension><space/>Other general population studies indicate that around half those who have an episode recover (whether treated or not) and remain well, while the other half will have at least one more, and around 15% of those experience chronic recurrence.<extension extension_name='ref' name="pmid18458203"><template><target>cite journal</target><arg name="author"><space/>Eaton WW, Shao H, Nestadt G, Lee HB, Lee BH, Bienvenu OJ, Zandi P<space/></arg><arg name="title"><space/>Population-based study of first onset and chronicity in major depressive disorder<space/></arg><arg name="journal"><space/>Archives of General Psychiatry<space/></arg><arg name="volume"><space/>65<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>513–20<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18458203<space/></arg><arg name="pmc"><space/>2761826<space/></arg><arg name="doi"><space/>10.1001/archpsyc.65.5.513<space/></arg></template></extension><space/>Studies recruiting from selective inpatient sources suggest lower recovery and higher chronicity, while studies of mostly outpatients show that nearly all recover, with a median episode duration of 11 months. Around 90% of those with severe or psychotic depression, most of whom also meet criteria for other mental disorders, experience recurrence.<extension extension_name='ref' name="pmid18251627"><template><target>cite journal</target><arg name="author"><space/>Holma KM, Holma IA, Melartin TK, Rytsälä HJ, Isometsä ET<space/></arg><arg name="title"><space/>Long-term outcome of major depressive disorder in psychiatric patients is variable<space/></arg><arg name="journal"><space/>Journal of Clinical Psychiatry<space/></arg><arg name="volume"><space/>69<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>196–205<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18251627<space/></arg><arg name="doi"><space/>10.4088/JCP.v69n0205<space/></arg></template></extension><extension extension_name='ref' name="pmid12877398"><template><target>cite journal</target><arg name="author"><space/>Kanai T, Takeuchi H, Furukawa TA, Yoshimura R, Imaizumi T, Kitamura T, Takahashi K<space/></arg><arg name="title"><space/>Time to recurrence after recovery from major depressive episodes and its predictors<space/></arg><arg name="journal"><space/>Psychological Medicine<space/></arg><arg name="volume"><space/>33<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>839–45<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12877398<space/></arg><arg name="doi"><space/>10.1017/S0033291703007827<space/></arg></template></extension></paragraph><paragraph>Recurrence is more likely if symptoms have not fully resolved with treatment. Current guidelines recommend continuing antidepressants for four to six&amp;nbsp;months after remission to prevent relapse. Evidence from many<space/><link><target>randomized controlled trial</target><trail>s</trail></link><space/>indicates continuing antidepressant medications after recovery can reduce the chance of relapse by 70% (41% on placebo vs. 18% on antidepressant). The preventive effect probably lasts for at least the first 36&amp;nbsp;months of use.<extension extension_name='ref' name="pmid12606176"><template><target>cite journal</target><arg name="author"><space/>Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E, Goodwin GM<space/></arg><arg name="title"><space/>Relapse prevention with antidepressant drug treatment in depressive disorders: A systematic review<space/></arg><arg name="journal"><space/>Lancet<space/></arg><arg name="volume"><space/>361<space/></arg><arg name="issue"><space/>9358<space/></arg><arg name="pages"><space/>653–61<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12606176<space/></arg><arg name="doi"><space/>10.1016/S0140-6736(03)12599-8<space/></arg></template></extension></paragraph><paragraph>Those people experiencing repeated episodes of depression require ongoing treatment in order to prevent more severe, long-term depression. In some cases, people must take medications for long periods of time or for the rest of their lives.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.nlm.nih.gov/medlineplus/ency/article/000945.htm</arg><arg name="title">Major Depression</arg><arg name="work">MedlinePlus</arg><arg name="date">10 March 2014</arg><arg name="accessdate"><space/>16 July 2010</arg></template></extension></paragraph><paragraph>Cases when outcome is poor are associated with inappropriate treatment, severe initial symptoms that may include psychosis, early age of onset, more previous episodes, incomplete recovery after 1 year, pre-existing severe mental or medical disorder, and<space/><link><target>family dysfunction</target></link><space/>as well.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.mdguidelines.com/depression-major/prognosis</arg><arg name="title">Depression, Major: Prognosis</arg><arg name="work">MDGuidlines</arg><arg name="publisher">[[Guardian Life Insurance Company of America]]</arg><arg name="accessdate"><space/>16 July 2010</arg></template></extension></paragraph><paragraph>Depressed individuals have a shorter<space/><link><target>life expectancy</target></link><space/>than those without depression, in part because depressed patients are at risk of dying by suicide.<extension extension_name='ref' name="pmid12377293"><template><target>cite journal</target><arg name="author"><space/>Cassano P, Fava M<space/></arg><arg name="title"><space/>Depression and public health: an overview<space/></arg><arg name="journal"><space/>J Psychosom Res<space/></arg><arg name="volume"><space/>53<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>849–57<space/></arg><arg name="year"><space/>2002<space/></arg><arg name="pmid"><space/>12377293<space/></arg><arg name="doi"><space/>10.1016/S0022-3999(02)00304-5<space/></arg></template></extension><space/>However, they also have a higher<space/><link><target>mortality rate</target><part>rate of dying</part></link><space/>from other causes,<extension extension_name='ref' name="pmid17640152"><template><target>cite journal</target><arg name="author"><space/>Rush AJ<space/></arg><arg name="title"><space/>The varied clinical presentations of major depressive disorder<space/></arg><arg name="journal"><space/>The Journal of clinical psychiatry<space/></arg><arg name="volume"><space/>68<space/></arg><arg name="issue"><space/>Supplement 8<space/></arg><arg name="pages"><space/>4–10<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17640152<space/></arg></template></extension><space/>being more susceptible to medical conditions such as heart disease.<extension extension_name='ref' name="pmid18334889"></extension><space/>Up to 60% of people who commit suicide have a mood disorder such as major depression, and the risk is especially high if a person has a marked sense of hopelessness or has both depression and<space/><link><target>borderline personality disorder</target></link>.<extension extension_name='ref' name="IntegrativeSuicide"><template><target>Harvnb</target><arg>Barlow</arg><arg>2005</arg><arg name="pp">248–49</arg></template></extension><space/>The lifetime risk of suicide associated with a diagnosis of major depression in the US is estimated at 3.4%, which averages two highly disparate figures of almost 7% for men and 1% for women<extension extension_name='ref' name="pmid11437805"><template><target>cite journal</target><arg name="author"><space/>Blair-West GW, Mellsop GW<space/></arg><arg name="title"><space/>Major depression: Does a gender-based down-rating of suicide risk challenge its diagnostic validity?<space/></arg><arg name="journal"><space/>Australian and New Zealand Journal of Psychiatry<space/></arg><arg name="volume"><space/>35<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>322–28<space/></arg><arg name="year"><space/>2001<space/></arg><arg name="pmid"><space/>11437805<space/></arg><arg name="doi"><space/>10.1046/j.1440-1614.2001.00895.x<space/></arg></template></extension><space/>(although suicide attempts are more frequent in women).<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Oquendo MA, Bongiovi-Garcia ME, Galfalvy H, Goldberg PH, Grunebaum MF, Burke AK, Mann JJ<space/></arg><arg name="title"><space/>Sex differences in clinical predictors of suicidal acts after major depression: a prospective study<space/></arg><arg name="journal"><space/>The American Journal of Psychiatry<space/></arg><arg name="volume"><space/>164<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>134–41<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17202555<space/></arg><arg name="doi"><space/>10.1176/ajp.2007.164.1.134</arg></template></extension><space/>The estimate is substantially lower than a previously accepted figure of 15%, which had been derived from older studies of hospitalized patients.<extension extension_name='ref' name="pmid11097952"><template><target>cite journal</target><arg name="author"><space/>Bostwick JM, Pankratz VS<space/></arg><arg name="title"><space/>Affective disorders and suicide risk: A reexamination<space/></arg><arg name="journal"><space/>American Journal of Psychiatry<space/></arg><arg name="volume"><space/>157<space/></arg><arg name="issue"><space/>12<space/></arg><arg name="pages"><space/>1925–32<space/></arg><arg name="year"><space/>2000<space/></arg><arg name="pmid"><space/>11097952<space/></arg><arg name="doi"><space/>10.1176/appi.ajp.157.12.1925<space/></arg><arg name="url"><space/>http://ajp.psychiatryonline.org/cgi/content/full/157/12/1925<space/></arg></template></extension></paragraph><paragraph>Depression is often associated with unemployment and poverty.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Weich S, Lewis G<space/></arg><arg name="title"><space/>Poverty, unemployment, and common mental disorders: Population based cohort study<space/></arg><arg name="journal"><space/>[[BMJ]]<space/></arg><arg name="volume"><space/>317<space/></arg><arg name="issue"><space/>7151<space/></arg><arg name="pages"><space/>115–19<space/></arg><arg name="year"><space/>1998<space/></arg><arg name="pmid"><space/>9657786<space/></arg><arg name="pmc"><space/>28602<space/></arg><arg name="doi"><space/>10.1136/bmj.317.7151.115<space/></arg><arg name="url"><space/>http://www.bmj.com/cgi/content/full/317/7151/115<space/></arg><arg name="accessdate"><space/>16 September 2008<space/></arg></template></extension><space/>Major depression is currently the leading cause of<space/><link><target>disease burden</target></link><space/>in North America and other high-income countries, and the fourth-leading cause worldwide. In the year 2030, it is predicted to be the second-leading cause of disease burden worldwide after<space/><link><target>HIV</target></link>, according to the World Health Organization.<extension extension_name='ref' name="pmid17132052"><template><target>cite journal</target><arg name="author"><space/>Mathers CD, Loncar D<space/></arg><arg name="title"><space/>Projections of global mortality and burden of disease from 2002 to 2030<space/></arg><arg name="journal"><space/>PLoS Med.<space/></arg><arg name="volume"><space/>3<space/></arg><arg name="issue"><space/>11<space/></arg><arg name="pages"><space/>e442<space/></arg><arg name="year"><space/>2006<space/></arg><arg name="pmid"><space/>17132052<space/></arg><arg name="pmc"><space/>1664601<space/></arg><arg name="doi"><space/>10.1371/journal.pmed.0030442<space/></arg></template></extension><space/>Delay or failure in seeking treatment after relapse, and the failure of health professionals to provide treatment, are two barriers to reducing disability.<extension extension_name='ref' name="Andrews08"><template><target>cite journal</target><arg name="author"><space/>Andrews G<space/></arg><arg name="title"><space/>In Review: Reducing the Burden of Depression<space/></arg><arg name="journal"><space/>Canadian Journal of Psychiatry<space/></arg><arg name="volume"><space/>53<space/></arg><arg name="issue"><space/>7<space/></arg><arg name="pages"><space/>420–27<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18674396<space/></arg><arg name="url"><space/>http://publications.cpa-apc.org/media.php?mid</arg></template></extension></paragraph><heading level='2'>Epidemiology</heading><paragraph><template><target>Main</target><arg>Epidemiology of depression</arg></template>[[File:Unipolar depressive disorders world map - DALY - WHO2004.svg|thumb|250px|<link><target>Disability-adjusted life year</target></link><space/>for unipolar depressive disorders per 100,000 inhabitants in 2004.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.who.int/healthinfo/global_burden_disease/estimates_country/en/index.html<space/></arg><arg name="title">WHO Disease and injury country estimates<space/></arg><arg name="year">2009<space/></arg><arg name="work">World Health Organization<space/></arg><arg name="accessdate">11 November 2009</arg></template></extension><template><target>Multicol</target></template><template><target>legend</target><arg>#b3b3b3</arg><arg>no data</arg></template><template><target>legend</target><arg>#ffff65</arg><arg><700</arg></template><template><target>legend</target><arg>#fff200</arg><arg>700–775</arg></template><template><target>legend</target><arg>#ffdc00</arg><arg>775–850</arg></template><template><target>legend</target><arg>#ffc600</arg><arg>850–925</arg></template><template><target>legend</target><arg>#ffb000</arg><arg>925–1000</arg></template><template><target>legend</target><arg>#ff9a00</arg><arg>1000–1075</arg></template><template><target>Multicol-break</target></template><template><target>legend</target><arg>#ff8400</arg><arg>1075–1150</arg></template><template><target>legend</target><arg>#ff6e00</arg><arg>1150–1225</arg></template><template><target>legend</target><arg>#ff5800</arg><arg>1225–1300</arg></template><template><target>legend</target><arg>#ff4200</arg><arg>1300–1375</arg></template><template><target>legend</target><arg>#ff2c00</arg><arg>1375–1450</arg></template><template><target>legend</target><arg>#cb0000</arg><arg>>1450</arg></template><template><target>Multicol-end</target></template>]]</paragraph><paragraph>Depression is a major cause of<space/><link><target>morbidity</target></link><space/>worldwide.<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.who.int/whr/2001/en/index.html<space/></arg><arg name="title">The world health report 2001&nbsp;– Mental Health: New Understanding, New Hope<space/></arg><arg name="accessdate">19 October 2008<space/></arg><arg name="work">WHO website<space/></arg><arg name="publisher">World Health Organization<space/></arg><arg name="year">2001</arg></template></extension><space/>It is believed to currently affect approximately 298&amp;nbsp;million people as of 2010 (4.3% of the global population).<extension extension_name='ref' name="LancetEpi2012"></extension><space/>Lifetime prevalence varies widely, from 3% in Japan to 17% in the United States.<extension extension_name='ref' name="pmid12830306"></extension><space/>In most countries the number of people who have depression during their lives falls within an 812% range.<extension extension_name='ref' name="pmid12830306"><template><target>cite journal</target><arg name="author"><space/>Andrade L, Caraveo-Anduaga JJ, Berglund P, Bijl RV, De Graaf R, Vollebergh W, Dragomirecka E, Kohn R, Keller M, Kessler RC, Kawakami N, Kiliç C, Offord D, Ustun TB, Wittchen HU<space/></arg><arg name="title"><space/>The epidemiology of major depressive episodes: results from the International Consortium of Psychiatric Epidemiology (ICPE) Surveys<space/></arg><arg name="journal"><space/>Int J Methods Psychiatr Res<space/></arg><arg name="volume"><space/>12<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>3–21<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12830306<space/></arg><arg name="doi"><space/>10.1002/mpr.138<space/></arg></template></extension><space/>In North America, the probability of having a major depressive episode within a year-long period is 35% for males and 810% for females.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE<space/></arg><arg name="title"><space/>Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication<space/></arg><arg name="journal"><space/>Archives of General Psychiatry<space/></arg><arg name="volume"><space/>62<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>593–602<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>15939837<space/></arg><arg name="doi"><space/>10.1001/archpsyc.62.6.593<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Murphy JM, Laird NM, Monson RR, Sobol AM, Leighton AH<space/></arg><arg name="title"><space/>A 40-year perspective on the prevalence of depression: The Stirling County Study<space/></arg><arg name="journal"><space/>Archives of General Psychiatry<space/></arg><arg name="volume"><space/>57<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>209–15<space/></arg><arg name="year"><space/>2000<space/></arg><arg name="pmid"><space/>10711905<space/></arg><arg name="doi"><space/>10.1001/archpsyc.57.3.209<space/></arg></template></extension><space/>Population studies have consistently shown major depression to be about twice as common in women as in men, although it is unclear why this is so, and whether factors unaccounted for are contributing to this.<extension extension_name='ref' name="Kuehner03"><template><target>cite journal</target><arg name="author"><space/>Kuehner C<space/></arg><arg name="title"><space/>Gender differences in unipolar depression: An update of epidemiological findings and possible explanations<space/></arg><arg name="journal"><space/>Acta Psychiatrica Scandinavica<space/></arg><arg name="volume"><space/>108<space/></arg><arg name="issue"><space/>3<space/></arg><arg name="pages"><space/>163–74<space/></arg><arg name="year"><space/>2003<space/></arg><arg name="pmid"><space/>12890270<space/></arg><arg name="doi"><space/>10.1034/j.1600-0447.2003.00204.x<space/></arg></template></extension><space/>The relative increase in occurrence is related to pubertal development rather than chronological age, reaches adult ratios between the ages of 15 and 18, and appears associated with psychosocial more than hormonal factors.<extension extension_name='ref' name="Kuehner03"></extension></paragraph><paragraph>People are most likely to suffer their first depressive episode between the ages of 30 and 40, and there is a second, smaller peak of incidence between ages 50 and 60.<extension extension_name='ref' name="Eaton97"><template><target>cite journal</target><arg name="author"><space/>Eaton WW, Anthony JC, Gallo J, Cai G, Tien A, Romanoski A, Lyketsos C, Chen LS<space/></arg><arg name="title"><space/>Natural history of diagnostic interview schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up<space/></arg><arg name="journal"><space/>Archives of General Psychiatry<space/></arg><arg name="volume"><space/>54<space/></arg><arg name="issue"><space/>11<space/></arg><arg name="pages"><space/>993–99<space/></arg><arg name="year"><space/>1997<space/></arg><arg name="pmid"><space/>9366655<space/></arg><arg name="doi"><space/>10.1001/archpsyc.1997.01830230023003<space/></arg></template></extension><space/>The risk of major depression is increased with neurological conditions such as<space/><link><target>stroke</target></link>,<space/><link><target>Parkinson's disease</target></link>, or<space/><link><target>multiple sclerosis</target></link>, and during the first year after childbirth.<extension extension_name='ref' name="Rickards05"><template><target>cite journal</target><arg name="author"><space/>Rickards H<space/></arg><arg name="title"><space/>Depression in neurological disorders: Parkinson's disease, multiple sclerosis, and stroke<space/></arg><arg name="journal"><space/>Journal of Neurology Neurosurgery and Psychiatry<space/></arg><arg name="volume"><space/>76<space/></arg><arg name="pages"><space/>i48–i52<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>15718222<space/></arg><arg name="pmc"><space/>1765679<space/></arg><arg name="doi"><space/>10.1136/jnnp.2004.060426<space/></arg><arg name="url"><space/>http://jnnp.bmj.com/cgi/content/full/76/suppl_1/i48<space/></arg></template></extension><space/>It is also more common after cardiovascular illnesses, and is related more to a poor outcome than to a better one.<extension extension_name='ref' name="pmid18334889"><template><target>cite journal</target><arg name="author"><space/>Alboni P, Favaron E, Paparella N, Sciammarella M, Pedaci M<space/></arg><arg name="title"><space/>Is there an association between depression and cardiovascular mortality or sudden death?<space/></arg><arg name="journal"><space/>Journal of cardiovascular medicine (Hagerstown, Md.)<space/></arg><arg name="volume"><space/>9<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>356–62<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18334889<space/></arg><arg name="doi"><space/>10.2459/JCM.0b013e3282785240<space/></arg></template></extension><extension extension_name='ref' name="pmid11383983"><template><target>cite journal</target><arg name="author"><space/>Strik JJ, Honig A, Maes M<space/></arg><arg name="title"><space/>Depression and myocardial infarction: relationship between heart and mind<space/></arg><arg name="journal"><space/>Progress in neuro-psychopharmacology & biological psychiatry<space/></arg><arg name="volume"><space/>25<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>879–92<space/></arg><arg name="year"><space/>2001<space/></arg><arg name="pmid"><space/>11383983<space/></arg><arg name="doi"><space/>10.1016/S0278-5846(01)00150-6<space/></arg></template></extension><space/>Studies conflict on the prevalence of depression in the elderly, but most data suggest there is a reduction in this age group.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Jorm AF<space/></arg><arg name="title"><space/>Does old age reduce the risk of anxiety and depression? A review of epidemiological studies across the adult life span<space/></arg><arg name="journal"><space/>Psychological Medicine<space/></arg><arg name="volume"><space/>30<space/></arg><arg name="issue"><space/>1<space/></arg><arg name="pages"><space/>11–22<space/></arg><arg name="year"><space/>2000<space/></arg><arg name="pmid"><space/>10722172<space/></arg><arg name="doi"><space/>10.1017/S0033291799001452<space/></arg></template></extension><space/>Depressive disorders are more common to observe in urban than in rural population and the prevalence is in groups with stronger socioeconomic factors i.e. homelessness.<extension extension_name='ref'>Gelder, M., Mayou, R. and Geddes, J. 2005. Psychiatry. 3rd ed. New York: Oxford. pp105.</extension></paragraph><heading level='2'>History</heading><paragraph><link><target>File:Hippocrates pushkin02.jpg</target><part>alt=</part><part>thumb</part><part>Diagnoses of depression go back at least as far as<space/><link><target>Hippocrates</target></link></part></link><template><target>Main</target><arg>History of depression</arg></template></paragraph><paragraph>The Ancient Greek physician<space/><link><target>Hippocrates</target></link><space/>described a syndrome of melancholia as a distinct disease with particular mental and physical symptoms; he characterized all &quot;fears and despondencies, if they last a long time&quot; as being symptomatic of the ailment.<extension extension_name='ref'>Hippocrates,<space/><italics>Aphorisms</italics>, Section 6.23</extension><space/>It was a similar but far broader concept than today's depression; prominence was given to a clustering of the symptoms of sadness, dejection, and despondency, and often fear, anger, delusions and obsessions were included.<extension extension_name='ref' name="Radden2003"><template><target>cite journal</target><arg name="author">Radden, J<space/></arg><arg name="year">2003<space/></arg><arg name="title">Is this dame melancholy? Equating today's depression and past melancholia<space/></arg><arg name="journal">Philosophy, Psychiatry, & Psychology<space/></arg><arg name="volume">10<space/></arg><arg name="issue">1<space/></arg><arg name="pages">37–52<space/></arg><arg name="url">http://muse.jhu.edu/journals/philosophy_psychiatry_and_psychology/v010/10.1radden01.html<space/></arg><arg name="doi">10.1353/ppp.2003.0081</arg></template></extension></paragraph><paragraph>The term<space/><italics>depression</italics><space/>itself was derived from the Latin verb<space/><italics>deprimere</italics>, &quot;to press down&quot;.<extension extension_name='ref'>depress. (n.d.). Online Etymology Dictionary. Retrieved 30 June 2008, from<space/><link type='external' href='http://dictionary.reference.com/browse/depress'>Dictionary.com</link></extension><space/>From the 14th&amp;nbsp;century, &quot;to depress&quot; meant to subjugate or to bring down in spirits. It was used in 1665 in English author<space/><link><target>Richard Baker (chronicler)</target><part>Richard Baker's</part></link><space/><italics>Chronicle</italics><space/>to refer to someone having &quot;a great depression of spirit&quot;, and by English author<space/><link><target>Samuel Johnson</target></link><space/>in a similar sense in 1753.<extension extension_name='ref'><template><target>cite web</target><arg name="author"><space/>Wolpert, L<space/></arg><arg name="year">1999</arg><arg name="title">Malignant Sadness: The Anatomy of Depression<space/></arg><arg name="work">The New York Times<space/></arg><arg name="url">http://www.nytimes.com/books/first/w/wolpert-sadness.html</arg><arg name="accessdate">30 October 2008</arg></template></extension><space/>The term also came into use in<space/><link><target>depression (physiology)</target><part>physiology</part></link><space/>and<space/><link><target>depression (economics)</target><part>economics</part></link>. An early usage referring to a psychiatric symptom was by French psychiatrist<space/><link><target>Louis Delasiauve</target></link><space/>in 1856, and by the 1860s it was appearing in medical dictionaries to refer to a physiological and metaphorical lowering of emotional function.<extension extension_name='ref' name="pmid3074848"><template><target>cite journal</target><arg name="author"><space/>Berrios GE<space/></arg><arg name="title"><space/>Melancholia and depression during the 19th&nbsp;century: A conceptual history<space/></arg><arg name="journal"><space/>British Journal of Psychiatry<space/></arg><arg name="volume"><space/>153<space/></arg><arg name="pages"><space/>298–304<space/></arg><arg name="year"><space/>1988<space/></arg><arg name="pmid"><space/>3074848<space/></arg><arg name="doi"><space/>10.1192/bjp.153.3.298<space/></arg></template></extension><space/>Since<space/><link><target>Aristotle</target></link>, melancholia had been associated with men of learning and intellectual brilliance, a hazard of contemplation and creativity. The newer concept abandoned these associations and through the 19th&amp;nbsp;century, became more associated with women.<extension extension_name='ref' name="Radden2003"></extension></paragraph><paragraph>Although<space/><italics>melancholia</italics><space/>remained the dominant diagnostic term,<space/><italics>depression</italics><space/>gained increasing currency in medical treatises and was a synonym by the end of the century; German psychiatrist<space/><link><target>Emil Kraepelin</target></link><space/>may have been the first to use it as the overarching term, referring to different kinds of melancholia as<space/><italics>depressive states</italics>.<extension extension_name='ref' name="Davison2006"><template><target>cite journal</target><arg name="last">Davison<space/></arg><arg name="first">K</arg><arg name="year">2006</arg><arg name="title">Historical aspects of mood disorders<space/></arg><arg name="journal">Psychiatry<space/></arg><arg name="volume">5<space/></arg><arg name="issue">4<space/></arg><arg name="pages">115–18<space/></arg><arg name="doi">10.1383/psyt.2006.5.4.115</arg></template></extension></paragraph><paragraph><link><target>Sigmund Freud</target></link><space/>likened the state of melancholia to mourning in his 1917 paper<space/><italics>Mourning and Melancholia</italics>. He theorized that<space/><link><target>object (philosophy)</target><part>objective</part></link><space/>loss, such as the loss of a valued relationship through death or a romantic break-up, results in<space/><link><target>subject (philosophy)</target><part>subjective</part></link><space/>loss as well; the depressed individual has identified with the object of affection through an<space/><link><target>unconscious mind</target><part>unconscious</part></link>,<space/><link><target>narcissism</target><part>narcissistic</part></link><space/>process called the<space/><italics>libidinal<space/><link><target>cathexis</target></link></italics><space/>of the<space/><link><target>Id, ego and super-ego</target><part>ego</part></link>. Such loss results in severe melancholic symptoms more profound than mourning; not only is the outside world viewed negatively but the ego itself is compromised.<extension extension_name='ref' name="Carhart-Harris08"></extension><space/>The patient's decline of self-perception is revealed in his belief of his own blame, inferiority, and unworthiness.<extension extension_name='ref' name="autogenerated1"></extension><space/>He also emphasized early life experiences as a predisposing factor.<extension extension_name='ref' name="Radden2003"></extension><space/><link><target>Adolf Meyer (psychiatrist)</target><part>Adolf Meyer</part></link><space/>put forward a mixed social and biological framework emphasizing<space/><italics>reactions</italics><space/>in the context of an individual's life, and argued that the term<space/><italics>depression</italics><space/>should be used instead of<space/><italics>melancholia</italics>.<extension extension_name='ref' name="Lewis1934"><template><target>cite journal</target><arg name="author">Lewis, AJ</arg><arg name="year">1934</arg><arg name="title">Melancholia: A historical review<space/></arg><arg name="journal">Journal of Mental Science<space/></arg><arg name="volume">80<space/></arg><arg name="pages">1–42</arg><arg name="doi"><space/>10.1192/bjp.80.328.1</arg></template></extension><space/>The first version of the DSM (DSM-I, 1952) contained<space/><italics>depressive reaction</italics><space/>and the DSM-II (1968)<space/><italics>depressive neurosis</italics>, defined as an excessive reaction to internal conflict or an identifiable event, and also included a depressive type of manic-depressive psychosis within Major affective disorders.<extension extension_name='ref' name="DSMII"><template><target>cite book</target><arg name="title">Diagnostic and statistical manual of mental disorders: DSM-II<space/></arg><arg name="author">American Psychiatric Association<space/></arg><arg name="publisher">American Psychiatric Publishing, Inc.<space/></arg><arg name="location">Washington, DC<space/></arg><arg name="year">1968<space/></arg><arg name="chapter">Schizophrenia<space/></arg><arg name="url">http://www.psychiatryonline.com/DSMPDF/dsm-ii.pdf</arg><arg name="format">PDF<space/></arg><arg name="accessdate">3 August 2008<space/></arg><arg name="pages"><space/>36–37, 40</arg></template></extension></paragraph><paragraph>In the mid-20th century, researchers theorized that depression was caused by a<space/><link><target>chemical imbalance theory</target><part>chemical imbalance</part></link><space/>in neurotransmitters in the brain, a theory based on observations made in the 1950s of the effects of<space/><link><target>reserpine</target></link><space/>and<space/><link><target>isoniazid</target></link><space/>in altering monoamine neurotransmitter levels and affecting depressive symptoms.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Schildkraut JJ<space/></arg><arg name="title"><space/>The catecholamine hypothesis of affective disorders: A review of supporting evidence<space/></arg><arg name="journal"><space/>American Journal of Psychiatry<space/></arg><arg name="volume"><space/>122<space/></arg><arg name="issue"><space/>5<space/></arg><arg name="pages"><space/>509–22<space/></arg><arg name="year"><space/>1965<space/></arg><arg name="pmid"><space/>5319766<space/></arg><arg name="doi"><space/>10.1176/ajp.122.5.509</arg></template></extension></paragraph><paragraph>The term &quot;unipolar&quot; (along with the related term &quot;<link><target>bipolar disorder</target><part>bipolar</part></link>&quot;) was coined by the neurologist and psychiatrist<space/><link><target>Karl Kleist</target></link>, and subsequently used by his disciples<space/><link><target>Edda Neele</target></link><space/>and<space/><link><target>Karl Leonhard</target></link>.<extension extension_name='ref'><link><target>Jules Angst</target><part>Angst J.</part></link><space/>Terminology, history and definition of bipolar spectrum. In: Maj M, Akiskal HS, Lpez-Ibor JJ, Sartorius N (eds.),<space/><italics>Bipolar disorders</italics>. Chichester: Wiley &amp; Sons, LTD; 2002. pp. 5355.</extension></paragraph><paragraph>The term<space/><italics>Major depressive disorder</italics><space/>was introduced by a group of US clinicians in the mid-1970s as part of proposals for diagnostic criteria based on patterns of symptoms (called the &quot;Research Diagnostic Criteria&quot;, building on earlier<space/><link><target>Feighner Criteria</target></link>),<extension extension_name='ref'><template><target>cite web</target><arg name="author">Spitzer RL, Endicott J, Robins E</arg><arg name="year">1975<space/></arg><arg name="url">http://www.garfield.library.upenn.edu/classics1989/A1989U309700001.pdf<space/></arg><arg name="title">The development of diagnostic criteria in psychiatry<space/></arg><arg name="accessdate">8 November 2008</arg><arg name="format">PDF</arg></template></extension><space/>and was incorporated into the DSM-III in 1980.<extension extension_name='ref' name="Philipp1991"><template><target>cite journal</target><arg name="author"><space/>Philipp M, Maier W, Delmo CD<space/></arg><arg name="title"><space/>The concept of major depression. I. Descriptive comparison of six competing operational definitions including ICD-10 and DSM-III-R<space/></arg><arg name="journal"><space/>European Archives of Psychiatry and Clinical Neuroscience<space/></arg><arg name="volume"><space/>240<space/></arg><arg name="issue"><space/>4–5<space/></arg><arg name="pages"><space/>258–65<space/></arg><arg name="year"><space/>1991<space/></arg><arg name="pmid"><space/>1829000<space/></arg><arg name="doi"><space/>10.1007/BF02189537<space/></arg><arg name="url"><space/>http://www.springerlink.com/content/y2460650rm747035/<space/></arg></template></extension><space/>To maintain consistency the ICD-10 used the same criteria, with only minor alterations, but using the DSM diagnostic threshold to mark a<space/><italics>mild depressive episode</italics>, adding higher threshold categories for moderate and severe episodes.<extension extension_name='ref' name="DSMvsICD"><template><target>cite web</target><arg name="author">Gruenberg, A.M., Goldstein, R.D., Pincus, H.A.<space/></arg><arg name="year">2005<space/></arg><arg name="url">http://media.wiley.com/product_data/excerpt/50/35273078/3527307850.pdf<space/></arg><arg name="title">Classification of Depression: Research and Diagnostic Criteria: DSM-IV and ICD-10<space/></arg><arg name="work">Biology of Depression: From Novel Insights to Therapeutic Strategies (eds J. Licinio and M.-L. Wong)</arg><arg name="publisher">Wiley-VCH Verlag GmbH</arg><arg name="accessdate">30 October 2008</arg><arg name="doi">10.1002/9783527619672.ch1</arg></template></extension><extension extension_name='ref' name="Philipp1991"></extension><space/>The ancient idea of<space/><italics>melancholia</italics><space/>still survives in the notion of a melancholic subtype.</paragraph><paragraph>The new definitions of depression were widely accepted, albeit with some conflicting findings and views. There have been some continued empirically based arguments for a return to the diagnosis of melancholia.<extension extension_name='ref' name="ActaPsychiatrica06"><template><target>cite journal</target><arg name="author"><space/>Bolwig, Tom G.<space/></arg><arg name="title"><space/>Melancholia: Beyond DSM, beyond neurotransmitters. Proceedings of a conference, May 2006, Copenhagen, Denmark<space/></arg><arg name="journal"><space/>Acta Psychiatrica Scandinavica Suppl<space/></arg><arg name="volume"><space/>115<space/></arg><arg name="issue"><space/>433<space/></arg><arg name="pages"><space/>4–183<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17280564<space/></arg><arg name="doi"><space/>10.1111/j.1600-0447.2007.00956.x<space/></arg><arg name="last2"><space/>Shorter<space/></arg><arg name="first2"><space/>Edward<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Fink M, Bolwig TG, Parker G, Shorter E<space/></arg><arg name="title"><space/>Melancholia: Restoration in psychiatric classification recommended<space/></arg><arg name="journal"><space/>Acta Psychiatrica Scandinavica<space/></arg><arg name="volume"><space/>115<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>89–92<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17244171<space/></arg><arg name="doi"><space/>10.1111/j.1600-0447.2006.00943.x<space/></arg></template></extension><space/>There has been some criticism of the expansion of coverage of the diagnosis, related to the development and promotion of antidepressants and the biological model since the late 1950s.<extension extension_name='ref'><template><target>cite book</target><arg name="title">The Antidepressant Era<space/></arg><arg name="last">Healy<space/></arg><arg name="first">David<space/></arg><arg name="authorlink">David Healy (psychiatrist)</arg><arg name="year">1999<space/></arg><arg name="publisher">Harvard University Press<space/></arg><arg name="location">Cambridge, MA<space/></arg><arg name="isbn">0-674-03958-0<space/></arg><arg name="pages">42</arg></template></extension></paragraph><heading level='2'>Society and culture</heading><paragraph><link><target>Image:Abraham Lincoln O-60 by Brady, 1862.jpg</target><part>thumb</part><part>The 16th<space/><link><target>President of the United States</target><part>American president</part></link><space/><link><target>Abraham Lincoln</target></link><space/>suffered from &quot;<link><target>Depression (mood)</target><part>melancholy</part></link>&quot;, a condition that now may be referred to as clinical depression.<extension extension_name='ref'>Wolf, Joshua<space/><link type='external' href='http://www.theatlantic.com/doc/200510/lincolns-clinical-depression'>&quot;Lincoln's Great Depression&quot;</link>,<space/><italics>The Atlantic</italics>, October 2005, Retrieved 10 October 2009</extension></part></link><template><target>See also</target><arg>List of people with major depressive disorder</arg></template></paragraph><paragraph>People's conceptualizations of depression vary widely, both within and among cultures. &quot;Because of the lack of scientific certainty,&quot; one commentator has observed, &quot;the debate over depression turns on questions of language. What we call it'disease,' 'disorder,' 'state of mind'affects how we view, diagnose, and treat it.&quot;<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.slate.com/id/2129377</arg><arg name="title">The Depression Wars: Would Honest Abe Have Written the Gettysburg Address on Prozac?<space/></arg><arg name="author">Maloney F</arg><arg name="date"><space/>3 November 2005</arg><arg name="work"><space/>Slate magazine<space/></arg><arg name="publisher"><space/>Washington Post</arg><arg name="accessdate">3 October 2008</arg></template></extension><space/>There are cultural differences in the extent to which serious depression is considered an illness requiring personal professional treatment, or is an indicator of something else, such as the need to address social or moral problems, the result of biological imbalances, or a reflection of individual differences in the understanding of distress that may reinforce feelings of powerlessness, and emotional struggle.<extension extension_name='ref' name="Karasz05"><template><target>cite journal</target><arg name="author"><space/>Karasz A<space/></arg><arg name="title"><space/>Cultural differences in conceptual models of depression<space/></arg><arg name="journal"><space/>Social Science in Medicine<space/></arg><arg name="volume"><space/>60<space/></arg><arg name="issue"><space/>7<space/></arg><arg name="pages"><space/>1625–35<space/></arg><arg name="year"><space/>2005<space/></arg><arg name="pmid"><space/>15652693<space/></arg><arg name="doi"><space/>10.1016/j.socscimed.2004.08.011<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author">Tilbury, F</arg><arg name="year">2004</arg><arg name="title">There are orphans in Africa still looking for my hands': African women refugees and the sources of emotional distress</arg><arg name="journal">Health Sociology Review</arg><arg name="volume">13</arg><arg name="issue">1</arg><arg name="pages">54–64</arg><arg name="url">http://www.atypon-link.com/EMP/doi/abs/10.5555/hesr.2004.13.1.54</arg><arg name="accessdate">3 October 2008</arg><arg name="doi">10.5555/hesr.2004.13.1.54</arg></template></extension></paragraph><paragraph>The diagnosis is less common in some countries, such as<space/><link><target>People's Republic of China</target><part>China</part></link>. It has been argued that the Chinese traditionally deny or<space/><link><target>Somatization</target><part>somatize</part></link><space/>emotional depression (although since the early 1980s, the Chinese denial of depression may have modified drastically).<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Parker G, Gladstone G, Chee KT<space/></arg><arg name="title"><space/>Depression in the planet's largest ethnic group: The Chinese<space/></arg><arg name="journal"><space/>American Journal of Psychiatry<space/></arg><arg name="volume"><space/>158<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>857–64<space/></arg><arg name="year"><space/>2001<space/></arg><arg name="pmid"><space/>11384889<space/></arg><arg name="doi"><space/>10.1176/appi.ajp.158.6.857</arg></template></extension><space/>Alternatively, it may be that Western cultures reframe and elevate some expressions of human distress to disorder status. Australian professor<space/><link><target>Gordon Parker</target></link><space/>and others have argued that the Western concept of depression &quot;medicalizes&quot; sadness or misery.<extension extension_name='ref' name="Parker07"><template><target>cite journal</target><arg name="author"><space/>Parker G<space/></arg><arg name="title"><space/>Is depression overdiagnosed? Yes<space/></arg><arg name="journal"><space/>[[BMJ]]<space/></arg><arg name="volume"><space/>335<space/></arg><arg name="issue"><space/>7615<space/></arg><arg name="pages"><space/>328<space/></arg><arg name="year"><space/>2007<space/></arg><arg name="pmid"><space/>17703040<space/></arg><arg name="pmc"><space/>1949440<space/></arg><arg name="doi"><space/>10.1136/bmj.39268.475799.AD<space/></arg><arg name="url"><space/>http://www.bmj.com/cgi/content/full/335/7615/328<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author">Pilgrim D, Bentall R</arg><arg name="year">1999</arg><arg name="title">The medicalisation of misery: A critical realist analysis of the concept of depression<space/></arg><arg name="journal">Journal of Mental Health<space/></arg><arg name="volume">8<space/></arg><arg name="issue">3<space/></arg><arg name="pages">261–74<space/></arg><arg name="url">http://www.ingentaconnect.com/content/apl/cjmh/1999/00000008/00000003/art00007<space/></arg><arg name="doi">10.1080/09638239917580</arg></template></extension><space/>Similarly, Hungarian-American psychiatrist<space/><link><target>Thomas Szasz</target></link><space/>and others argue that depression is a metaphorical illness that is inappropriately regarded as an actual disease.<extension extension_name='ref'><template><target>cite web</target><arg name="author">Steibel W (Producer)<space/></arg><arg name="year">1998<space/></arg><arg name="url">http://www.szasz.com/isdepressionadiseasetranscript.html<space/></arg><arg name="title">Is depression a disease?<space/></arg><arg name="work">Debatesdebates<space/></arg><arg name="accessdate">16 November 2008</arg></template></extension><space/>There has also been concern that the DSM, as well as the field of<space/><link><target>descriptive psychiatry</target></link><space/>that employs it, tends to<space/><link><target>Reification (fallacy)</target><part>reify</part></link><space/>abstract phenomena such as depression, which may in fact be<space/><link><target>Social constructionism</target><part>social constructs</part></link>.<extension extension_name='ref' name="Blazer"><template><target>cite book</target><arg name="author">Blazer DG<space/></arg><arg name="title">The age of melancholy: "Major depression" and its social origins<space/></arg><arg name="publisher"><space/>Routledge</arg><arg name="location">New York, NY, USA<space/></arg><arg name="year">2005<space/></arg><arg name="isbn">978-0-415-95188-3</arg></template></extension><space/>American<space/><link><target>Archetypal psychology</target><part>archetypal psychologist</part></link><space/><link><target>James Hillman</target></link><space/>writes that depression can be healthy for the<space/><link><target>Soul (spirit)</target><part>soul</part></link>, insofar as &quot;it brings refuge, limitation, focus, gravity, weight, and humble powerlessness.&quot;<extension extension_name='ref' name="Hillman"><template><target>cite book</target><arg name="author">Hillman J (T Moore, Ed.)<space/></arg><arg name="title">A blue fire: Selected writings by James Hillman<space/></arg><arg name="publisher"><space/>Harper & Row</arg><arg name="location">New York, NY, USA<space/></arg><arg name="year">1989<space/></arg><arg name="pages">152–53<space/></arg><arg name="isbn">0-06-016132-9</arg></template></extension><space/>Hillman argues that therapeutic attempts to eliminate depression echo the Christian theme of<space/><link><target>resurrection</target></link>, but have the unfortunate effect of demonizing a soulful state of being.</paragraph><preblock><preline>Historical figures were often reluctant to discuss or seek treatment for depression due to<space/><link><target>social stigma</target></link><space/>about the condition, or due to ignorance of diagnosis or treatments. Nevertheless, analysis or interpretation of letters, journals, artwork, writings, or statements of family and friends of some historical personalities has led to the presumption that they may have had some form of depression. People who may have had depression include English author<space/><link><target>Mary Shelley</target></link>,<extension extension_name='ref'><template><target>cite book</target><arg name="last">Seymour</arg><arg name="first">Miranda<space/></arg><arg name="title"><space/>Mary Shelley</arg><arg name="publisher">Grove Press</arg><arg name="year">2002<space/></arg><arg name="pages">560–61<space/></arg><arg name="isbn">0-8021-3948-5</arg></template></extension><space/>American-British writer<space/><link><target>Henry James</target></link>,<extension extension_name='ref'><template><target>cite web</target><arg name="url">http://www.pbs.org/wgbh/masterpiece/americancollection/american/genius/henry_bio.html</arg><arg name="title">Biography of Henry James</arg><arg name="publisher">[[Public Broadcasting Service|pbs.org]]</arg><arg name="accessdate">19 August 2008</arg></template></extension><space/>and American president<space/><link><target>Abraham Lincoln</target></link>.<extension extension_name='ref'><template><target>cite book</target><arg name="author"><space/>Burlingame, Michael<space/></arg><arg name="title"><space/>The Inner World of Abraham Lincoln<space/></arg><arg name="publisher"><space/>University of Illinois Press<space/></arg><arg name="location"><space/>Urbana<space/></arg><arg name="year"><space/>1997<space/></arg><arg name="isbn"><space/>0-252-06667-7<space/></arg><arg name="pages"><space/>xvii, 92–113<space/></arg></template></extension><space/>Some well-known contemporary people with possible depression include Canadian songwriter<space/><link><target>Leonard Cohen</target></link><extension extension_name='ref'><template><target>cite web</target><arg name="author">Pita E
</arg><arg name="url">http://www.webheights.net/10newsongs/press/elmunmag.htm
</arg><arg name="title">An Intimate Conversation with...Leonard Cohen
</arg><arg name="date">26 September 2001
</arg><arg name="accessdate">3 October 2008
</arg></template></extension><space/>and American playwright and novelist<space/><link><target>Tennessee Williams</target></link>.<extension extension_name='ref' name="Jeste04"><template><target>cite journal</target><arg name="author"><space/>Jeste ND, Palmer BW, Jeste DV<space/></arg><arg name="title"><space/>Tennessee Williams<space/></arg><arg name="journal"><space/>American Journal of Geriatric Psychiatry<space/></arg><arg name="volume"><space/>12<space/></arg><arg name="issue"><space/>4<space/></arg><arg name="pages"><space/>370–75<space/></arg><arg name="year"><space/>2004<space/></arg><arg name="pmid"><space/>15249274<space/></arg><arg name="doi"><space/>10.1097/00019442-200407000-00004</arg></template></extension><space/>Some pioneering psychologists, such as Americans<space/><link><target>William James</target></link><extension extension_name='ref' name="James"><template><target>cite book</target><arg name="author">James H (Ed.)<space/></arg><arg name="title">Letters of William James (Vols. 1 and 2)<space/></arg><arg name="publisher">Kessinger Publishing Co</arg><arg name="location">Montana USA<space/></arg><arg name="pages">147–48</arg><arg name="isbn">978-0-7661-7566-2<space/></arg><arg name="year">1920</arg></template></extension><extension extension_name='ref' name="HistoryJames"><template><target>Harvnb</target><arg>Hergenhahn</arg><arg>2005</arg><arg name="p">311</arg></template></extension><space/>and<space/><link><target>John B. Watson</target></link>,<extension extension_name='ref' name="Cohen"><template><target>cite book</target><arg name="author">Cohen D<space/></arg><arg name="title">J. B. Watson: The Founder of Behaviourism<space/></arg><arg name="publisher">Routledge & Kegan Paul<space/></arg><arg name="location">London, UK<space/></arg><arg name="year">1979<space/></arg><arg name="pages">7<space/></arg><arg name="isbn">0-7100-0054-5</arg></template></extension><space/>dealt with their own depression.</preline></preblock><paragraph>There has been a continuing discussion of whether neurological disorders and mood disorders may be linked to<space/><link><target>creativity</target></link>, a discussion that goes back to Aristotelian times.<extension extension_name='ref' name="pmid18689294"><template><target>cite journal</target><arg name="author"><space/>Andreasen NC<space/></arg><arg name="title"><space/>The relationship between creativity and mood disorders<space/></arg><arg name="journal"><space/>Dialogues in clinical neuroscience<space/></arg><arg name="volume"><space/>10<space/></arg><arg name="issue"><space/>2<space/></arg><arg name="pages"><space/>251–5<space/></arg><arg name="year"><space/>2008<space/></arg><arg name="pmid"><space/>18689294<space/></arg><arg name="pmc"><space/>3181877<space/></arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author">Simonton, DK<space/></arg><arg name="year">2005<space/></arg><arg name="title">Are genius and madness related? Contemporary answers to an ancient question<space/></arg><arg name="journal">Psychiatric Times<space/></arg><arg name="volume">22<space/></arg><arg name="issue">7<space/></arg><arg name="url">http://www.psychiatrictimes.com/display/article/10168/52456?pageNumber</arg></template></extension><space/>British literature gives many examples of reflections on depression.<extension extension_name='ref' name="Heffernan"><template><target>cite book</target><arg name="author">Heffernan CF<space/></arg><arg name="title">The melancholy muse: Chaucer, Shakespeare and early medicine<space/></arg><arg name="publisher">Duquesne University Press<space/></arg><arg name="location">Pittsburgh, PA, USA<space/></arg><arg name="year">1996<space/></arg><arg name="isbn">0-8207-0262-5</arg></template></extension><space/>English philosopher<space/><link><target>John Stuart Mill</target></link><space/>experienced a several-months-long period of what he called &quot;a dull state of nerves&quot;, when one is &quot;unsusceptible to enjoyment or pleasurable excitement; one of those moods when what is pleasure at other times, becomes insipid or indifferent&quot;. He quoted English poet<space/><link><target>Samuel Taylor Coleridge</target></link>'s &quot;Dejection&quot; as a perfect description of his case: &quot;A grief without a pang, void, dark and drear, / A drowsy, stifled, unimpassioned grief, / Which finds no natural outlet or relief / In word, or sigh, or tear.&quot;<extension extension_name='ref' name="Mill"><template><target>cite book</target><arg name="url">http://www.gutenberg.org/files/10378/10378-8.txt<space/></arg><arg name="title">Autobiography<space/></arg><arg name="author">[[John Stuart Mill|Mill JS]]<space/></arg><arg name="format">txt<space/></arg><arg name="publisher">Project Gutenberg EBook<space/></arg><arg name="pages">1826–32</arg><arg name="chapter"><space/>A crisis in my mental history: One stage onward<space/></arg><arg name="accessdate">9 August 2008<space/></arg><arg name="isbn">1-4212-4200-1</arg><arg name="year">2003</arg></template></extension><extension extension_name='ref'><template><target>cite journal</target><arg name="author">Sterba R<space/></arg><arg name="title">The 'Mental Crisis' of John Stuart Mill</arg><arg name="journal">Psychoanalytic Quarterly</arg><arg name="volume">16<space/></arg><arg name="issue">2<space/></arg><arg name="pages">271–72<space/></arg><arg name="year">1947</arg><arg name="url">http://www.pep-web.org/document.php?id</arg><arg name="accessdate">5 November 2008</arg></template></extension><space/>English writer<space/><link><target>Samuel Johnson</target></link><space/>used the term &quot;the black dog&quot; in the 1780s to describe his own depression,<extension extension_name='ref' name="McKinlay05"><template><target>cite web</target><arg name="url">http://www.blackdoginstitute.org.au/docs/McKinlay.pdf<space/></arg><arg name="title">Churchill’s Black Dog?: The History of the ‘Black Dog’ as a Metaphor for Depression<space/></arg><arg name="year">2005</arg><arg name="accessdate">18 August 2008<space/></arg><arg name="work">Black Dog Institute website<space/></arg><arg name="publisher">Black Dog Institute</arg><arg name="format">PDF</arg></template></extension><space/>and it was subsequently popularized by depression sufferer former British Prime Minister Sir<space/><link><target>Winston Churchill</target></link>.<extension extension_name='ref' name="McKinlay05"></extension></paragraph><paragraph>Social stigma of major depression is widespread, and contact with mental health services reduces this only slightly. Public opinions on treatment differ markedly to those of health professionals; alternative treatments are held to be more helpful than pharmacological ones, which are viewed poorly.<extension extension_name='ref'><template><target>cite book</target><arg name="title">Unmet Need in Psychiatry:Problems, Resources, Responses<space/></arg><arg name="editor">Andrews G, Henderson S ''(eds)''</arg><arg name="year">2000<space/></arg><arg name="publisher">Cambridge University Press<space/></arg><arg name="pages">409</arg><arg name="chapter"><space/>Public knowledge of and attitudes to mental disorders: a limiting factor in the optimal use of treatment services</arg><arg name="author">Jorm AF, Angermeyer M, Katschnig H</arg><arg name="isbn">0-521-66229-X</arg></template></extension><space/>In the UK, the<space/><link><target>Royal College of Psychiatrists</target></link><space/>and the<space/><link><target>Royal College of General Practitioners</target></link><space/>conducted a joint Five-year Defeat Depression campaign to educate and reduce stigma from 1992 to 1996;<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Paykel ES, Tylee A, Wright A, Priest RG, Rix S, Hart D<space/></arg><arg name="title"><space/>The Defeat Depression Campaign: psychiatry in the public arena<space/></arg><arg name="journal"><space/>American Journal of Psychiatry<space/></arg><arg name="volume"><space/>154<space/></arg><arg name="issue"><space/>6 Suppl<space/></arg><arg name="pages"><space/>59–65<space/></arg><arg name="year"><space/>1997<space/></arg><arg name="pmid"><space/>9167546</arg></template></extension><space/>a<space/><link><target>Ipsos MORI</target><part>MORI</part></link><space/>study conducted afterwards showed a small positive change in public attitudes to depression and treatment.<extension extension_name='ref'><template><target>cite journal</target><arg name="author"><space/>Paykel ES, Hart D, Priest RG<space/></arg><arg name="title"><space/>Changes in public attitudes to depression during the Defeat Depression Campaign<space/></arg><arg name="journal"><space/>British Journal of Psychiatry<space/></arg><arg name="volume"><space/>173<space/></arg><arg name="issue"><space/>6<space/></arg><arg name="pages"><space/>519–22<space/></arg><arg name="year"><space/>1998<space/></arg><arg name="pmid"><space/>9926082<space/></arg><arg name="doi"><space/>10.1192/bjp.173.6.519</arg></template></extension></paragraph><heading level='2'>Other animals</heading><paragraph><template><target>further2</target><arg>[[Animal psychopathology#Depression|Animal Psychopathology]]</arg></template></paragraph><heading level='2'>References</heading><paragraph><template><target>Reflist</target><arg>32em</arg><arg name="refs">
<ref name</arg></template></paragraph><heading level='3'>Cited works</heading><list type='bullet'><listitem><template><target>cite book</target><arg name="title">Diagnostic and statistical manual of mental disorders, Fourth Edition, Text Revision: DSM-IV-TR<space/></arg><arg name="publisher">American Psychiatric Publishing, Inc.<space/></arg><arg name="location">Washington, DC<space/></arg><arg name="year">2000a</arg><arg name="isbn">0-89042-025-4</arg><arg name="ref"><space/>CITEREFAmerican_Psychiatric_Association2000a<space/></arg><arg name="author">American Psychiatric Association</arg></template></listitem><listitem><template><target>cite book</target><arg name="author">Barlow DH<space/></arg><arg name="author2">Durand VM<space/></arg><arg name="title">Abnormal psychology: An integrative approach (5th ed.)<space/></arg><arg name="publisher">Thomson Wadsworth<space/></arg><arg name="location">Belmont, CA, USA<space/></arg><arg name="year">2005<space/></arg><arg name="isbn">0-534-63356-0</arg><arg name="ref"><space/>CITEREFBarlow2005</arg></template></listitem><listitem><template><target>cite book</target><arg name="author">Beck AT, Rush J, Shaw BF, Emery G</arg><arg name="title">Cognitive Therapy of depression<space/></arg><arg name="publisher">Guilford Press<space/></arg><arg name="location">New York, NY, USA<space/></arg><arg name="year">1987</arg><arg name="origyear">1979<space/></arg><arg name="isbn">0-89862-919-5</arg><arg name="ref"><space/>CITEREFBeck1987</arg></template></listitem><listitem><template><target>cite book</target><arg name="author">Hergenhahn BR</arg><arg name="title">An Introduction to the History of Psychology<space/></arg><arg name="edition">5th<space/></arg><arg name="publisher">Thomson Wadsworth<space/></arg><arg name="location">Belmont, CA, USA<space/></arg><arg name="year">2005</arg><arg name="isbn">0-534-55401-6</arg><arg name="ref"><space/>CITEREFHergenhahn2005</arg></template></listitem><listitem><template><target>cite book</target><arg name="author">May R<space/></arg><arg name="title">The discovery of being: Writings in existential psychology<space/></arg><arg name="publisher"><space/>W. W. Norton & Company<space/></arg><arg name="location">New York, NY, USA<space/></arg><arg name="year">1994</arg><arg name="isbn">0-393-31240-2</arg><arg name="ref"><space/>CITEREFMay1994</arg></template></listitem><listitem><template><target>cite book</target><arg name="author">Hadzi-Pavlovic, Dusan; Parker, Gordon<space/></arg><arg name="title">Melancholia: a disorder of movement and mood: a phenomenological and neurobiological review<space/></arg><arg name="publisher">Cambridge University Press<space/></arg><arg name="location">Cambridge, UK<space/></arg><arg name="year">1996<space/></arg><arg name="isbn">0-521-47275-X</arg><arg name="ref"><space/>CITEREFParker1996</arg></template></listitem><listitem><template><target>cite book</target><arg name="title"><space/>British National Formulary (BNF 56)<space/></arg><arg name="author"><space/>Royal Pharmaceutical Society of Great Britain</arg><arg name="year">2008<space/></arg><arg name="publisher">BMJ Group and RPS Publishing<space/></arg><arg name="location"><space/>UK</arg><arg name="isbn">978-0-85369-778-7<space/></arg><arg name="url">http://www.bnf.org/bnf/<space/></arg><arg name="ref">CITEREFRoyal_Pharmaceutical_Society_of_Great_Britain2008</arg></template></listitem><listitem><template><target>cite book</target><arg name="author">Sadock, Virginia A.; Sadock, Benjamin J.; Kaplan, Harold I.<space/></arg><arg name="title">Kaplan & Sadock's synopsis of psychiatry: behavioral sciences/clinical psychiatry<space/></arg><arg name="publisher">Lippincott Williams & Wilkins<space/></arg><arg name="location">Philadelphia<space/></arg><arg name="year">2003<space/></arg><arg name="isbn"><space/>0-7817-3183-6</arg><arg name="ref"><space/>CITEREFSadock2002</arg></template></listitem></list><heading level='2'>External links</heading><list type='bullet'><listitem><template><target>dmoz</target><arg>Health/Mental_Health/Disorders/Mood/Depression</arg><arg>Depression</arg></template></listitem></list><paragraph><template><target>Spoken Wikipedia</target><arg>Mdd2 003.ogg</arg><arg>2014-10-06</arg></template><template><target>Mental and behavioural disorders</target><arg name="selected"><space/>mood</arg></template><template><target>Mood disorders</target></template><template><target>Featured article</target></template></paragraph><paragraph><template><target>Authority control</target></template></paragraph><paragraph><template><target>DEFAULTSORT:Major Depressive Disorder</target></template><link><target>Category:Abnormal psychology</target></link><link><target>Category:Bipolar spectrum</target></link><link><target>Category:History of medicine</target></link><link><target>Category:Mood disorders</target></link><link><target>Category:Depression (psychology)</target></link><link><target>Category:Psychiatric diagnosis</target></link></paragraph></article>